<SEC-DOCUMENT>0001493152-24-005268.txt : 20240207
<SEC-HEADER>0001493152-24-005268.hdr.sgml : 20240207
<ACCEPTANCE-DATETIME>20240207170601
ACCESSION NUMBER:		0001493152-24-005268
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20240201
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240207
DATE AS OF CHANGE:		20240207

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			STREAMLINE HEALTH SOLUTIONS INC.
		CENTRAL INDEX KEY:			0001008586
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		ORGANIZATION NAME:           	06 Technology
		IRS NUMBER:				311455414
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0131

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-28132
		FILM NUMBER:		24605139

	BUSINESS ADDRESS:	
		STREET 1:		2400 OLD MILTON PARKWAY
		STREET 2:		BOX 1353
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30009
		BUSINESS PHONE:		888-997-8732

	MAIL ADDRESS:	
		STREET 1:		2400 OLD MILTON PARKWAY
		STREET 2:		BOX 1353
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30009

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STREEAMLINE HEALTH SOLUTIONS INC.
		DATE OF NAME CHANGE:	20060809

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LANVISION SYSTEMS INC
		DATE OF NAME CHANGE:	19960220
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:STRM="http://streamlinehealth.net/20240201">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_035_STRM_streamlinehealth.net_20240201 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20240201_20240201 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05D_edei%2D%2DEntityCentralIndexKey_0001008586 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:AmendmentFlag" id="ixv-598">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityCentralIndexKey" id="ixv-599">0001008586</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-02-01" id="xdx2ixbrl0012" name="dei:EntityIncorporationStateCountryCode">DE</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="strm-20240201.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-02-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001008586</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-02-01</xbrli:startDate>
        <xbrli:endDate>2024-02-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1.5pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_902_edei--DocumentType_c20240201__20240201_zaQGvGfcJqg6"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:DocumentType" id="ixv-620">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pursuant
to Section 13 or 15(d) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
the Securities Exchange Act of 1934 </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_90D_edei--DocumentPeriodEndDate_c20240201__20240201_zGFBEUFQYa53"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="ixv-621">February
1, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_90F_edei--EntityRegistrantName_c20240201__20240201_zVUmvmkq1wa7" style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityRegistrantName" id="ixv-622">Streamline
Health Solutions, Inc.</ix:nonNumeric></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span id="xdx_90B_edei--EntityIncorporationStateCountryCode_dxL_c20240201__20240201_zkMEgXItvYIa" title="::XDX::DE" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0012">Delaware</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span id="xdx_906_edei--EntityFileNumber_c20240201__20240201_z08On4SlLWQe" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityFileNumber" id="ixv-623">0-28132</ix:nonNumeric></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center; width: 32%"><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20240201__20240201_zEkxsV5WWUBc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityTaxIdentificationNumber" id="ixv-624">31-1455414</ix:nonNumeric></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
                                            or other jurisdiction of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation
    or organization)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>File
    Number)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
                                            Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: center"><span id="xdx_90F_edei--EntityAddressAddressLine1_c20240201__20240201_zkr1RPmTDtH9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityAddressAddressLine1" id="ixv-625">2400
    Old Milton Pkwy.</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_900_edei--EntityAddressAddressLine2_c20240201__20240201_z5sxkIgf64T1"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityAddressAddressLine2" id="ixv-626">Box
    1353</ix:nonNumeric></span></span></b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, <span id="xdx_905_edei--EntityAddressCityOrTown_c20240201__20240201_zVMP9WLNQW9a"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityAddressCityOrTown" id="ixv-627">Alpharetta</ix:nonNumeric></span></span></b><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
    <span id="xdx_90C_edei--EntityAddressStateOrProvince_c20240201__20240201_zifz5nSKdSJ3"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityAddressStateOrProvince" id="ixv-628">GA</ix:nonNumeric></span></span></b></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: center"><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20240201__20240201_zc2dfJQuTVJk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:EntityAddressPostalZipCode" id="ixv-629">30009</ix:nonNumeric></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
    of principal executive offices)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
    Code)</b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: <span id="xdx_902_edei--CityAreaCode_c20240201__20240201_zKVgjn2Si8Bj"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:CityAreaCode" id="ixv-630">(888)</ix:nonNumeric></span></b></span><b>
<span id="xdx_901_edei--LocalPhoneNumber_c20240201__20240201_zaP2AqiSMzF2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:LocalPhoneNumber" id="ixv-631">997-8732</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report) </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90E_edei--WrittenCommunications_c20240201__20240201_zM4u9z9zyA4l" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:booleanfalse" name="dei:WrittenCommunications" id="ixv-632">&#9744;</ix:nonNumeric></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written
    communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90D_edei--SolicitingMaterial_c20240201__20240201_zZP3VKZ4HYt9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:booleanfalse" name="dei:SolicitingMaterial" id="ixv-633">&#9744;</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_908_edei--PreCommencementTenderOffer_c20240201__20240201_zuXzYQbdiUGb" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer" id="ixv-634">&#9744;</ix:nonNumeric></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_909_edei--PreCommencementIssuerTenderOffer_c20240201__20240201_zSQe7WOUc2I2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer" id="ixv-635">&#9744;</ix:nonNumeric></span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center; width: 38%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Symbol(s)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 40%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
                                            of each exchange</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>on
    which registered</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span id="xdx_908_edei--Security12bTitle_c20240201__20240201_zNvQGsouFKJ8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:Security12bTitle" id="ixv-636">Common
    Stock, $0.01 par value</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span id="xdx_908_edei--TradingSymbol_c20240201__20240201_zFn7EPMdUxog" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" name="dei:TradingSymbol" id="ixv-637">STRM</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span id="xdx_901_edei--SecurityExchangeName_c20240201__20240201_zj7qc6EgL8w6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="ixv-638">Nasdaq</ix:nonNumeric>
    </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capital Market</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_906_edei--EntityEmergingGrowthCompany_c20240201__20240201_zR3fF8GoapDf"><ix:nonNumeric contextRef="AsOf2024-02-01" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany" id="ixv-639">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; border-bottom: Black 4pt solid; font: 1pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
1.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Entry
                                            into a Material Definitive Agreement</b><b>.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Private
Placement of Notes and Warrants</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 1, 2024, Streamline Health Solutions, Inc. (the &#8220;Company&#8221;) entered into a securities purchase agreement (the &#8220;Securities
Purchase Agreement&#8221;) with certain accredited investors, including certain directors and officers of the Company (collectively,
the &#8220;Investors&#8221;), pursuant to which the Company agreed to sell to the Investors unsecured subordinated promissory notes (the
&#8220;Notes&#8221;) in the aggregate principal amount of $4.4 million and warrants (the &#8220;Warrants&#8221;) to purchase up to an
aggregate of 4,052,631 shares of the Company&#8217;s common stock, par value $0.01 per share (the &#8220;Common Stock&#8221;) in a private
placement (the &#8220;Debt Private Placement&#8221;). The closing of the Debt Private Placement occurred on February 7, 2024 (the &#8220;Closing
Date&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with the Debt Private Placement, the Investors and each of the Company&#8217;s directors and officers agreed, subject to certain
exceptions set forth in the lock-up agreements, not to offer, sell, contract to sell, pledge, grant any option to purchase, make any
short sale or otherwise dispose of any shares of Common Stock, or any options or warrants to purchase any shares of Common Stock, or
any securities convertible into, exchangeable for or that represent the right to receive shares of Common Stock, for a period commencing
on the date of the lock-up agreement and ending 90 days from the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Notes</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes bear interest at a rate of 15% per annum and mature on August 7, 2026 (the &#8220;Maturity Date&#8221;). All accrued and unpaid
interest on the Notes will be capitalized and added to the outstanding principal balance of the Notes and will be payable in cash on
the Maturity Date. The Company may redeem the Notes, in whole or in part, prior to the Maturity Date without any premium or penalty.
In the event the Company prepays any portion of the then outstanding principal balance of the Notes on or before the twelve (12) month
anniversary of the Closing Date, in addition to such prepayment of the principal balance, the Company must pay to the Investors a prepayment
fee (in accordance with the each Investor&#8217;s pro-rata share of the Notes) in an amount equal to the amount of interest that would
have accrued but for the prepayment from the date of such prepayment through such twelve (12) month anniversary of the Closing Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
rights of each Investor to receive payments under the Notes are subordinate to the rights of Western Alliance Bank (&#8220;WAB&#8221;),
pursuant to a subordination agreement which the Investors entered into with WAB concurrently with the Debt Private Placement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants have an exercise price of $0.38, are immediately exercisable, and will expire on the fourth anniversary of the Closing Date.
The Warrants are subject to customary adjustments for certain transactions affecting the Company&#8217;s capitalization. The terms of
the Warrants preclude a holder thereof from exercising such holder&#8217;s Warrants, and the Company from giving effect to such exercise,
if after giving effect to the issuance of Common Stock upon such exercise, the holder (together with the holder&#8217;s affiliates and
any other persons acting as a group together with the holder or any of the holder&#8217;s affiliates) would beneficially own in excess
of 9.99% of the number of shares of Common Stock outstanding immediately after giving effect to the issuance of Common Stock upon such
exercise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes and the Warrants described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended
(the &#8220;Securities Act&#8221;), and/or Regulation D promulgated thereunder and, along with the Common Stock underlying the Warrants,
have not been registered under the Securities Act or applicable state securities laws. Accordingly, the Notes, the Warrants and the Common
Stock underlying the Warrants may not be offered or sold in the United States absent registration with the SEC or an applicable exemption
from such registration requirements and in accordance with applicable state securities laws. The securities were offered and sold to
&#8220;accredited investors&#8221; as that term is defined in Rule 501(a) under the Securities Act.<br/>
<br/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Sale
of Common Stock</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 6, 2024, the Company completed the sale of 263,158 shares of Common Stock to an accredited investor at a purchase price of $0.38
per share for an aggregate purchase price of $100,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Common Stock described above was offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the
&#8220;Securities Act&#8221;), and/or Regulation D promulgated thereunder and has not been registered under the Securities Act or applicable
state securities laws. Accordingly, the Common Stock may not be offered or sold in the United States absent registration with the SEC
or an applicable exemption from such registration requirements and in accordance with applicable state securities laws. The Common Stock
was offered and sold to an &#8220;accredited investor&#8221; as that term is defined in Rule 501(a) under the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing descriptions of the Debt Private Placement, the Securities Purchase Agreement, the Notes and the Warrants are not complete
and are qualified in their entirety by the full text of such documents, copies of which are filed as exhibits to this Current Report
on Form 8-K and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 2.03 of this Current Report on Form 8-K is incorporated by reference into this Item 1.01.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
2.03.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Creation
                                            of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
                                            of a Registrant.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2024, the Company and certain of its subsidiaries entered into a Third Modification and Waiver (the &#8220;Third Modification&#8221;)
to Second Amended and Restated Loan and Security Agreement (the &#8220;Loan and Security Agreement&#8221;) with WAB. The Third Modification
amended certain financial covenants in the Loan and Security Agreement, including updating the maximum debt-to-EBITDA ratio thresholds
and removing the minimum cash and maximum debt-to-annualized recurring revenue requirements. The Third Modification also requires the
Company to achieve certain modified quarterly adjusted EBITDA levels. The Loan and Security Agreement also includes negative covenants,
subject to exceptions, which limit transfers, capital expenditures, indebtedness, certain liens, investments, acquisitions, dispositions
of assets, restricted payments and the business activities of the Company, as well as customary representations and warranties, affirmative
covenants and events of default, including cross defaults and a change of control default.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the terms of the Third Modification does not purport to be complete and is qualified in its entirety by reference
to the full text of the Third Modification, which is attached hereto as Exhibit 10.5 and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
3.02</b></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unregistered
                                            Sales of Equity Securities.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference into this Item 3.02.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
5.02.</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Departure
                                            of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;
                                            Compensatory Arrangements of Certain Officers.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 5, 2024, the board of directors (the &#8220;Board&#8221;) of the Company increased the size of the Board to seven members and
appointed Benjamin L. Stilwill and Matthew Etheridge to serve as directors of the Company, effective as of the closing of the Debt Private
Placement on February 7, 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Matthew
W. Etheridge, age 51, is a private investor with over 20 years of investment management experience, with a primary focus on healthcare
services and information technology. Previously, Mr. Etheridge was a Managing Partner of Perry Capital LLC, a private investment management
firm, where he was Co-Portfolio Manager of the firm&#8217;s healthcare group, which managed public and private investments in healthcare
and other industries. Prior to joining Perry Capital in 2001, Mr. Etheridge was an investment analyst for Stanford Management Company,
the investment manager of Stanford University&#8217;s endowment. Prior to joining Stanford Management in 1997, Mr. Etheridge was a consultant
with McKinsey &amp; Company. Mr. Etheridge received his J.D. from Stanford Law School and his A.B. in Economics from Stanford University.
Mr. Etheridge currently serves on the boards of Lightbeam Health Solutions, Conversio Health, and Healthmine. He previously served on
the boards of Universal American Corp (NYSE: UAM), naviHealth, and S.A.C. Re.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Stilwill&#8217;s biography is set forth in the Company&#8217;s definitive proxy statement on Schedule 14A, filed with the Securities
and Exchange Commission on May 11, 2023.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with his appointment, the Board approved a grant of restricted common stock and cash to Mr. Etheridge in an aggregate amount
of $167,000. Mr. Stilwill and Mr. Etheridge will also be entitled to reimbursement of their expenses incurred in connection with the
performance of their services as directors.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Neither
Mr. Stilwill nor Mr. Etheridge have any family relationship with any director or executive officer of the Company, nor any direct or
indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
7.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Regulation
                                            FD Disclosure.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 7, 2024, the Company issued a press release announcing the closing of the Debt Private Placement and the Common Stock Private
Placement, the Third Modification and the appointment of Mr. Stilwill and Mr. Etheridge. The full text of the press release is attached
as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item
9.01</b></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Financial
                                            Statements and Exhibits.</b></span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Below
is a list of exhibits included with this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit<br/>
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 88%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Document</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="ex4-1.htm"><span style="font-size: 10pt">Form
    of Warrant</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="ex10-1.htm"><span style="font-size: 10pt">Form
    of Securities Purchase Agreement, by and among Streamline Health Solutions, Inc. and each purchaser identified on the signature pages
    thereto</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="ex10-2.htm"><span style="font-size: 10pt">Form
    of Promissory Note</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif"><a href="ex10-3.htm"><span style="font-size: 10pt">Third
    Modification to Second Amended and Restated Loan and Security Agreement, dated February 7, 2024, by and between Streamline Health
    Solutions, Inc. and certain of its subsidiaries party thereto, and Western Alliance Bank</span></a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex99-1.htm">Press release, dated February 7, 2024</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE
</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Streamline
    Health</b></span><b> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solutions,
    Inc.</span></b></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Wyche T. &#8220;Tee&#8221; Green, III</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wyche
    T. &#8220;Tee&#8221; Green, III</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Executive
    Chairman</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
February 7, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 5; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>









<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>ex4-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THESE
SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>THIS
WARRANT IS ONE OF THE WARRANTS TO PURCHASE COMMON STOCK ISSUED PURSUANT TO THAT CERTAIN SECURITIES PURCHASE AGREEMENT, DATED AS OF FEBRUARY
1, 2024 (THE &ldquo;SECURITIES PURCHASE AGREEMENT&rdquo;), BY AND AMONG THE COMPANY AND THE INVESTORS REFERRED TO THEREIN. ANY HOLDER
OF THIS WARRANT TAKES SUCH WARRANT SUBJECT TO THE TERMS AND CONDITIONS OF SUCH SECURITIES PURCHASE AGREEMENT AND, BY ITS ACCEPTANCE HEREOF,
AGREES TO ABIDE BY THE TERMS AND CONDITIONS THEREOF NOTWITHSTANDING ANYTHING TO THE CONTRARY SET FORTH HEREIN.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>STREAMLINE
HEALTH SOLUTIONS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-variant: small-caps"><B>Warrant
To Purchase Common Stock</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
No.: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
of Shares of Common Stock: [&#9679;]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date
of Issuance: February [&#9679;], 2024 (&ldquo;<B>Issuance Date</B>&rdquo;)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health Solutions, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), hereby certifies that, for good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged<FONT STYLE="text-transform: uppercase">, [Investor]</FONT>, the registered
holder hereof or its permitted assigns (the &ldquo;<B>Holder</B>&rdquo;), is entitled, subject to the terms set forth below, to purchase
from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the Issuance Date, but not
after 11:59 p.m., New York time, on the Expiration Date, (as defined below), [&#9679;] ([&#9679;]) fully paid nonassessable shares of
Common Stock, subject to adjustment as provided herein (the &ldquo;<B>Warrant Shares</B>&rdquo;). Except as otherwise defined herein,
capitalized terms in this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer
or replacement hereof, this &ldquo;<B>Warrant</B>&rdquo;), shall have the meanings set forth in <U>Section 16</U>. This Warrant is one
of the Warrants to purchase Common Stock (the &ldquo;<B>2024 Warrants</B>&rdquo;) issued pursuant to <U>Section 2.2(a)(iii)</U> of that
certain Securities Purchase Agreement, dated as of February 1, 2024 (the &ldquo;<B>Subscription Date</B>&rdquo;), by and among the Company
and the investors (the &ldquo;<B>Purchasers</B>&rdquo;) referred to therein (the &ldquo;<B>Securities Purchase Agreement</B>&rdquo;).
Capitalized terms used herein and not otherwise defined shall have the definitions ascribed to such terms in the Securities Purchase
Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.&nbsp;<U>EXERCISE
OF WARRANT.</U></FONT></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Mechanics of Exercise</U>. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in
Section 1(e)), this Warrant may be exercised by the Holder at any time or times on or after the Issuance Date, in whole or in part, by
(i) delivery to the Company of a duly executed written notice, in the form attached hereto as <U>Exhibit A</U> (the &ldquo;<B>Exercise
Notice</B>&rdquo;), of the Holder&rsquo;s election to exercise this Warrant and (ii) (A) payment to the Company of an amount equal to
the applicable Exercise Price multiplied by the number of Warrant Shares as to which this Warrant is being exercised (the &ldquo;<B>Aggregate
Exercise Price</B>&rdquo;) in cash by wire transfer of immediately available funds to an account designated in writing by the Company
or (B) by notifying the Company in writing that this Warrant is being exercised pursuant to a Cashless Exercise (as defined in <U>Section
1(d)</U>). No ink-original Exercise Notice shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization)
of any Exercise Notice be required, provided that the Company shall have no liability to the Holder for honoring a non-medallion guaranteed
Exercise Notice that the Company reasonably believes to be genuine. The registered Holder shall not be required to deliver the original
Warrant in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than all of the
Warrant Shares shall have the same effect as cancellation of the original Warrant and issuance of a new Warrant evidencing the right
to purchase the remaining number of Warrant Shares. On or before the first (1<SUP>st</SUP>) Trading Day following the Trading Day on
which the Holder has delivered an Exercise Notice and the Aggregate Exercise Price (or notice of a Cashless Exercise) to the Company
(for purposes of this Warrant, if an Exercise Notice is delivered to the Company on a day that is not a Trading Day, such Exercise Notice
shall be deemed to have been delivered on the first Trading Day following the day of actual delivery), the Company shall transmit by
electronic mail an acknowledgment of confirmation of receipt of the Exercise Notice to the Holder. On or before the earlier of (i) the
second (2<SUP>nd</SUP>) Trading Day and (ii) the number of Trading Days comprising the Standard Settlement Period, in each case, following
the date on which the Holder has delivered the Exercise Notice and the Aggregate Exercise Price to the Company (or notice of a Cashless
Exercise to the Company) (a &ldquo;<B>Share Delivery Date</B>&rdquo;), the Company shall (X) provided that the Company&rsquo;s transfer
agent (the &ldquo;<B>Transfer Agent</B>&rdquo;) is participating in The Depository Trust Company (&ldquo;<B>DTC</B>&rdquo;) Fast Automated
Securities Transfer Program <FONT STYLE="background-color: white">and (A) the Warrant Shares are subject to an effective resale registration
statement in favor of the Holder and the Holder has delivered to the Company a representation that such Warrant Shares have been sold
pursuant to such registration statement or (B) if exercised via Cashless Exercise, at a time when Rule 144 would be available for immediate
resale of the Warrant Shares by the Holder, and the Holder has delivered to the Company a representation that such Warrant Shares have
been sold pursuant to Rule 144</FONT>, cause the aggregate number of Warrant Shares to which the Holder is entitled pursuant to such
exercise to be transmitted by Transfer Agent to the Holder by crediting the Holder&rsquo;s or its designee&rsquo;s balance account with
DTC through its Deposit / Withdrawal At Custodian system, or (Y) if (A) the Transfer Agent is not participating in the DTC Fast Automated
Securities Transfer Program <FONT STYLE="background-color: white">or (B) the Warrant Shares are not subject to an effective resale registration
statement in favor of the Holder or the Holder has not delivered to the Company a representation that such Warrant Shares have been sold
pursuant to such registration statement and, if exercised via Cashless Exercise, at a time when Rule 144 would not be available for immediate
resale of the Warrant Shares by the Holder or the Holder has not delivered to the Company a representation that such Warrant Shares have
been sold pursuant to such registration statement</FONT>, cause the Transfer Agent to (i) issue and dispatch by overnight courier to
the address as specified in the Exercise Notice, a certificate, registered in the Company&rsquo;s share register in the name of the Holder
or its designee and bearing such restrictive legends as the Company deems necessary, for the number of Warrant Shares to which the Holder
is entitled pursuant to such exercise, or (ii) issue and dispatch by electronic mail to the address as specified in the Exercise Notice,
evidence of book entry, registered in the Company&rsquo;s share register in the name of the Holder or its designee and bearing such restrictive
legends as the Company deems necessary, for the number of Warrant Shares to which the Holder is entitled pursuant to such exercise. The
Company shall be responsible for all fees and expenses of the Company and the Transfer Agent and all fees and expenses with respect to
the issuance of Warrant Shares via DTC, if any, including without limitation for same day processing. Upon delivery of the Exercise Notice
and the Aggregate Exercise Price (or notice of a Cashless Exercise), the Holder shall be deemed for all corporate purposes to have become
the holder of record of the Warrant Shares with respect to which this Warrant has been exercised, irrespective of the date such Warrant
Shares are credited to the Holder&rsquo;s DTC account or the date of delivery of the certificates or book entry evidence evidencing such
Warrant Shares, as the case may be. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the
number of Warrant Shares represented by this Warrant submitted for exercise is greater than the number of Warrant Shares being acquired
upon an exercise, then the Company shall as soon as practicable and in no event later than five (5) Trading Days after any exercise and
at its own expense, issue a new Warrant (in accordance with Section 6(d)) representing the right to purchase the number of Warrant Shares
issuable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant
is exercised. No fractional Warrant Shares are to be issued upon the exercise of this Warrant, but rather the number of Warrant Shares
to be issued shall be rounded to the nearest whole number. The Company shall pay any and all taxes which may be payable with respect
to the issuance and delivery of Warrant Shares upon exercise of this Warrant. If the materials discussed in this Section 1(a) are received
or deemed to be received after the Expiration Date, the Exercise Notice (or notice of a Cashless Exercise) will be null and void and
any funds delivered to the Company will be returned to the Holder, as soon as practicable. In no event will interest accrue on any funds
deposited with the Company in respect of an exercise or attempted exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Exercise Price</U>. For purposes of this Warrant, &ldquo;<B>Exercise Price</B>&rdquo; means $0.38, subject to adjustment as provided
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Company&rsquo;s Failure to Timely Deliver Securities</U>. If either (i) the Company shall fail for any reason or for no reason to
issue to the Holder on or prior to the applicable Share Delivery Date, if (A) the Transfer Agent is not participating in the DTC Fast
Automated Securities Transfer Program, a certificate or book entry for the number of shares of Common Stock to which the Holder is entitled
and register such Common Stock on the Company&rsquo;s share register or (B) if the Transfer Agent is participating in the DTC Fast Automated
Securities Transfer Program, to credit the Holder&rsquo;s balance account with DTC, for such number of shares of Common Stock to which
the Holder is entitled upon the Holder&rsquo;s exercise of this Warrant, (ii) the Company shall not within thirty (30) days after the
Issuance Date file with the SEC a registration statement for the resale by the Holder or any transferee therefrom of the Warrant Shares
(the &ldquo;<B>Registration Statement</B>&rdquo;), or (iii) a registration statement (which may be the Registration Statement) covering
the issuance or resale of the Warrant Shares is not available for the issuance or resale, as applicable, of such Warrant Shares during
a time when a registration statement is required to be available pursuant to the Securities Purchase Agreement and (A) the Company fails
to promptly, but in no event later than one (1) Business Day after such registration statement becomes unavailable, to so notify the
Holder and (B) the Company is unable to deliver the Warrant Shares electronically without any restrictive legend by crediting such aggregate
number of Warrant Shares to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian
system (the event described in the immediately foregoing clause (iii) is hereinafter referred as a &ldquo;<B>Notice Failure</B>&rdquo;
and together with the events described in clauses (i) and (ii) above, an &ldquo;<B>Exercise Failure</B>&rdquo;), then, in addition to
all other remedies available to the Holder, if on or prior to the applicable Share Delivery Date either (i) if the Transfer Agent is
not participating in the DTC Fast Automated Securities Transfer Program, the Company shall fail to issue and deliver a certificate or
book entry to the Holder and register such shares of Common Stock on the Company&rsquo;s share register or, if the Transfer Agent is
participating in the DTC Fast Automated Securities Transfer Program, credit the Holder&rsquo;s balance account with DTC for the number
of shares of Common Stock to which the Holder is entitled upon the Holder&rsquo;s exercise hereunder or pursuant to the Company&rsquo;s
obligation pursuant to clause (II) below or (ii) a Notice Failure occurs, and if on or after such Trading Day the Holder purchases (in
an open market transaction or otherwise) Common Stock to deliver in satisfaction of a sale by the Holder of shares of Common Stock issuable
upon such exercise that the Holder anticipated receiving from the Company (a &ldquo;<B>Buy-In</B>&rdquo;), then the Company shall, within
three (3) Trading Days after the Holder&rsquo;s request and in the Holder&rsquo;s discretion, either (I) pay cash to the Holder in an
amount equal to the Holder&rsquo;s total purchase price (including brokerage commissions and other out-of-pocket expenses, if any) for
the shares of Common Stock so purchased (the &ldquo;<B>Buy-In Price</B>&rdquo;), at which point the Company&rsquo;s obligation to deliver
such certificate (and to issue such shares of Common Stock) or credit such Holder&rsquo;s balance account with DTC for such shares of
Common Stock shall terminate, or (II) promptly honor its obligation to deliver to the Holder a certificate or certificates or book entry
or entries representing such shares of Common Stock or credit such Holder&rsquo;s balance account with DTC, as applicable, and pay cash
to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (x) such number of shares of Common Stock,
times (y) any trading price of the Common Stock selected by the Holder in writing as in effect at any time during the period beginning
on the date of the applicable Exercise Notice and ending on the applicable Share Delivery Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Nothing
shall limit the Holder&rsquo;s right to pursue any other remedies available to it hereunder, at law or in equity, including, without
limitation, a decree of specific performance and/or injunctive relief with respect to the Company&rsquo;s failure to timely deliver certificates
representing Warrant Shares (or to electronically deliver such Warrant Shares) upon the exercise of this Warrant as required pursuant
to the terms hereof. While this Warrant is outstanding, the Company shall cause the Transfer Agent to participate in the DTC Fast Automated
Securities Transfer Program. In addition to the foregoing rights, (i) if the Company fails to deliver the applicable number of Warrant
Shares upon an exercise pursuant to Section 1(a) by the applicable Share Delivery Date, then the Holder shall have the right to rescind
such exercise in whole or in part and retain and/or have the Company return, as the case may be, any portion of this Warrant that has
not been exercised pursuant to such Exercise Notice; provided that the rescission of an exercise shall not affect the Company&rsquo;s
obligation to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise, and (ii)
if a registration statement (which may be the Registration Statement) covering the issuance or resale of the Warrant Shares that are
subject to an Exercise Notice is not available for the issuance or resale, as applicable, of such Warrant Shares during a time when a
registration statement is required to be available pursuant to the Securities Purchase Agreement and the Holder has submitted an Exercise
Notice prior to receiving notice of the non-availability of such registration statement and the Company has not already delivered the
Warrant Shares underlying such Exercise Notice electronically without any restrictive legend by crediting such aggregate number of Warrant
Shares to which the Holder is entitled pursuant to such exercise to the Holder&rsquo;s or its designee&rsquo;s balance account with DTC
through its Deposit / Withdrawal At Custodian system, the Holder shall have the option, by delivery of notice to the Company, to rescind
such Exercise Notice in whole or in part and retain or have returned, as the case may be, any portion of this Warrant that has not been
exercised pursuant to such Exercise Notice; provided that the rescission of an Exercise Notice shall not affect the Company&rsquo;s obligation
to make any payments that have accrued prior to the date of such notice pursuant to this Section 1(c) or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Cashless Exercise</U>. Notwithstanding anything contained herein to the contrary, the Holder may, in its sole discretion, exercise
this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon such exercise
in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the &ldquo;<B>Net Number</B>&rdquo; of shares
of Common Stock determined according to the following formula (a &ldquo;<B>Cashless Exercise</B>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net
Number = <U>(A x B) &ndash; (A x C)</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.7in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the foregoing formula:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
  <TD STYLE="text-align: justify; width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the total number of shares with respect to which this Warrant
is then being exercised.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">as applicable: (i) the Weighted Average Price of the Common
Stock on the Trading Day immediately preceding the date of the applicable Exercise Notice if such Exercise Notice is (1) both executed
and delivered pursuant to Section 1(a) hereof on a day that is not a Trading Day or (2) both executed and delivered pursuant to Section
1(a) hereof on a Trading Day prior to the opening of &ldquo;regular trading hours&rdquo; (as defined in Rule 600(b)(68) of Regulation
NMS promulgated under the federal securities laws) on such Trading Day, (ii) at the option of the Holder indicated in the Exercise Notice,
either (x) the Weighted Average Price of the Common Stock on the Trading Day immediately preceding the date of the applicable Exercise
Notice, or (y) the Weighted Average Price of the Common Stock on the Trading Day of the applicable Exercise Notice if such Exercise Notice
is executed and delivered during &ldquo;regular trading hours&rdquo; on a Trading Day pursuant to <U>Section 1(a)</U> hereof, or (iii)
the Weighted Average Price of the Common Stock on the date of the applicable Exercise Notice if the date of such Exercise Notice is a
Trading Day and such Exercise Notice is both executed and delivered pursuant to <U>Section 1(a)</U> hereof after the close of &ldquo;regular
trading hours&rdquo; on such Trading Day.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD>
  <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C=</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the Exercise Price then in effect for the applicable Warrant
Shares at the time of such exercise.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: justify; text-indent: -0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Disputes</U>. In the case of a dispute as to the determination of the Exercise Price, the Black Scholes Value (as defined below) or
the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of Warrant Shares that are
not disputed and resolve such dispute in accordance with <U>Section 13</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Beneficial Ownership Limitations on Exercises</U>. Notwithstanding anything to the contrary contained herein, the Company shall not
effect the exercise of any portion of this Warrant, and the Holder shall not have the right to exercise any portion of this Warrant,
and any such exercise shall be null and void and treated as if never made, to the extent that as a result of, and after giving effect
to, such exercise, the Holder together with the other Attribution Parties collectively would beneficially own in excess of 9.99% (the
&ldquo;<B>Maximum Percentage</B>&rdquo;) of the number of shares of Common Stock outstanding immediately after giving effect to such
exercise. For purposes of this <U>Section 1(e)</U>, beneficial ownership shall be calculated in accordance with Section 13(d) of the
1934 Act). For purposes of determining the number of outstanding shares of Common Stock the Holder may acquire upon the exercise of this
Warrant without exceeding the Maximum Percentage, the Holder may rely on the number of outstanding shares of Common Stock as reflected
in (x) the Company&rsquo;s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other
public filing with the Securities and Exchange Commission (the &ldquo;<B>SEC</B>&rdquo;), as the case may be, (y) a more recent public
announcement by the Company or (z) any other written notice by the Company or the Transfer Agent setting forth the number of shares of
Common Stock outstanding (the &ldquo;<B>Reported Outstanding Share Number</B>&rdquo;). If the Company receives an Exercise Notice from
the Holder at a time when the actual number of outstanding shares of Common Stock is less than the Reported Outstanding Share Number,
the Company shall (i) notify the Holder in writing of the number of shares of Common Stock then outstanding and, to the extent that such
Exercise Notice would otherwise cause the Holder&rsquo;s beneficial ownership, as determined pursuant to this <U>Section 1(e)</U>, to
exceed the Maximum Percentage, the Holder must notify the Company of a reduced number of Warrant Shares to be purchased pursuant to such
Exercise Notice (the number of shares by which such purchase is reduced, the &ldquo;<B>Reduction Shares</B>&rdquo;) and (ii) as soon
as reasonably practicable, the Company shall return to the Holder any Exercise Price paid by the Holder for the Reduction Shares. For
any reason at any time, upon the written or oral request of the Holder, the Company shall within one (1) Trading Day confirm orally and
in writing or by electronic mail to the Holder the number of shares of Common Stock then outstanding. The number of outstanding shares
of Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company, including this Warrant,
by the Holder and any other Attribution Party since the date as of which the Reported Outstanding Share Number was reported. In the event
that the issuance of shares of Common Stock to the Holder upon exercise of this Warrant results in the Holder and the other Attribution
Parties being deemed to beneficially own, in the aggregate, more than the Maximum Percentage of the number of outstanding shares of Common
Stock (as determined under Section 13(d) of the 1934 Act), the number of shares so issued by which the Holder&rsquo;s and the other Attribution
Parties&rsquo; aggregate beneficial ownership exceeds the Maximum Percentage (the &ldquo;<B>Excess Shares</B>&rdquo;) shall be deemed
null and void and shall be cancelled ab initio, and the Holder shall not have the power to vote or to transfer the Excess Shares. As
soon as reasonably practicable after the issuance of the Excess Shares has been deemed null and void, the Company shall return to the
Holder the Exercise Price paid by the Holder for the Excess Shares. Upon delivery of a written notice to the Company, the Holder may
from time to time increase or decrease the Maximum Percentage to any other percentage as specified in such notice; provided that (i)
any such increase in the Maximum Percentage will not be effective until the sixty-first (61<SUP>st</SUP>) day after such notice is delivered
to the Company and (ii) any such increase or decrease will apply only to the Holder and the other Attribution Parties and not to any
other holder of 2024 Warrants that is not an Attribution Party of the Holder. For purposes of clarity, the shares of Common Stock issuable
pursuant to the terms of this Warrant in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Holder
for any purpose including for purposes of Section 13(d) or Rule 16a-1(a)(1) of the 1934 Act. No prior inability to exercise this Warrant
pursuant to this paragraph shall have any effect on the applicability of the provisions of this paragraph with respect to any subsequent
determination of exercisability. The provisions of this paragraph shall be construed and implemented in a manner otherwise than in strict
conformity with the terms of this <U>Section 1(e)</U> to the extent necessary to correct this paragraph or any portion of this paragraph
which may be defective or inconsistent with the intended beneficial ownership limitation contained in this Section 1(e) or to make changes
or supplements necessary or desirable to properly give effect to such limitation. The limitation contained in this paragraph may not
be waived and shall apply to a successor holder of this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<FONT STYLE="text-transform: uppercase"><U>Adjustment of Exercise Price and Number of Warrant Shares Upon Subdivision or Combination
of Shares of Common Stock</U></FONT>. If the Company at any time on or after the Subscription Date subdivides (by any stock split, stock
dividend, recapitalization or otherwise) its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in
effect immediately prior to such subdivision will be proportionately reduced and the number of Warrant Shares will be proportionately
increased. If the Company at any time on or after the Subscription Date combines (by combination, reverse stock split or otherwise) its
outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination
will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any adjustment under this <U>Section
2(a)</U> shall become effective at the close of business on the date the subdivision or combination becomes effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
 <U>FUNDAMENTAL TRANSACTIONS</U>. In the event of a Fundamental Transaction, the Company shall
make appropriate provision to ensure that (a) the purchaser (or its parent) shall assume this Warrant (with appropriate changes to the
Exercise Price to take into account the value of the securities substituted for the Common Stock so as to preserve the intrinsic spread
between the fair market value of any substituted securities and the Exercise Price), or (b) Holder will thereafter have the right to
receive upon an exercise of this Warrant, in lieu of the shares of the Common Stock (or other securities, cash, assets or other property)
issuable upon the exercise of this Warrant prior to such Fundamental Transaction, such securities, cash or other assets (including warrants
or other purchase or subscription rights) which the Holder would have been entitled to receive on a per share basis upon the happening
of such Fundamental Transaction had this Warrant been exercised immediately prior to such Fundamental Transaction (without regard to
any limitations on the exercise of this Warrant); provided, however, that following any Fundamental Transaction, this Warrant shall only
be exercisable via Cashless Exercise. The provisions of this Section 3 shall apply similarly and equally to successive Fundamental Transactions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<U>NON-CIRCUMVENTION</U>. The Company hereby covenants and agrees that the Company will not, by amendment of its Certificate of Incorporation,
as amended, or Amended and Restated Bylaws, as amended, or through any reorganization, transfer of assets, consolidation, merger, scheme
of arrangement, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to avoid the observance or performance
of any of the terms of this Warrant, and will at all times in good faith carry out all of the provisions of this Warrant and take all
action as may be required to protect the rights of the Holder. Without limiting the generality of the foregoing, the Company (a) shall
not increase the par value of any shares of Common Stock receivable upon the exercise of this Warrant above the Exercise Price then in
effect, (b) shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully
paid and nonassessable shares of Common Stock upon the exercise of this Warrant, and (c) shall, so long as any of the 2024 Warrants are
outstanding, take all action necessary to reserve and keep available out of its authorized and unissued shares of Common Stock, solely
for the purpose of effecting the exercise of the 2024 Warrants, 100% of the number of shares of Common Stock as shall from time to time
be necessary to effect the exercise of the 2024 Warrants then outstanding (without regard to any limitations on exercise).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<U>WARRANT HOLDER NOT DEEMED A STOCKHOLDER</U>. Except as otherwise specifically provided herein, the Holder, solely in such Person&rsquo;s
capacity as a holder of this Warrant, shall not be entitled to vote or receive dividends or be deemed the holder of capital stock of
the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person&rsquo;s
capacity as the Holder of this Warrant, any of the rights of a stockholder of the Company or any right to vote, give or withhold consent
to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or
otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of
the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing contained
in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant
or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<U>REISSUANCE OF WARRANTS</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Transfer of Warrant</U>. If this Warrant is to be transferred, the Holder shall surrender this Warrant to the Company, whereupon the
Company will forthwith issue and deliver upon the order of the Holder a new Warrant (in accordance with <U>Section 6(d)</U>), registered
with the Company as the Holder may request, representing the right to purchase the number of Warrant Shares being transferred by the
Holder and, if less than the total number of Warrant Shares then underlying this Warrant is being transferred, a new Warrant (in accordance
with <U>Section 6(d)</U>) to the Holder representing the right to purchase the number of Warrant Shares not being transferred; <U>provided</U>,
<U>however</U>, that in the event that a Warrant surrendered for transfer bears a restrictive legend, the Company shall not cancel such
Warrant and issue new Warrants in exchange thereof until the Company has received an opinion of counsel for the Company (who may be in-house
counsel) stating that such transfer may be made and indicating whether the new Warrants must also bear the restrictive legend.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Lost, Stolen or Mutilated Warrant</U>. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss,
theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of any indemnification undertaking
by the Holder to the Company in customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company
shall execute and deliver to the Holder a new Warrant (in accordance with <U>Section 6(d)</U>) representing the right to purchase the
Warrant Shares then underlying this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Exchangeable for Multiple Warrants</U>. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office
of the Company, for a new Warrant or Warrants (in accordance with <U>Section 6(d)</U>) representing in the aggregate the right to purchase
the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion
of such Warrant Shares as is designated by the Holder at the time of such surrender; <U>provided</U>, <U>however</U>, that no 2024 Warrants
for fractional Warrant Shares shall be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Issuance of New Warrants</U>. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such
new Warrant (i) shall be of like tenor with this Warrant, (ii) shall represent, as indicated on the face of such new Warrant, the right
to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to <U>Section 6(a)</U>,
<U>Section 6(b)</U> or <U>Section 6(c)</U>, the Warrant Shares designated by the Holder which, when added to the number of shares of
Common Stock underlying the other new Warrants issued in connection with such issuance, does not exceed the number of Warrant Shares
then underlying this Warrant), (iii) shall have an issuance date, as indicated on the face of such new Warrant which is the same as the
Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>PRINCIPAL MARKET REGULATION</U>. Unless permitted by the applicable rules and regulations of the Principal Market, the Company shall
not issue any Warrant Shares if the issuance of such Warrant Shares would exceed the aggregate number of shares of Common Stock which
the Company may issue upon exercise of the Warrants without breaching the Company&rsquo;s obligations under the rules or regulations
of the Principal Market (the number of shares which may be issued without violating such rules and regulations, the &ldquo;<B>Exchange
Cap</B>&rdquo;). Notwithstanding the foregoing, such limitation shall not apply in the event that the Company (A) obtains the approval
of its stockholders as required by the applicable rules of the Principal Market for issuances of shares of Common Stock in excess of
such amount or (B) obtains a written opinion from outside counsel to the Company that such approval is not required, which opinion shall
be reasonably satisfactory to the Holder. In the event that any Holder shall sell or otherwise transfer such Holder&rsquo;s Warrant,
the Exchange Cap restrictions set forth herein shall continue to apply to the Warrant and such transferee.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8. <U>RULE
144</U>. At any time the Company is not subject to the reporting requirements under Section 13 or 15(d) of the 1934 Act, the Company
shall, upon written request, furnish to any Holder, beneficial owner or prospective purchaser of the Warrants, the information required
to be delivered pursuant to Rule 144A(d)(4) under the 1933 Act to facilitate the resale of such Warrants pursuant to Rule 144A under
the 1933 Act. The Company shall take such further action as any such beneficial owner may reasonably request to the extent required from
time to time to enable such beneficial Holder to sell such Warrants in accordance with Rule 144A under the 1933 Act, as such rule may
be amended from time to time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9. <U>NOTICES</U>.
Whenever notice is required to be given under this Warrant, unless otherwise provided herein, such notice shall be given in accordance
with Section 7.3 of the Securities Purchase Agreement. The Company will give written notice to the Holder (a) promptly following any
adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (b) at least
ten (10) days prior to the date on which the Company closes its books or takes a record (i) with respect to any dividend or distribution
upon the shares of Common Stock, (ii) with respect to any grants, issuances or sales of any options, convertible securities or rights
to purchase stock, warrants, securities or other property, in each case pro rata to all record holders of Common Stock, or (iii) for
determining rights to vote with respect to any Fundamental Transaction, dissolution or liquidation; provided in each case that such information
shall be made known to the public prior to or in conjunction with such notice being provided to the Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<U>AMENDMENT AND WAIVER</U>. Except as otherwise provided herein, the provisions of this Warrant may be amended or waived and the Company
may take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained
the written consent of the Required Holders. Any amendment or waiver by the Company and the Required Holders shall be binding on the
Holder of this Warrant and all holders of the 2024 Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<U>GOVERNING LAW; JURISDICTION; JURY TRIAL</U>. This Warrant shall be governed by and construed and enforced in accordance with, and
all questions concerning the construction, validity, interpretation and performance of this Warrant shall be governed by, the internal
laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State
of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New
York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New
York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that
it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way
any right to serve process in any manner permitted by law. Nothing contained herein shall be deemed or operate to preclude the Holder
from bringing suit or taking other legal action against the Company in any other jurisdiction to collect on the Company&rsquo;s obligations
to the Holder, to realize on any collateral or any other security for such obligations, or to enforce a judgment or other court ruling
in favor of the Holder. <B>THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE
ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION WITH OR ARISING OUT OF THIS WARRANT OR ANY TRANSACTION CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<U>CONSTRUCTION; HEADINGS</U>. This Warrant shall be deemed to be jointly drafted by the Company and all of the Purchasers and shall
not be construed against any Person as the drafter hereof. The headings of this Warrant are for convenience of reference and shall not
form part of, or affect the interpretation of, this Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<U>DISPUTE RESOLUTION</U>. In the case of a dispute as to the determination of the Exercise Price, the Black Scholes Value or the arithmetic
calculation of the Warrant Shares, the Company shall submit the disputed determinations or arithmetic calculations via electronic mail
within three (3) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the
Holder and the Company are unable to agree upon such determination or calculation of the Exercise Price, the Black Scholes Value or the
Warrant Shares within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Holder,
then the Company shall, within three (3) Business Days submit via electronic mail (a) the disputed determination of the Exercise Price
or the Black Scholes Value, as applicable, together with the Company&rsquo;s and Holder&rsquo;s respective calculations, to an independent,
reputable investment bank or financial services firm selected by the Holder and approved by the Company, such approval not to be unreasonably
withheld, conditioned, or delayed, or (b) the disputed arithmetic calculation of the Warrant Shares, together with the Company&rsquo;s
and Holder&rsquo;s respective calculations, to an independent, outside accountant, selected by the Holder and approved by the Company,
such approval not to be unreasonably withheld, conditioned, or delayed. The Company shall cause the investment bank, financial services
firm or accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results
no later than five (5) Business Days from the time it receives the disputed determinations or calculations. Such investment bank&rsquo;s,
financial services firm&rsquo;s or accountant&rsquo;s determination or calculation, as the case may be, shall be binding upon all parties
absent demonstrable error. The costs of such investment bank, financial services firm or accountant shall be allocated by such firm between
the Company and the Holder proportionally based on such firm&rsquo;s determination or calculation and the Company&rsquo;s and Holder&rsquo;s
respective calculations submitted to such firm.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<U>REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF</U>. The remedies provided in this Warrant shall be cumulative and in
addition to all other remedies available under this Warrant and the other Transaction Documents (as defined in the Securities Purchase
Agreement), at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall
limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of this Warrant. The Company
acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for
any such breach may be inadequate. The Company therefore agrees that, in the event of any such breach or threatened breach, the holder
of this Warrant shall be entitled, in addition to all other available remedies, to seek an injunction restraining any breach, without
the necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<U>TRANSFER</U>. This Warrant and the Warrant Shares may be offered for sale, sold, transferred, pledged or assigned without the consent
of the Company, except as may otherwise be required by Section 4.1 of the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<U>SEVERABILITY</U>. If any provision of this Warrant is prohibited by law or otherwise determined to be invalid or unenforceable by
a court of competent jurisdiction, the provision that would otherwise be prohibited, invalid or unenforceable shall be deemed amended
to apply to the broadest extent that it would be valid and enforceable, and the invalidity or unenforceability of such provision shall
not affect the validity of the remaining provisions of this Warrant so long as this Warrant as so modified continues to express, without
material change, the original intentions of the parties as to the subject matter hereof and the prohibited nature, invalidity or unenforceability
of the provision(s) in question does not substantially impair the respective expectations or reciprocal obligations of the parties or
the practical realization of the benefits that would otherwise be conferred upon the parties. The parties will endeavor in good faith
negotiations to replace the prohibited, invalid or unenforceable provision(s) with a valid provision(s), the effect of which comes as
close as possible to that of the prohibited, invalid or unenforceable provision(s).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<U>DISCLOSURE</U>. Upon delivery by the Company to the Holder of any notice required to be given in accordance with the terms of this
Warrant, unless the Company has in good faith determined that the matters relating to such notice do not constitute material, nonpublic
information relating to the Company or its Subsidiaries, the Company shall contemporaneously with any such delivery publicly disclose
such material, nonpublic information on a Current Report on Form 8-K or otherwise. In the event that the Company believes that any notice
required to be delivered by the Company in accordance with the terms of this Warrant contains material, nonpublic information relating
to the Company or its Subsidiaries, the Company so shall indicate to the Holder contemporaneously with delivery of such notice, and in
the absence of any such indication, the Holder shall be allowed to presume that all matters relating to such notice do not constitute
material, nonpublic information relating to the Company or its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<U>CERTAIN DEFINITIONS</U>. For purposes of this Warrant, the following terms shall have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
&ldquo;<B>1933 Act</B>&rdquo; means the Securities Act of 1933, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
&ldquo;<B>1934 Act</B>&rdquo; means the Securities and Exchange Act of 1934, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
&ldquo;<B>Affiliate</B>&rdquo; shall have the meaning ascribed to such term in Rule 405 of the 1933 Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
&ldquo;<B>Attribution Parties</B>&rdquo; means, collectively, the following Persons and entities: (i) any investment vehicle, including,
any funds, feeder funds or managed accounts, currently, or from time to time after the Issuance Date, directly or indirectly managed
or advised by the Holder&rsquo;s investment manager or any of its Affiliates or principals, (ii) any direct or indirect Affiliates of
the Holder or any of the foregoing, (iii) any Person acting or who could be deemed to be acting as a Group together with the Holder or
any of the foregoing and (iv) any other Persons whose beneficial ownership of the Common Stock would or could be aggregated with the
Holder&rsquo;s and the other Attribution Parties for purposes of Section 13(d) of the 1934 Act. For clarity, the purpose of the foregoing
is to subject collectively the Holder and all other Attribution Parties to the Maximum Percentage.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
&ldquo;<B>Black Scholes Value</B>&rdquo; means the value of the unexercised portion of this Warrant remaining on the date of the Holder&rsquo;s
request pursuant to <U>Section 3</U>, which value is calculated using the Black Scholes Option Pricing Model obtained from the &ldquo;OV&rdquo;
function on Bloomberg utilizing (i) an underlying price per share equal to the greater of (1) the highest closing sale price of the Common
Stock during the period beginning on the Trading Day immediately preceding the announcement of the applicable Fundamental Transaction
(or the consummation of the applicable Fundamental Transaction, if earlier) and ending on the Trading Day of the Holder&rsquo;s request
pursuant to Section 3 and (2) the sum of the price per share being offered in cash in the applicable Fundamental Transaction (if any)
plus the value of the non-cash consideration being offered in the applicable Fundamental Transaction (if any), (ii) a strike price equal
to the Exercise Price in effect on the date of the Holder&rsquo;s request pursuant to <U>Section 3</U>, (iii) a risk-free interest rate
corresponding to the U.S. Treasury rate for a period equal to the greater of (1) the remaining term of this Warrant as of the date of
the Holder&rsquo;s request pursuant to Section 3 and (2) the remaining term of this Warrant as of the date of consummation of the applicable
Fundamental Transaction or as of the date of the Holder&rsquo;s request pursuant to <U>Section 3</U> if such request is prior to the
date of the consummation of the applicable Fundamental Transaction, (iv) a zero cost of borrow and (v) an expected volatility equal to
the greater of 100% and the thirty (30) day volatility obtained from the &ldquo;HVT&rdquo; function on Bloomberg (determined utilizing
a 365 day annualization factor) as of the Trading Day immediately following the earliest to occur of (A) the public disclosure of the
applicable Fundamental Transaction and (B) the date of the Holder&rsquo;s request pursuant to Section 3.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
&ldquo;<B>Bloomberg</B>&rdquo; means Bloomberg Financial Markets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
&ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other day on which commercial banks in The City of New
York, New York are authorized or required by law to remain closed; provided, <U>however</U>, for clarification, commercial banks shall
not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;, &ldquo;shelter-in-place&rdquo;,
&ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any physical branch locations at the
direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers) of commercial
banks in The City of New York, New York generally are open for use by customers on such day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
&ldquo;<B>Common Stock</B>&rdquo; means (i) the Company&rsquo;s shares of common stock, par value $0.01 per share, and (ii) any capital
stock into which such Common Stock shall have been changed or any capital stock resulting from a reclassification, reorganization or
recapitalization of such Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
&ldquo;<B>Expiration Date</B>&rdquo; means the date that is forty-eight (48) months after the Issuance Date or, if such date falls on
a day other than a Business Day or on which trading does not take place on the Principal Market (a &ldquo;<B>Holiday</B>&rdquo;), the
next day that is not a Holiday.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
&ldquo;<B>Fundamental Transaction</B>&rdquo; means (A) that the Company shall, directly or indirectly, including through Subsidiaries,
Affiliates or otherwise, in one or more related transactions, (i) consolidate or merge with or into (whether or not the Company is the
surviving corporation) another Subject Entity, or (ii) sell, assign, transfer, convey or otherwise dispose of all or substantially all
of the properties or assets of the Company, or (iii) make, or allow one or more Subject Entities to make, or allow the Company to be
subject to or have its Common Stock be subject to or party to one or more Subject Entities making, a purchase, tender or exchange offer
that is accepted by the holders of at least either (x) 50% of the outstanding shares of Common Stock, (y) 50% of the outstanding shares
of Common Stock calculated as if any shares of Common Stock held by all Subject Entities making or party to, or Affiliated with any Subject
Entities making or party to, such purchase, tender or exchange offer were not outstanding; or (z) such number of shares of Common Stock
such that all Subject Entities making or party to, or Affiliated with any Subject Entity making or party to, such purchase, tender or
exchange offer, become collectively the beneficial owners (as defined in Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding
shares of Common Stock, or (iv) consummate a stock purchase agreement or other business combination (including, without limitation, a
reorganization, recapitalization, spin-off or scheme of arrangement) with one or more Subject Entities whereby such Subject Entities,
individually or in the aggregate, acquire, either (x) at least 50% of the outstanding shares of Common Stock, (y) at least 50% of the
outstanding shares of Common Stock calculated as if any shares of Common Stock held by all the Subject Entities making or party to, or
Affiliated with any Subject Entity making or party to, such stock purchase agreement or other business combination were not outstanding;
or (z) such number of shares of Common Stock such that the Subject Entities become collectively the beneficial owners (as defined in
Rule 13d-3 under the 1934 Act) of at least 50% of the outstanding shares of Common Stock, or (v) reorganize, recapitalize or reclassify
its Common Stock, (B) that the Company shall, directly or indirectly, including through Subsidiaries, Affiliates or otherwise, in one
or more related transactions, allow any Subject Entity individually or the Subject Entities in the aggregate to be or become the &ldquo;beneficial
owner&rdquo; (as defined in Rule 13d-3 under the 1934 Act), directly or indirectly, whether through acquisition, purchase, assignment,
conveyance, tender, tender offer, exchange, reduction in outstanding shares of Common Stock, merger, consolidation, business combination,
reorganization, recapitalization, spin-off, scheme of arrangement, reorganization, recapitalization or reclassification or otherwise
in any manner whatsoever, of either (x) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common
Stock, (y) at least 50% of the aggregate ordinary voting power represented by issued and outstanding Common Stock not held by all such
Subject Entities as of the Subscription Date calculated as if any shares of Common Stock held by all such Subject Entities were not outstanding,
or (z) a percentage of the aggregate ordinary voting power represented by issued and outstanding shares of Common Stock or other equity
securities of the Company sufficient to allow such Subject Entities to effect a statutory short form merger or other transaction requiring
other stockholders of the Company to surrender their shares of Common Stock without approval of the stockholders of the Company or (C)
directly or indirectly, including through Subsidiaries, Affiliates or otherwise, in one or more related transactions, the issuance of
or the entering into any other instrument or transaction structured in a manner to circumvent, or that circumvents, the intent of this
definition in which case this definition shall be construed and implemented in a manner otherwise than in strict conformity with the
terms of this definition to the extent necessary to correct this definition or any portion of this definition which may be defective
or inconsistent with the intended treatment of such instrument or transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
&ldquo;<B>Group</B>&rdquo; means a &ldquo;group&rdquo; as that term is used in Section 13(d) of the 1934 Act and as defined in Rule 13d-5
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
&ldquo;<B>Person</B>&rdquo; means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust,
an unincorporated organization, any other entity and a government or any department or agency thereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
&ldquo;<B>Principal Market</B>&rdquo; means The Nasdaq Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
&ldquo;<B>Required Holders</B>&rdquo; means the holders of the 2024 Warrants representing at least a majority of the shares of Common
Stock underlying the 2024 Warrants then outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
&ldquo;<B>Standard Settlement Period</B>&rdquo; means the standard settlement period, expressed in a number of Trading Days, on the principal
securities exchange or securities market on which the Common Stock is then traded as in effect on the date of delivery of the applicable
Exercise Notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
&ldquo;<B>Subject Entity</B>&rdquo; means any Person, Persons or Group or any Affiliate or associate of any such Person, Persons or Group.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
&ldquo;<B>Subsidiary</B>&rdquo; has the meaning as set forth in the Securities Purchase Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
&ldquo;<B>Trading Day</B>&rdquo; means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market
is not the principal trading market for the Common Stock on such day, then on the principal securities exchange or securities market
on which the Common Stock is then traded.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
&ldquo;<B>Weighted Average Price</B>&rdquo; means, for any security as of any date, the dollar volume-weighted average price for such
security on the Principal Market during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market
publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market
publicly announces is the official close of trading), as reported by Bloomberg through its &ldquo;Volume at Price&rdquo; function or,
if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the electronic
bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time as such market publicly
announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as such market publicly announces
is the official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security
by Bloomberg for such hours, the average of the highest closing bid price and the lowest closing ask price of any of the market makers
for such security as reported in the OTC Link or &ldquo;pink sheets&rdquo; by OTC Markets Group Inc. (formerly Pink OTC Markets Inc.).
If the Weighted Average Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Weighted Average
Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company
and the Holder are unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to <U>Section
11</U> with the term &ldquo;Weighted Average Price&rdquo; being substituted for the term &ldquo;Exercise Price.&rdquo; All such determinations
shall be appropriately adjusted for any stock dividend, stock split, stock combination, reclassification or other similar transaction
during the applicable calculation period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF,</B> the Company has caused this Warrant to be duly executed as of the Issuance Date set out above in accordance with
the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 3in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STREAMLINE
  HEALTH SOLUTIONS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bryant J. Reeves, III</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim Chief Financial Officer</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXHIBIT
A</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>EXERCISE
NOTICE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>TO
BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WARRANT
TO PURCHASE COMMON STOCK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>STREAMLINE
HEALTH SOLUTIONS, INC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned holder hereby exercises the right to purchase _________________ of the shares of Common Stock (&ldquo;<B>Warrant Shares</B>&rdquo;)
of Streamline Health Solutions, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), evidenced by the attached Warrant to
Purchase Common Stock (the &ldquo;<B>Warrant</B>&rdquo;). Capitalized terms used herein and not otherwise defined shall have the respective
meanings set forth in the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<U>Form of Exercise Price</U>. The Holder intends that payment of the Exercise Price shall be made as:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.
    &ldquo;<U>Cash Exercise&rdquo;</U> with respect to _________________ Warrant Shares; and/or</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.
&ldquo;<U>Cashless Exercise</U>&rdquo; with respect to _______________ Warrant Shares<FONT STYLE="background-color: white">, resulting
in a delivery obligation of the Company to the Holder of __________ shares of Common Stock representing the applicable Net Number</FONT>.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<U>Payment of Exercise Price</U>. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant
Shares to be issued pursuant hereto, the holder shall pay the Aggregate Exercise Price in the sum of $___________________ to the Company
in accordance with the terms of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>Delivery of Warrant Shares</U>. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of
the Warrant as follows, subject to Section 1(a) of the Warrant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares have been sold pursuant to an effective resale registration statement and should be credited to the Holder&rsquo;s or its designee&rsquo;s
balance account with DTC through its Deposit / Withdrawal At Custodian system pursuant to the information that accompanies this notice;
and/or</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares acquired via Cashless Exercise have been sold pursuant to Rule 144 and the Holder has delivered to the Company representations
from the Holder and the Holder&rsquo;s broker indicating such and such Warrant Shares should be credited to the Holder&rsquo;s or its
designee&rsquo;s balance account with DTC through its Deposit / Withdrawal At Custodian system pursuant to the information that accompanies
this notice; and/or</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">____________</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrant
Shares represented by a certificate or evidence of book entry should be sent to the Holder or its designee at the address below.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
_______ __, ________</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name
    of Registered Holder</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:
    </FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name</FONT>:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title</FONT>:</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
for certificate or evidence of book entry delivery (if applicable):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DTC
Information (if applicable):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ACKNOWLEDGMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company hereby acknowledges this Exercise Notice and hereby directs Computershare, Inc. to issue the above indicated number of shares
of Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STREAMLINE
  HEALTH SOLUTIONS, INC.</B></FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: Black 1.5pt solid; text-align: justify; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>

<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
  <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 14; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>3
<FILENAME>ex10-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.1</B></FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SECURITIES
PURCHASE AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Securities Purchase Agreement (this &ldquo;<I>Agreement</I>&rdquo;) is dated as of February 1, 2024, by and among Streamline Health Solutions,
Inc., a Delaware corporation (the &ldquo;<I>Company</I>&rdquo;), and each purchaser identified on the signature pages hereto (each, including
its successors and assigns, a &ldquo;<I>Purchaser</I>&rdquo; and collectively, the &ldquo;<I>Purchasers</I>&rdquo;). Certain capitalized
terms used but not otherwise defined herein shall have the meanings given to such terms in <U>Section 1.1</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RECITALS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
The Company and each Purchaser is executing and delivering this Agreement in reliance upon the exemption from securities registration
afforded by Section 4(a)(2) of the Securities Act of 1933, as amended (the &ldquo;<I>Securities Act</I>&rdquo;), and Rule 506 of Regulation
D as promulgated by the United States Securities and Exchange Commission (the &ldquo;<I>Commission</I>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
Each Purchaser, severally and not jointly, wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in
this Agreement, (i) an unsecured subordinated note, substantially in the form attached hereto as <U>Exhibit A</U> (each, a &ldquo;<I>Note</I>&rdquo;),
in the original principal amount set forth below such Purchaser&rsquo;s name on the signature page of this Agreement and (ii) that number
of Warrants (as defined below) set forth below such Purchaser&rsquo;s name on the signature page of this Agreement in accordance with
<U>Section 2.2(a)(iii)</U> of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
The Purchasers hereunder are collectively purchasing up to (i) $4.0 million in aggregate principal amount of Notes (collectively, the
&ldquo;<I>Notes</I>&rdquo;) and (ii) Warrants (as defined below).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt
and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
I.<BR>
DEFINITIONS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1
<U>Definitions</U>. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms
shall have the meanings indicated in this <U>Section 1.1</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Action</I>&rdquo;
means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or investigation
pending or, to the Company&rsquo;s Knowledge, threatened in writing against the Company, any Subsidiary or any of their respective properties
or any officer, director or employee of the Company or any Subsidiary acting in his or her capacity as an officer, director or employee
before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative agency, regulatory authority,
stock market, stock exchange or trading facility.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Affiliate</I>&rdquo;
means, with respect to any Person, any other Person that, directly or indirectly through one or more intermediaries, Controls, is controlled
by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act. With
respect to a Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same investment manager
as such Purchaser will be deemed to be an Affiliate of such Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Agreement</I>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Board
of Directors</I>&rdquo; means the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Business
Day</I>&rdquo; means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any day on which
banking institutions in the State of New York are authorized or required by law or other governmental action to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Bylaws</I>&rdquo;
means the Amended and Restated Bylaws of the Company, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Certificate
of Incorporation</I>&rdquo; means the Certificate of Incorporation of the Company, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Closing</I>&rdquo;
means the closing of the purchase and sale of the Notes and Warrants pursuant to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Closing
Date</I>&rdquo; means February 5, 2024 (the second Trading Day following the execution of this Agreement), or such other date as the
parties may agree.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&ldquo;Code&rdquo;
</I>means the Internal Revenue Code of 1986, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Commission</I>&rdquo;
means the Securities and Exchange Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Commission
Comments</I>&rdquo; means written comments pertaining solely to Rule 415 which are received by the Company from the Commission, and a
copy of which shall have been provided by the Company to each of the Purchasers, to a filed Registration Statement which require the
Company to limit the amount of Warrant Shares which may be included therein to a number of Warrant Shares, which is less than such amount
sought to be included thereon as filed with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Common
Stock</I>&rdquo; means the common stock, par value $0.01 per share, of the Company, and also includes any other class of securities into
which the Common Stock may hereafter be reclassified or changed into.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Common
Stock Equivalents</I>&rdquo; means any securities of the Company or any Subsidiary which would entitle the holder thereof to acquire
at any time Common Stock, including, without limitation, any debt, preferred stock, rights, options, warrants or other instrument that
is at any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock or other securities
that entitle the holder to receive, directly or indirectly, Common Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Company</I>&rdquo;
has the meaning set forth in the Preamble.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Company
Counsel</I>&rdquo; means Troutman Pepper Hamilton Sanders LLP, with offices located at 600 Peachtree Street NE, Suite 3000, Atlanta,
Georgia 30308.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Company
Deliverables</I>&rdquo; has the meaning set forth in <U>Section 2.2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Company&rsquo;s
Knowledge</I>&rdquo; means with respect to any statement made to the Company&rsquo;s Knowledge, that the statement is based upon the
actual knowledge of the executive officers of the Company having responsibility for the matter or matters that are the subject of the
statement, after a reasonable inquiry.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Control</I>&rdquo;
(including the terms &ldquo;controlling&rdquo;, &ldquo;controlled by&rdquo; or &ldquo;under common control with&rdquo;) means the possession,
direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership
of voting securities, by contract or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Disclosure
Materials</I>&rdquo; has the meaning set forth in <U>Section 3.1(h)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Disclosure
Schedules</I>&rdquo; has the meaning set forth in <U>Section 3.1</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Effective
Date</I>&rdquo; means the date on which a Registration Statement, as required by <U>Section 6.1</U> hereof, is first declared effective
by the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Effectiveness
Period</I>&rdquo; has the meaning set forth in <U>Section 6.1(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Evaluation
Date</I>&rdquo; has the meaning set forth in <U>Section 3.1(p)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Exchange
Act</I>&rdquo; means the Securities Exchange Act of 1934, as amended, or any successor statute, and the rules and regulations promulgated
thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Filing
Date</I>&rdquo; means the date that is thirty (30) days after the Closing Date or, if such date is not a Business Day, the next date
that is a Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>GAAP</I>&rdquo;
means U.S. generally accepted accounting principles, as applied by the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Intellectual
Property Rights</I>&rdquo; has the meaning set forth in <U>Section 3.1(n)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Irrevocable
Transfer Agent Instructions</I>&rdquo; means, with respect to the Company, the Irrevocable Transfer Agent Instructions, in the form of
<U>Exhibit D</U>, executed by the Company and delivered to and acknowledged in writing by the Transfer Agent.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>IRS&rdquo;
</I>means the Internal Revenue Service.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Lien</I>&rdquo;
means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or other restrictions of any
kind.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Lock-Up
Agreement</I>&rdquo; has the meaning set forth in <U>Section 2.2(a)(viii)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Losses</I>&rdquo;
has the meaning set forth in <U>Section 6.5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Material
Adverse Effect</I>&rdquo; means a material adverse effect on the results of operations, assets, prospects, management, business or financial
condition of the Company and the Subsidiaries, taken as a whole, except that any of the following, either alone or in combination, shall
not be deemed a Material Adverse Effect: (i) effects caused by changes or circumstances affecting general market conditions in the U.S.
economy or which are generally applicable to the industry in which the Company operates, provided that such effects are not borne disproportionately
by the Company, (ii) effects resulting from or relating to the announcement or disclosure of the sale of the Securities or other transactions
contemplated by this Agreement, or (iii) effects caused by any event, occurrence or condition resulting from or relating to the taking
of any action in accordance with this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Material
Contract</I>&rdquo; means any contract of the Company that has been filed or was required to have been filed as an exhibit to the SEC
Reports pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation S-K.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Material
Permits</I>&rdquo; has the meaning set forth in <U>Section 3.1(n)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>New
York Courts</I>&rdquo; means the state and federal courts sitting in the City of New York, Borough of Manhattan, New York.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Outside
Date</I>&rdquo; means the tenth day following the date of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Person</I>&rdquo;
means an individual, corporation, partnership, limited liability company, trust, business trust, association, joint stock company, joint
venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Press
Release</I>&rdquo; has the meaning set forth in <U>Section 4.4</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Principal
Trading Market</I>&rdquo; means the Trading Market on which the Common Stock is primarily listed on and quoted for trading, which, as
of the date of this Agreement and the Closing Date, shall be the NASDAQ Capital Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Proceeding</I>&rdquo;
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such
as a deposition), whether commenced or threatened.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Prospectus</I>&rdquo;
means the prospectus included in the Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A, as amended or supplemented
by any prospectus supplement, with respect to the terms of the offering of any portion of the Warrant Shares covered by the Registration
Statement, and all other amendments and supplements to the Prospectus including post-effective amendments, and all material incorporated
by reference or deemed to be incorporated by reference in such Prospectus.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Purchase
Price</I>&rdquo; has the meaning set forth in <U>Section 2.1(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Purchaser</I>&rdquo;
or &ldquo;<I>Purchasers</I>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Purchaser
Deliverables</I>&rdquo; has the meaning set forth in <U>Section 2.2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Purchaser
Party</I>&rdquo; has the meaning set forth in <U>Section 6.5(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Registration
Statement</I>&rdquo; means each registration statement required to be filed under <U>Article VI</U>, including (in each case) the Prospectus,
amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments, all exhibits thereto,
and all material incorporated by reference or deemed to be incorporated by reference in such registration statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Required
Approvals</I>&rdquo; has the meaning set forth in <U>Section 3.1(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Required
Effectiveness Date</I>&rdquo; means the date which is, (i) if there is no review of the Registration Statement by the Commission, one
hundred and twenty (120) days after the Closing Date or, if such date is not a Business Day, the next date that is a Business Day, or,
(ii) if there is a review of the Registration Statement by the Commission, one hundred and fifty (150) days after the date of the Closing
Date or, if such date is not a Business Day, the next date that is a Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Rule
144</I>&rdquo; means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to
time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>SEC
Report</I>s&rdquo; has the meaning set forth in <U>Section 3.1(h)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Secretary&rsquo;s
Certificate</I>&rdquo; has the meaning set forth in <U>Section 2.2(a)(vi)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Securities</I>&rdquo;
means, collectively, the Notes, the Warrants and the Warrant Shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Securities
Act</I>&rdquo; has the meaning set forth in the Recitals.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Senior
Lender</I>&rdquo; means Western Alliance Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Short
Sales</I>&rdquo; include, without limitation, (i) all &ldquo;short sales&rdquo; as defined in Rule 200 promulgated under Regulation SHO
under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options,
puts, calls, short sales, swaps, &ldquo;put equivalent positions&rdquo; (as defined in Rule 16a-1(h) under the Exchange Act) and similar
arrangements (including on a total return basis), and (ii) sales and other transactions through non-U.S. broker dealers or foreign regulated
brokers (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Subordination
Agreement</I>&rdquo; means that certain Subordination Agreement, dated as of the date hereof, by and among the Purchasers, the Company
and the Senior Lender, substantially in the form attached hereto as <U>Exhibit L</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Subsidiary</I>&rdquo;
means the subsidiaries of the Company as set forth on <U>Schedule 3.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Trading
Day</I>&rdquo; means (i) a day on which the Common Stock is listed or quoted and traded on its Principal Trading Market (other than the
OTC Bulletin Board), or (ii) if the Common Stock is not listed on a Trading Market (other than the OTC Bulletin Board), a day on which
the Common Stock is traded in the over-the-counter market, as reported by the OTC Bulletin Board; <I>provided</I>, that in the event
that the Common Stock is not listed or quoted as set forth in (i) and (ii) hereof, then Trading Day shall mean a Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Trading
Market</I>&rdquo; means whichever of the New York Stock Exchange, the NYSE Amex, the NASDAQ Global Select Market, the NASDAQ Global Market,
the NASDAQ Capital Market or the OTC Bulletin Board on which the Common Stock is listed or quoted for trading on the date in question.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Transaction
Documents</I>&rdquo; means this Agreement, the schedules and exhibits attached hereto, the Notes, the Warrants, the Subordination Agreement,
the Irrevocable Transfer Agent Instructions and any other documents or agreements explicitly contemplated hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Transfer
Agent</I>&rdquo; means Computershare Trust Company, N.A., the current transfer agent of the Company with respect to the Securities, with
a mailing address of 150 Royall Street, Suite 101, Canton, Massachusetts 02021 <FONT STYLE="background-color: white">or any successor
transfer agent for the Company</FONT>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Warrants</I>&rdquo;
means, collectively, the warrants to purchase shares of Common Stock, delivered to the Purchasers at Closing in accordance with <U>Section
2.2(a)</U> hereof, which Warrants shall be exercisable immediately and shall expire on 5:00 p.m. on the date four (4) years thereafter,
in the form of <U>Exhibit B</U>. For the avoidance of doubt, had the Warrant Strike Price been calculated based on the closing price
of the Common Stock on January 29, 2024, approximately 3,579,648 Warrants would have been issuable pursuant to the terms of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Warrant
Shares</I>&rdquo; means the shares of Common Stock issuable upon exercise of the Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<I>Warrant
Strike Price</I>&rdquo; means the lower of (i) the closing price of the Common Stock on the date immediately prior to the date hereof
and (ii) the average closing price of the Common Stock for the five (5) trading days immediately prior to the date hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
II.<BR>
PURCHASE AND SALE</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1
<U>Closing</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Notes and Warrants</U>. Subject to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and
sell to each Purchaser, and each Purchaser shall, severally and not jointly, purchase from the Company, (i) a Note in the original principal
amount as set forth on such Purchaser&rsquo;s signature page to this Agreement and (ii) Warrants, as determined pursuant to <U>Section
2.2(a)(iii)</U> and as set forth on such Purchaser&rsquo;s signature page to this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Closing</U>. The Closing of the purchase and sale of the Notes and Warrants shall take place at the offices of Troutman Pepper Hamilton
Sanders LLP on the Closing Date or at such other locations or remotely by facsimile transmission or other electronic means as the parties
may mutually agree.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Purchase Price</U>. The aggregate purchase price for the Notes and the Warrants to be purchased by each Purchaser (the &ldquo;<I>Purchase
Price</I>&rdquo;) shall be an amount equal to the initial principal amount of the Note set forth below such Purchaser&rsquo;s name on
the signature page of this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Form of Payment</U>. On or prior to the Closing Date, (a) the Company shall deliver to each Purchaser (i) a Note in the original principal
amount as set forth on such Purchaser&rsquo;s signature page to this Agreement and (ii) a Warrant pursuant to which such Purchaser shall
have the right to initially acquire up to such number of Warrant Shares as set forth on such Purchaser&rsquo;s signature page to this
Agreement, in the form of a certificate, duly executed and authenticated by the Company and the Transfer Agent, and such other documents,
certificates and agreements as required pursuant to the terms of this Agreement&#894; and (b) each Purchaser shall pay its respective
Purchase Price for the Note and the Warrant to be issued and sold to such Purchaser at the Closing, by wire transfer of immediately available
funds in accordance with the Company&rsquo;s written wire instructions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2
<U>Closing Deliveries</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
On or prior to the Closing (or at such other time as may be specifically referred to below), the Company shall issue, deliver or cause
to be delivered to each Purchaser the following (the &ldquo;<I>Company Deliverables</I>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement, duly executed by the Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
a Note, in the original principal amount as set forth on such Purchaser&rsquo;s signature page to this Agreement, duly executed by the
Company;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
a Warrant, duly executed by the Company, registered in the name of such Purchaser to purchase up to a number of shares of Common Stock
equal to the Purchase Price, <U>divided by</U> the Warrant Strike Price, <U>multiplied by</U> thirty-five percent (35%), and rounded
to the nearest whole Warrant, subject to adjustment;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Subordination Agreement, duly executed by the Company and the Senior Lender;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
duly executed Irrevocable Transfer Agent Instructions acknowledged in writing by the Transfer Agent;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)
a certificate of the Secretary of the Company (the &ldquo;<I>Secretary&rsquo;s Certificate</I>&rdquo;), dated as of the Closing Date,
(a) certifying the resolutions adopted by the Board of Directors of the Company or a duly authorized committee thereof approving the
transactions contemplated by this Agreement and the other Transaction Documents and the issuance of the Notes, the Warrants and the Warrant
Shares, (b) certifying the current versions of the Certificate of Incorporation and the Bylaws of the Company and the Subsidiaries (or
the organizational equivalents of such documents in the case of the Subsidiaries), (c) certifying as to the good standing (or jurisdictional
equivalent) of the Company and the Subsidiaries under the laws of their respective jurisdictions and each state in which the Company
and each Subsidiary is authorized as a foreign corporation or organization to conduct business and their qualification to conduct business
in the State of Delaware and each such other state in which the Company and each Subsidiary is authorized as a foreign corporation or
organization to conduct business; and (d) certifying as to the signatures and authority of persons signing the Transaction Documents
and related documents on behalf of the Company, in the form attached hereto as <U>Exhibit F</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)
the Compliance Certificate referred to in <U>Section 5.1(i)</U>;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)
a Lock-Up Agreement, substantially in the form of <U>Exhibit I</U> hereto (the &ldquo;<I>Lock-Up Agreement</I>&rdquo;) executed by each
person listed on <U>Exhibit J</U> hereto, and each such Lock-Up Agreement shall be in full force and effect on the Closing Date;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ix)
a certificate evidencing the formation and good standing of the Company issued by the Secretary of State of Delaware, as of a date within
three (3) Business Days of the Closing Date; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
such other documents relating to the transactions contemplated by this Agreement as the Purchasers or their counsel may reasonably request,
including, upon request: (i) a duly completed and executed Internal Revenue Service Form W-9 or W-8BenE and (ii) the names and contact
information for two authorized persons at the Company, in each case, to be delivered to any requesting Purchaser, not less than two (2)
Business Days prior to the Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
On or prior to the Closing, each Purchaser shall deliver or cause to be delivered to the Company the following (the &ldquo;<I>Purchaser
Deliverables</I>&rdquo;):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
this Agreement, duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
the Purchase Price for the Note and the related Warrants being purchased by such Purchaser at the Closing, in United States dollars and
in immediately available funds by wire transfer;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)
the Subordination Agreement, duly executed by such Purchaser;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)
the Lock-Up Agreement, duly executed by such Purchaser; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
a fully completed and duly executed Accredited Investor Questionnaire, satisfactory to the Company, and DRS Book-Entry Questionnaire,
if applicable, in forms substantially similar to the forms attached hereto as <U>Exhibits C-1</U> and <U>C-2</U>, respectively.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
III.<BR>
REPRESENTATIONS AND WARRANTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1
<U>Representations and Warranties of the Company</U>. Except as set forth in the schedules delivered herewith (the &ldquo;<I>Disclosure
Schedules</I>&rdquo;), which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation made herein to the
extent of the disclosure contained in the corresponding section of the Disclosure Schedules or other representations relating to the
subject matter of such disclosure, the Company hereby represents and warrants as of the date hereof and the Closing Date (except for
the representations and warranties that speak as of a specific date, which shall be made as of such date), to each of the Purchasers:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Subsidiaries</U>. The Company has no direct or indirect subsidiaries other than those disclosed in the SEC Reports. The Company owns,
directly or indirectly, all of the capital stock or comparable equity interests of each Subsidiary free and clear of any and all Liens,
and all the issued and outstanding shares of capital stock or comparable equity interest of each Subsidiary are validly issued and are
fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Organization; Qualification</U>. The Company and each of its Subsidiaries is an entity duly incorporated or otherwise organized, validly
existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite
corporate power and authority to own or lease and use its properties and assets and to carry on its business as currently conducted.
Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective certificate or articles
of incorporation, bylaws or other organizational or charter documents. The Company and each of its Subsidiaries is duly qualified to
conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business
conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing,
as the case may be, would not have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Authorization; Enforcement; Validity</U>. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by this Agreement and each of the Transaction Documents to which it is a party and otherwise to carry out
its obligations hereunder and thereunder. The Company&rsquo;s execution and delivery of each of the Transaction Documents to which it
is a party and the consummation by it of the transactions contemplated hereby and thereby (including, but not limited to, the sale and
delivery of the Securities) have been duly authorized by all necessary corporate action on the part of the Company, and no further corporate
action is required by the Company, its Board of Directors or its stockholders in connection therewith other than in connection with the
Required Approvals. Each of the Transaction Documents to which it is a party has been (or upon delivery will have been) duly executed
by the Company and is, or when delivered in accordance with the terms hereof, will constitute the legal, valid and binding obligation
of the Company enforceable against the Company in accordance with its terms, except (i) as such enforceability may be limited by applicable
bankruptcy, insolvency, reorganization or similar laws relating to, or affecting generally the enforcement of, creditors&rsquo; rights
and remedies or by other equitable principles of general application, (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited
by applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>No Conflicts</U>. The execution, delivery and performance by the Company of the Transaction Documents to which it is a party and the
consummation by the Company of the transactions contemplated hereby or thereby (including, without limitation, the issuance of the Securities)
do not and will not (i) conflict with or violate any provisions of the Company&rsquo;s Certificate of Incorporation or any Subsidiary&rsquo;s
certificate or articles of incorporation, bylaws or otherwise result in a violation of the organizational documents of the Company, (ii)
conflict with, or constitute a default (or an event that with notice or lapse of time or both would result in a default) under, result
in the creation of any Lien upon any of the properties or assets of the Company or any Subsidiary or give to others any rights of termination,
amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any Material Contract, or (iii) subject to
the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other
restriction of any court or governmental authority to which the Company or a Subsidiary is subject, or by which any property or asset
of the Company or a Subsidiary is bound or affected, except in the case of clauses (ii) and (iii) such as would not, individually or
in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Filings, Consents and Approvals</U>. Neither the Company nor any of its Subsidiaries is required to obtain any consent, waiver, authorization
or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental
authority or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents (including
the issuance of the Securities), other than (i) the filing with the Commission of one or more Registration Statements in accordance with
the requirements hereunder, (ii) filings required by applicable state securities laws, (iii) the filing of a Form D pursuant to Regulation
D under the 1933 Act, (iv) the filing of any requisite notices and/or application(s) to the Principal Trading Market for the issuance
and sale of the Securities and the listing of the Warrant Shares for trading or quotation, as the case may be, thereon in the time and
manner required thereby, (v) the filings required in accordance with <U>Section 4.4</U> of this Agreement, and (vi) those that have been
made or obtained prior to the date of this Agreement (collectively, the &ldquo;<I>Required Approvals</I>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Issuance of the Securities</U>. The Securities have been duly authorized and, when issued and paid for in accordance with the terms
of the Transaction Documents, will be duly and validly issued, fully paid and nonassessable and free and clear of all Liens, other than
restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws and Liens created by or imposed
by a Purchaser, and shall not be subject to preemptive or similar rights, except for any such preemptive or contractual rights that have
been effectively waived or satisfied. Assuming the accuracy of the representations and warranties of the Purchasers in this Agreement
and the information disclosed in the Accredited Investor Questionnaires provided by the Purchasers, the Securities will be issued in
compliance with all applicable federal and state securities laws. The Company has reserved from its duly authorized capital stock the
maximum aggregate number of shares of Common Stock issuable upon exercise in full of all Warrants.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Capitalization</U>. The number of shares and type of all authorized, issued and outstanding capital stock, options and other securities
of the Company (whether or not presently convertible into or exercisable or exchangeable for shares of capital stock of the Company)
as of December 11, 2023 is set forth in <U>Schedule 3.1(g)</U> hereto. All of the outstanding shares of capital stock of the Company
are validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws
in all material respects, and none of such outstanding shares was issued in violation of any preemptive rights or similar rights to subscribe
for or purchase securities which violation would have or would reasonably be expected to result in a Material Adverse Effect. No further
approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities.
Except as set forth on <U>Schedule 3.1(g)</U>, there are no stockholders agreements, voting agreements or other similar agreements with
respect to the Company&rsquo;s capital stock to which the Company is a party or, to the Company&rsquo;s Knowledge, between or among any
of the Company&rsquo;s stockholders. There are no stockholders agreements, voting agreements or other similar agreements with respect
to the Company&rsquo;s capital stock to which the Company is a party or, to the Company&rsquo;s Knowledge, between or among any of the
Company&rsquo;s stockholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>SEC Reports; Disclosure Materials</U>. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by it under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date
hereof (or such shorter period as the Company was required by law or regulation to file such material) (the foregoing materials, including
the exhibits thereto and documents incorporated by reference therein, being collectively referred to herein as the &ldquo;<I>SEC Reports</I>&rdquo;,
and the SEC Reports, together with the Disclosure Schedules, being collectively referred to as the &ldquo;<I>Disclosure Materials</I>&rdquo;)
on a timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration
of any such extension. As of their respective filing dates, or to the extent corrected by a subsequent restatement, the SEC Reports complied
in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the Commission
promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under
which they were made, not misleading. The Company has never been an issuer subject to Rule 144(i) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Financial Statements</U>. The financial statements of the Company included in the SEC Reports comply in all material respects with
applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing
(or to the extent corrected by a subsequent restatement). Such financial statements have been prepared in accordance with GAAP applied
on a consistent basis during the periods involved, except as may be otherwise specified in such financial statements or the notes thereto
and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects
the financial position of the Company and its consolidated subsidiaries taken as a whole as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial year-end
audit adjustments.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Material Changes</U>. Since the date of the latest audited financial statements included within the SEC Reports, except as specifically
disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there have been no events, occurrences or developments that
have had or would reasonably be expected to have, either individually or in the aggregate, a Material Adverse Effect, (ii) the Company
has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the
ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company&rsquo;s financial
statements pursuant to GAAP or required to be disclosed in filings made with the Commission, (iii) the Company has not altered materially
its method of accounting or the manner in which it keeps its accounting books and records, and (iv) the Company has not declared or made
any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to purchase
or redeem any shares of its capital stock (other than in connection with repurchases of unvested stock issued to employees of the Company).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Compliance</U>. Neither the Company nor any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred
that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any of its Subsidiaries
under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it is in
violation of, any Material Contract (whether or not such default or violation has been waived), (ii) is in violation of any order of
any court, arbitrator or governmental body having jurisdiction over the Company or its properties or assets, or (iii) is in violation
of, or in receipt of written notice that it is in violation of, any statute, rule or regulation of any governmental authority applicable
to the Company, except in each case as would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>Regulatory Permits</U>. The Company and each of its Subsidiaries possess all certificates, authorizations and permits issued by the
appropriate federal, state, local or foreign regulatory authorities necessary to conduct its respective business as currently conducted
and as described in the SEC Reports, except where the failure to possess such permits, individually or in the aggregate, has not and
would not have or reasonably be expected to result in a Material Adverse Effect (&ldquo;<I>Material Permits</I>&rdquo;), and neither
the Company nor any of its Subsidiaries has received any notice of Proceedings relating to the revocation or modification of any such
Material Permits.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Title to Assets</U>. The Company and its Subsidiaries do not own any real property. Except as disclosed in the SEC Reports, the Company
and its Subsidiaries have good and marketable title to all tangible personal property owned by them that is material to the business
of the Company and its Subsidiaries, taken as whole, in each case free and clear of all Liens except such as do not materially affect
the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and any of
its Subsidiaries. Any real property and facilities held under lease by the Company and any of its Subsidiaries are held by them under
valid, subsisting and enforceable leases with such exceptions as are not material and do not interfere with the use made and proposed
to be made of such property and buildings by the Company and its Subsidiaries.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Intellectual Property</U>. To the Company&rsquo;s knowledge, the Company and the Subsidiaries own, possess, license or have other
rights to use, all patents, patent applications, trade and service marks, trade and service mark applications and registrations, trade
names, trade secrets, inventions, copyrights, licenses, technology, know-how and other intellectual property rights and similar rights
described in the SEC Reports necessary or material for use in connection with their respective businesses and which the failure to so
have would have or reasonably be expected to result in a Material Adverse Effect (collectively, the &ldquo;<I>Intellectual Property Rights</I>&rdquo;).
To the Company&rsquo;s knowledge, none of the Intellectual Property Rights used by the Company or any Subsidiary violates or infringes
upon the rights of any Person, except as would not, individually or in the aggregate, have or reasonably be expected to result in a Material
Adverse Effect. There is no pending or, to the Company&rsquo;s Knowledge, threatened Action by any Person that the Company&rsquo;s business
as now conducted infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of another,
except in each case as would not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.
To the Company&rsquo;s Knowledge, there is no existing infringement by another Person of any of the Company&rsquo;s Intellectual Property
Rights. The Company and its Subsidiaries have taken commercially reasonable security measures to protect the secrecy, confidentiality
and value of all of their Intellectual Property Rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(o)
<U>Internal Accounting Controls</U>. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management&rsquo;s general or specific authorizations, (ii) transactions
are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset and liability accountability,
(iii) access to assets or incurrence of liabilities is permitted only in accordance with management&rsquo;s general or specific authorization,
and (iv) the recorded accountability for assets and liabilities is compared with the existing assets and liabilities at reasonable intervals
and appropriate action is taken with respect to any differences.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(p)
<U>Sarbanes-Oxley; Disclosure Controls</U>. The Company is in compliance in all material respects with all of the provisions of the Sarbanes-Oxley
Act of 2002 which are applicable to it as of the Closing Date. The Company has established disclosure controls and procedures (as such
term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) for the Company and designed such disclosure controls and procedures
to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded,
processed, summarized and reported, within the time periods specified in the Commission&rsquo;s rules and forms. The Company&rsquo;s
certifying officers have evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures as of the end of the period
covered by the Company&rsquo;s most recently filed periodic report under the Exchange Act (such date, the &ldquo;<I>Evaluation Date</I>&rdquo;).
The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about
the effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation
Date, there have been no changes in the Company&rsquo;s internal control over financial reporting (as such term is defined in the Exchange
Act) that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal control over financial
reporting.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(q)
<U>Certain Fees</U>. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest or
claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Company with respect to the offer and sale of the Securities (which fees are being
paid by the Company). The Purchasers shall have no obligation with respect to any fees or with respect to any claims made by or on behalf
of other Persons for fees of a type contemplated in this paragraph (q) that may be due in connection with the transactions contemplated
by the Transaction Documents. The Company shall indemnify, pay, and hold each Purchaser harmless against, any liability, loss or expense
(including, without limitation, attorneys&rsquo; fees and out-of-pocket expenses) arising in connection with any such right, interest
or claim.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(r)
<U>Private Placement</U>. Assuming the accuracy of the Purchasers&rsquo; representations and warranties set forth in <U>Section 3.2</U>
of this Agreement and the accuracy of the information disclosed in the Accredited Investor Questionnaire provided by the Purchasers,
no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers under
the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(s)
<U>Investment Company</U>. The Company is not, and immediately after receipt of payment for the Securities, will not be an &ldquo;investment
company,&rdquo; an affiliate of an &ldquo;investment company,&rdquo; a company controlled by an &ldquo;investment company&rdquo; or an
&ldquo;affiliated person&rdquo; of, or &ldquo;promoter&rdquo; or &ldquo;principal underwriter&rdquo; for, an &ldquo;investment company&rdquo;
within the meaning of the Investment Company Act of 1940, as amended.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(t)
<U>Registration Rights</U>. Other than each of the Purchasers or as set forth in <U>Schedule 3.1(n)</U> hereto, no Person has any right
to cause the Company to effect the registration under the Securities Act of any securities of the Company other than those securities
which are currently registered on an effective registration statement on file with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(u)
<U>Listing and Maintenance Requirements</U>. The Company&rsquo;s Common Stock is, and the Warrant Shares when issued will be, registered
pursuant to Section 12(b) or 12(g) of the Exchange Act, and the Company has taken no action designed to terminate the registration of
the Common Stock under the Exchange Act nor has the Company received any notification that the Commission is contemplating terminating
such registration. Except as set forth in the SEC Reports, the Company has not, in the twelve (12) months preceding the date hereof,
received written notice from any Trading Market on which the Common Stock is listed or quoted to the effect that the Company is not in
compliance with the listing or maintenance requirements of such Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)
<U>No Integrated Offering</U>. None of the Company, its Subsidiaries nor, to the Company&rsquo;s Knowledge, any of its Affiliates or
any Person acting on its behalf has, directly or indirectly, at any time within the past six (6) months, made any offers or sales of
any Company security or solicited any offers to buy any security under circumstances that would (i) eliminate the availability of the
exemption from registration under the Securities Act in connection with the offer and sale by the Company of the Securities as contemplated
hereby or (ii) cause the offering of the Securities pursuant to the Transaction Documents to be integrated with prior offerings by the
Company for purposes of any applicable law, regulation or stockholder approval provisions, including, without limitation, under the rules
and regulations of any Trading Market on which any of the securities of the Company are listed or designated.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(w)
<U>No General Solicitation</U>. Neither the Company nor, to the Company&rsquo;s Knowledge, any person acting on behalf of the Company
has offered or sold any of Securities by any form of general solicitation or general advertising.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(x)
<U>Acknowledgment Regarding Purchasers&rsquo; Purchase of Securities</U>. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm&rsquo;s length purchaser with respect to the Transaction Documents and the transactions contemplated
hereby and thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or
in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by
any Purchaser or any of their respective representatives or agents in connection with the Transaction Documents and the transactions
contemplated thereby is merely incidental to the Purchasers&rsquo; purchase of the Securities. The Company further represents to each
Purchaser that the Company&rsquo;s decision to enter into this Agreement and the other Transaction Documents has been based solely on
the independent evaluation of the transactions contemplated hereby by the Company and its representatives.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(y)
<U>Regulation M Compliance</U>. The Company has not, and to the Company&rsquo;s Knowledge, no one acting on its behalf has, (i) taken,
directly or indirectly, any action designed to cause or to result in the stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of any of the Securities, (ii) sold, bid for, purchased, or paid any compensation for soliciting
purchases of, any of the securities of the Company or (iii) paid or agreed to pay to any Person any compensation for soliciting another
to purchase any other securities of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(z)
<U>No Defaults</U>. Except as disclosed in the SEC Reports, neither the Company nor any of its Subsidiaries (a) is in default in the
performance, observance or fulfillment of any of the obligations, covenants or conditions contained in any indenture, loan, credit agreement,
note, lease, license agreement, contract, franchise or other instrument (including, without limitation, any pledge agreement, security
agreement, mortgage or other instrument or agreement evidencing, guaranteeing, securing or relating to indebtedness) to which the Company
or any of its Subsidiaries is a party or by which it or any of them may be bound, or to which any of their respective properties or assets
are subject, and (b) no condition exists which, with the giving of notice or the lapse of time or both, could constitute such a default,
except, in each case of the foregoing subclauses (a)-(b), where the consequences, direct or indirect, of such default or defaults, if
any, could not reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(aa)
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2
<U>Representations and Warranties of the Purchasers</U>. Each Purchaser hereby, for itself and for no other Purchaser, represents and
warrants as of the date hereof and as of the Closing Date to the Company as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Organization; Authority</U>. If the Purchaser is an entity, such Purchaser is an entity duly organized, validly existing and in good
standing under the laws of the jurisdiction of its organization with the requisite corporate, partnership, limited liability company
or similar power and authority to enter into and to consummate the transactions contemplated by the applicable Transaction Documents
and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of this Agreement by such Purchaser and
performance by such Purchaser of the transactions contemplated by this Agreement have been, to the extent such Purchaser is an entity,
duly authorized by all necessary corporate or, if such Purchaser is not a corporation, such partnership, limited liability company or
other applicable like action, on the part of such Purchaser. Each Transaction Document to which such Purchaser is a party has been duly
executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally
binding obligation of such Purchaser, enforceable against it in accordance with its terms, except as such enforceability may be limited
by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the
enforcement of, creditors&rsquo; rights and remedies or by other equitable principles of general application.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>No Conflicts</U>. The execution, delivery and performance by such Purchaser of this Agreement and the consummation by such Purchaser
of the transactions contemplated hereby and thereby will not (i) result in a violation of the organizational documents of such Purchaser,
(ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or
give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which
such Purchaser is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal
and state securities laws) applicable to such Purchaser, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults,
rights or violations which would not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the
ability of such Purchaser to perform its obligations hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Investment Intent</U>. Such Purchaser understands that the Securities are &ldquo;restricted securities&rdquo; and have not been registered
under the Securities Act or any applicable state securities law and is acquiring the Securities as principal for its own account and
not with a view to, or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable
state securities laws; <I>provided, however</I>, that by making the representations herein, such Purchaser reserves the right, subject
to the provisions of this Agreement, to sell or otherwise dispose of all or any part of such Securities pursuant to an effective registration
statement under the Securities Act or under an exemption from such registration and in compliance with applicable federal and state securities
laws. Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser does not presently
have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or effect any distribution of any of
the Securities (or any securities which are derivatives thereof) to or through any person or entity; such Purchaser is not a registered
broker-dealer under Section 15 of the Exchange Act or an entity engaged in a business that would require it to be so registered as a
broker-dealer.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Purchaser Status</U>. At the time such Purchaser was offered the Securities, it was, and at the date hereof it is, and on each date
on which it exercises any Warrants and receives Warrant Shares, it will be either a &ldquo;qualified institutional buyer&rdquo; or an
&ldquo;accredited investor&rdquo; as such terms are defined under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>General Solicitation</U>. Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other
communication regarding the Securities published in any newspaper, magazine or similar media or broadcast over television or radio or
presented at any seminar or any other general advertisement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Experience of Such Purchaser</U>. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication
and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment
in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of
an investment in the Securities and, at the present time, is able to afford a complete loss of such investment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Access to Information</U>. Such Purchaser acknowledges that it has had the opportunity to review the Disclosure Materials and has
been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of
the Company concerning the terms and conditions of the offering of the Securities and the merits and risks of investing in the Securities;
(ii) access to information about the Company and the Subsidiaries and their respective financial condition, results of operations, business,
properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to obtain such additional
information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment
decision with respect to the investment. Neither such inquiries nor any other investigation conducted by or on behalf of such Purchaser
or its representatives or counsel shall modify, amend or affect such Purchaser&rsquo;s right to rely on the truth, accuracy and completeness
of the Disclosure Materials and the Company&rsquo;s representations and warranties contained in the Transaction Documents. Such Purchaser
has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with respect to its acquisition
of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Certain Trading Activities and Confidentiality</U>. Other than consummating the transactions contemplated hereunder, such Purchaser
has not, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, directly or indirectly executed
any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such
Purchaser first received a term sheet (written or oral) from the Company or any other Person representing the Company setting forth the
material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the foregoing,
in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of
such Purchaser&rsquo;s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers
managing other portions of such Purchaser&rsquo;s assets, the representation set forth above shall only apply with respect to the portion
of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement. Other
than to other Persons party to this Agreement or to such Purchaser&rsquo;s representatives, including, without limitation, its officers,
directors, partners, legal and other advisors, employees, agents and Affiliates, such Purchaser has maintained the confidentiality of
all disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding
the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty, or preclude any actions,
with respect to locating or borrowing shares in order to effect Short Sales or similar transactions in the future.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Brokers and Finders</U>. No Person will have, as a result of the transactions contemplated by this Agreement, any valid right, interest
or claim against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement
or understanding entered into by or on behalf of the Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Independent Investment Decision</U>. Such Purchaser has independently evaluated the merits of its decision to purchase Securities
pursuant to the Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser&rsquo;s
business and/or legal counsel in making such decision. Such Purchaser understands that nothing in this Agreement or any other materials
presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or
investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary
or appropriate in connection with its purchase of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
<U>Reliance on Exemptions</U>. Such Purchaser understands that the Securities being offered and sold to it in reliance on specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the
truth and accuracy of, and such Purchaser&rsquo;s compliance with, the representations, warranties, agreements, acknowledgements and
understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such
Purchaser to acquire the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
<U>No Governmental Review</U>. Such Purchaser understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in
the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
<U>Regulation M</U>. Such Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may apply to sales
of Common Stock and other activities with respect to the Common Stock by the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(n)
<U>Residency</U>. Such Purchaser&rsquo;s residence (if an individual) or offices in which its investment decision with respect to the
Securities was made (if an entity) are located at the address immediately below such Purchaser&rsquo;s name on its signature page hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company and each of the Purchasers acknowledge and agree that no party to this Agreement has made or makes any representations or warranties
with respect to the transactions contemplated hereby other than those specifically set forth in this <U>Article III</U> and the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
IV.<BR>
OTHER AGREEMENTS OF THE PARTIES</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1
<U>Transfer Restrictions</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 22.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Compliance with Laws</U>. Notwithstanding any other provision of this <U>Article IV</U>, each Purchaser covenants that the Securities
may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities
Act, or pursuant to an available exemption from, or in a transaction not subject to, the registration requirements of the Securities
Act, and in compliance with any applicable state and federal securities laws. In connection with any transfer of the Securities other
than (i) pursuant to an effective registration statement, (ii) to the Company, (iii) pursuant to Rule 144 (<I>provided</I> that the Purchaser
provides the Company with reasonable assurances (in the form of seller and, if applicable, broker representation letters) that the securities
may be sold pursuant to such rule) or (iv) in connection with a bona fide pledge as contemplated in <U>Section 4.1(b)</U>, the Company
may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable
to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer
does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, other than pursuant
to clause (i), (ii), or (iii) of this <U>Section 4.1(a)</U>, any such transferee shall agree in writing to be bound by the terms of this
Agreement and shall have the rights of a Purchaser under this Agreement with respect to such transferred Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Legends</U>. The Purchasers understand that, unless provided otherwise in this Agreement, the Securities, whether certificated or
uncertificated, will be endorsed with a restrictive legend in substantially the following form, until such time as they are not required
under <U>Section 4.1(c)</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THESE
SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED (THE &ldquo;SECURITIES ACT&rdquo;), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE
OF THESE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION
OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES
ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES AND THE SECURITIES ISSUABLE UPON EXERCISE OF THESE SECURITIES MAY BE PLEDGED IN CONNECTION
WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company acknowledges and agrees that a Purchaser may from time to time pledge, and/or grant a security interest in, some or all of the
legended Securities in connection with applicable securities laws, pursuant to a bona fide margin agreement in compliance with a bona
fide margin loan. Such a pledge would not be subject to approval or consent of the Company and no legal opinion of legal counsel to the
pledgee, secured party or pledgor shall be required in connection with the pledge, but such legal opinion shall be required in connection
with a subsequent transfer or foreclosure following default by the Purchaser transferee of the pledge. No notice shall be required of
such pledge, but Purchaser&rsquo;s transferee shall promptly notify the Company of any such subsequent transfer or foreclosure. Each
Purchaser acknowledges that the Company shall not be responsible for any pledges relating to, or the grant of any security interest in,
any of the Securities or for any agreement, understanding or arrangement between any Purchaser and its pledgee or secured party. At the
appropriate Purchaser&rsquo;s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party
of Securities may reasonably request in connection with a pledge or transfer of the Securities, including the preparation and filing
of any required prospectus supplement under Rule 424(b)(3) of the Securities Act or other applicable provision of the Securities Act
to appropriately amend the list of Selling Stockholders thereunder. Each Purchaser acknowledges and agrees that, except as otherwise
provided in <U>Section 4.1(c)</U>, any Securities subject to a pledge or security interest as contemplated by this <U>Section 4.1(b)
</U>shall continue to bear the legend set forth in this <U>Section 4.1(b)</U> and be subject to the restrictions on transfer set forth
in <U>Section 4.1(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Removal of Legends</U>. The legend set forth in <U>Section 4.1(b)</U> above shall be removed if (i) such Securities are registered
for resale under the Securities Act (provided that, if the Purchaser is selling pursuant to the effective registration statement registering
the Securities for resale, the Purchaser agrees to only sell such Securities during such time that such registration statement is effective
and not withdrawn or suspended, and only as permitted by such registration statement), (ii) such Securities are sold or transferred pursuant
to Rule 144 (if the transferor is not an Affiliate of the Company), or (iii) such Securities are eligible for resale under Rule 144(b)
or any successor provision, without volume or manner-of-sale restrictions. Following the earlier of (i) the Effective Date or (ii) Rule
144 becoming available for the resale of the Securities, without volume or manner-of-sale restrictions, the Company shall cause Company
Counsel to issue to the Transfer Agent the legal opinion referred to in the Irrevocable Transfer Agent Instructions. Any fees (with respect
to the Transfer Agent, Company Counsel or otherwise) associated with the issuance of such opinion or the removal of such legend shall
be borne by the Company. Following the Effective Date, or at such earlier time as a legend is no longer required for the Securities,
if requested by a Purchaser, the Company shall request that the Transfer Agent remove any restrictive legends related to such Securities,
whether certificated or uncertificated, and issue a new, unlegended stock certificate or make a new, unlegended book entry for such Securities,
as the case may be, within three (3) Trading Days of any such request, provided that the Company has timely received from such Purchaser
customary representations and other documentation reasonably acceptable to the Company and the Transfer Agent in connection therewith
and an opinion of counsel to the extent required by <U>Section 4.1(a)</U>. The Company may not make any notation on its records or give
instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this <U>Section 4.1(c)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Irrevocable Transfer Agent Instructions</U>. The Company shall issue irrevocable instructions to its transfer agent, and any subsequent
transfer agent, in the form of <U>Exhibit D</U> attached hereto (the &ldquo;<I>Irrevocable Transfer Agent Instructions</I>&rdquo;). The
Company represents and warrants that no instruction other than the Irrevocable Transfer Agent Instructions referred to in this <U>Section
4.1(d)</U> (or instructions that are consistent therewith) will be given by the Company to its transfer agent regarding the Securities
in connection with <U>Section 4.1(c)</U>, and that such Securities shall otherwise be freely transferable on the books and records of
the Company as and to the extent provided in this Agreement and the other Transaction Documents and applicable law. The Company acknowledges
that a breach by it of its obligations under this <U>Section 4.1(d)</U> will cause irreparable harm to a Purchaser. Accordingly, the
Company acknowledges that the remedy at law for a breach of its obligations under this <U>Section 4.1(d)</U> will be inadequate and agrees,
in the event of a breach or threatened breach by the Company of the provisions of this <U>Section 4.1(d)</U>, that a Purchaser shall
be entitled, in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring immediate
issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Acknowledgement</U>. Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will
not sell or otherwise transfer the Securities or any interest therein without complying with the requirements of the Securities Act.
While the Registration Statement remains effective, each Purchaser hereunder may sell the Securities in accordance with the plan of distribution
contained in the Registration Statement and if it does so it will comply therewith and with the related prospectus delivery requirements
unless an exemption therefrom is available. Each Purchaser, severally and not jointly with the other Purchasers, agrees that if it is
notified by the Company in writing at any time that the Registration Statement registering the resale of the Securities is not effective
or that the prospectus included in such Registration Statement no longer complies with the requirements of Section 10 of the Securities
Act, the Purchaser will refrain from selling such Securities until such time as the Purchaser is notified by the Company that such Registration
Statement is effective or such prospectus is compliant with Section 10 of the Securities Act, unless such Purchaser is able to, and does,
sell such Securities pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act. Both the
Company and its Transfer Agent, and their respective directors, officers, employees and agents, may rely on this <U>Section 4.1(e)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2
<U>Furnishing of Information</U>. In order to enable the Purchasers to sell the Securities under Rule 144, the Company shall use its
commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period)
all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. If the Company is not required to
file reports pursuant to the Exchange Act, it will prepare and furnish to the Purchasers and make publicly available in accordance with
Rule 144(c) such information as is required for the Purchasers to sell the Securities under Rule 144.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3
<U>Integration</U>. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the
Securities Act) that will be integrated with the offer or sale of the Securities in a manner that would require the registration under
the Securities Act of the sale of the Securities to the Purchasers, or that will be integrated with the offer or sale of the Securities
for purposes of the rules and regulations of any Trading Market such that it would require stockholder approval prior to the closing
of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4
<U>Securities Laws Disclosure; Publicity</U>. The Company shall (i) by 9:00 A.M. Eastern time on the second Trading Day immediately following
the date hereof, issue a press release (the &ldquo;<I>Press Release</I>&rdquo;) disclosing all material terms of the transactions contemplated
hereby and (ii) within the time required by the Exchange Act, the Company will file a Current Report on Form 8-K with the Commission
including this Agreement as an exhibit thereto. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any
Purchaser or an Affiliate of any Purchaser, or include the name of any Purchaser or an Affiliate of any Purchaser in any press release
or filing with the Commission (other than the Registration Statement) or any regulatory agency or Trading Market, without the prior written
consent of such Purchaser, except (i) as required by federal securities law in connection with (A) any Registration Statement contemplated
hereunder and (B) the filing of final Transaction Documents (including signature pages thereto, only if requested by the Commission)
with the Commission and (ii) to the extent such disclosure is required by law, request of the Staff of the Commission or Trading Market
regulations, in which case the Company shall provide the Purchasers with prior written notice of such disclosure permitted under this
subclause (ii).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5
<U>Non-Public Information</U>. Except with respect to the material terms and conditions of the transactions contemplated by the Transaction
Documents, including this Agreement, or as expressly required by any applicable securities law, the Company covenants and agrees that
neither it, nor any other Person acting on its behalf, will provide any Purchaser or its agents or counsel with any information regarding
the Company that the Company believes constitutes material non-public information without the express written consent of such Purchaser,
unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such information.
The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities
of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6
<U>Use of Proceeds</U>. The Company shall use the net proceeds from the sale of the Securities hereunder for general corporate purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7
<U>Principal Trading Market Listing</U>. In the time and manner required by the Principal Trading Market, the Company shall prepare and
file with such Principal Trading Market a listing of additional shares notification covering the Warrant Shares and shall use its commercially
reasonable efforts to take all steps necessary to cause the Warrant Shares to be approved for listing on the Principal Trading Market
as promptly as possible thereafter.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8
<U>Blue Sky</U>. The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary
in order to obtain an exemption for or to qualify the Securities for sale to the Purchasers under applicable securities or &ldquo;Blue
Sky&rdquo; laws of the states of the United States (or to obtain an exemption from such qualification) and shall provide evidence of
such actions promptly upon the written request of any Purchaser.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9
<U>Delivery of Securities</U>. The Company shall deliver, or cause to be delivered, the respective Securities purchased by each Purchaser
in accordance with <U>Section 2.1(d)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.10
<U>Subsequent Equity Sales</U>. Without the prior written consent of each Purchaser, from the date hereof until thirty (30) days following
the Closing Date, neither the Company nor any Subsidiary shall issue shares of Common Stock or Common Stock Equivalents. Notwithstanding
anything to the contrary contained herein, the foregoing restriction shall not apply to (a) securities required to be issued pursuant
to the Transaction Documents, (b) securities required to be issued to contractual obligations of the Company in effect as of the date
of this Agreement, (c) equity securities issued or issuable pursuant to employee benefit or purchase plans in effect as of the date of
this Agreement or pursuant to bona fide employee benefit or purchase plans established during the period described in the first sentence
of this <U>Section 4.10</U> and (d) the issuance of shares of Common Stock in connection with mergers or acquisitions of businesses,
entities, property or other assets, joint ventures or strategic alliances.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
V.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">CONDITIONS
PRECEDENT TO CLOSING</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1
<U>Conditions Precedent to the Obligations of the Purchasers to Purchase Securities</U>. The obligation of each Purchaser to acquire
Securities at the Closing is subject to the fulfillment to such Purchaser&rsquo;s satisfaction, on or prior to the Closing Date, of each
of the following conditions, any of which may be waived by such Purchaser (as to itself only):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Representations and Warranties</U>. The representations and warranties of the Company contained herein shall be true and correct in
all material respects (except for those representations and warranties which are qualified as to materiality or Material Adverse Effect,
in which case such representations and warranties shall be true and correct in all respects) as of the date when made and as of the Closing
Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific date which shall
be true as of such date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Performance</U>. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>No Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Consents</U>. The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers
necessary for consummation of the purchase and sale of the Securities (including all Required Approvals), all of which shall be and remain
so long as necessary in full force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Adverse Changes</U>. Since the date of execution of this Agreement, no event or series of events shall have occurred that has had
or would reasonably be expected to have a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Listing</U>. The NASDAQ Capital Market shall have notified the Company that its obligation to submit the listing of additional shares
notification form for the Warrant Shares is completed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>No Suspensions of Trading in Common Stock</U>. The Common Stock shall not have been suspended, as of the Closing Date, by the Commission
or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the Commission or the Principal
Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market
or (B) by falling below the minimum listing maintenance requirements of the Principal Trading Market.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Company Deliverables</U>. The Company shall have delivered the Company Deliverables in accordance with <U>Section 2.2(a)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
<U>Compliance Certificate</U>. The Company shall have delivered to each Purchaser a certificate, dated as of the Closing Date and signed
by its Chief Executive Officer or its Interim Chief Financial Officer, dated as of the Closing Date, certifying to the fulfillment of
the conditions specified in <U>Sections 5.1(a)</U> and <U>(b)</U> in the form attached hereto as <U>Exhibit G</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
<U>Termination</U>. This Agreement shall not have been terminated as to such Purchaser in accordance with <U>Section 7.17</U> herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2
<U>Conditions Precedent to the Obligations of the Company to sell Securities</U>. The Company&rsquo;s obligation to sell and issue the
Securities at the Closing to the Purchasers is subject to the fulfillment to the satisfaction of the Company on or prior to the Closing
Date of the following conditions, any of which may be waived by the Company:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Representations and Warranties</U>. The representations and warranties made by the Purchasers contained herein hereof shall be true
and correct in all material respects (except for those representations and warranties which are qualified as to materiality or Material
Adverse Effect, in which case such representations and warranties shall be true and correct in all respects) as of the date when made,
and as of the Closing Date as though made on and as of such date, except for representations and warranties that speak as of a specific
date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Performance</U>. Such Purchaser shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the
Closing Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>No Injunction</U>. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions
contemplated by the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Consents</U>. The Company shall have obtained in a timely fashion any and all consents, permits, approvals, registrations and waivers
necessary for consummation of the purchase and sale of the Securities, all of which shall be and remain so long as necessary in full
force and effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Purchasers Deliverables</U>. Such Purchaser shall have delivered its Purchaser Deliverables in accordance with <U>Section 2.2(b)</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Termination</U>. This Agreement shall not have been terminated as to such Purchaser in accordance with <U>Section 7.17</U> herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VI.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">REGISTRATION
RIGHTS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.1
<U>Required Registration Statement</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
As promptly as possible, and in any event on or prior to the Filing Date, the Company shall prepare and file with the Commission a Registration
Statement covering the resale of all Warrant Shares for an offering to be made on a continuous basis pursuant to Rule 415. The Registration
Statement shall be on Form S-3 (except if the Company is not then eligible to register for resale the Warrant Shares on Form S-3, in
which case such registration shall be on another appropriate form in accordance with the Securities Act and the Exchange Act).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall use its commercially reasonable efforts to cause the Registration Statement to be declared effective by the Commission
as promptly as possible after the filing thereof, but in any event prior to the Required Effectiveness Date, and shall use its commercially
reasonable efforts to keep the Registration Statement continuously effective under the Securities Act until the date that all Warrant
Shares covered by such Registration Statement have been sold or can be sold publicly under Rule 144 without volume limitations or manner
of sale restrictions by the holders of the Securities (the &ldquo;<I>Effectiveness Period</I>&rdquo;). Upon notification by the Commission
that a Registration Statement will not be reviewed or is no longer subject to further review and comments, the Company shall request
acceleration of such Registration Statement within five (5) Trading Days after receipt of such notice and request that it become effective
no later than 4:00 p.m. New York City time on the second Trading Day following the delivery of such an acceleration request (but no earlier
than the Effective Date) and file a prospectus supplement for any Registration Statement, whether or not required under Rule 424 (or
otherwise), by 9:00 a.m. New York City time the day after the Effective Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
If the Company receives Commission Comments to a Registration Statement filed pursuant to <U>Section 6.1(a)</U>, the Company shall be
obligated to use its commercially reasonable efforts to advocate with the Commission for the registration of all of the Warrant Shares
requested to be included in the Registration Statement in accordance with applicable Commission guidance. If it is determined by the
Company that all of the Securities requested to be included in a Registration Statement cannot be included due to the Commission Comments,
then the Company shall use its commercially reasonable efforts to prepare and file as expeditiously as practicable, such number of additional
Registration Statements as may be necessary in order to ensure that all Warrant Shares are covered by an existing and effective Registration
Statement. Any cutbacks of Securities from a Registration Statement filed pursuant to <U>Section 6.1(a)</U>, due to Commission Comments
shall be applied to the Purchasers pro rata in accordance with the number of such Warrant Shares sought to be included in such Registration
Statement by reference to the number of such Purchaser&rsquo;s Warrant Shares relative to all outstanding Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
The Company shall notify the Purchasers in writing promptly (and in any event within two Trading Days) after receiving notification from
the Commission that the Registration Statement has been declared effective.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
Neither the Company nor any of its security holders (other than the Purchasers in such capacity pursuant hereto) may include securities
of the Company in the Registration Statement required to be filed under <U>Section 6.1(a)</U> other than the Securities, except as otherwise
required pursuant to that certain Registration Rights Agreement, dated as of October 10, 2019, by and among the Company and the purchasers
signatory thereto (the &ldquo;<I>Registration Rights Agreement</I>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.2
<U>Effectiveness of Registration Statement</U>. Notwithstanding anything in this Agreement to the contrary, the Company may, by written
notice to the Purchasers, suspend sales under a Registration Statement after the Effective Date thereof and/or require that the Purchasers
immediately cease the sale of Warrant Shares pursuant thereto and/or defer the filing of any subsequent Registration Statement if the
board of directors of the Company determines in good faith, by appropriate resolutions, that, the disclosure of material non-public information
concerning the Company (A) would be materially detrimental to the Company (other than as relating solely to the price of the Common Stock)
to maintain a Registration Statement at such time or (B) it is in the good faith determination of the Company&rsquo;s board of directors
that it is in the best interests of the Company to suspend sales under such registration at such time; provided, however, that the Company
may not delay or suspend the Registration Statement on more than two occasions or for more than thirty (30) consecutive calendar days,
or more than sixty (60) total calendar days, in each case during any twelve-month period. Upon receipt of such notice, each Purchaser
shall immediately discontinue any sales of Warrant Shares pursuant to such registration until such Purchaser is advised in writing by
the Company that the current Prospectus or amended Prospectus, as applicable, may be used. In no event, however, shall this right be
exercised to suspend sales beyond the period during which (in the good faith determination of the Company&rsquo;s board of directors)
the failure to require such suspension would be materially detrimental to the Company. Immediately after the end of any suspension period
under this <U>Section 6.2</U>, the Company shall take all necessary actions (including filing any required supplemental prospectus) to
restore the effectiveness of the applicable Registration Statement and the ability of the Purchasers to publicly resell their Warrant
Shares pursuant to such effective Registration Statement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.3
<U>Registration Procedures</U>. In connection with the Company&rsquo;s registration obligations under <U>Section 6.1</U>, the Company
shall:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Not less than three Trading Days prior to the filing of a Registration Statement or any related Prospectus or any amendment or supplement
thereto, furnish via email to those Purchasers who have supplied the Company with email addresses copies of all such documents and correspondence
proposed to be filed, which documents (other than any document that is incorporated or deemed to be incorporated by reference therein)
will be subject to the review of such Purchasers. The Company shall reflect in each such document when so filed with the Commission such
comments regarding the Purchasers and the plan of distribution as the Purchasers may reasonably and promptly propose no later than two
Trading Days after the Purchasers have been so furnished with copies of such documents as aforesaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
Subject to <U>Section 6.2</U>, prepare and file with the Commission such amendments, including post-effective amendments, to each Registration
Statement and the Prospectus used in connection therewith as may be necessary to keep the Registration Statement continuously effective,
as to the applicable Warrant Shares for the Effectiveness Period and prepare and file with the Commission such additional Registration
Statements in order to register for resale under the Securities Act all of the Warrant Shares; (ii) cause the related Prospectus to be
amended or supplemented by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424; (iii)
respond as promptly as reasonably possible, and in any event within fifteen (15) Trading Days (except to the extent that the Company
reasonably requires additional time to respond to accounting comments), to any comments received from the Commission with respect to
the Registration Statement or any amendment thereto; and (iv) comply in all material respects with the provisions of the Securities Act
and the Exchange Act with respect to the disposition of all Warrant Shares covered by the Registration Statement during the applicable
period in accordance with the intended methods of disposition by the Purchasers thereof set forth in the Registration Statement as so
amended or in such Prospectus as so supplemented.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
Notify the Purchasers as promptly as reasonably possible, and (if requested by the Purchasers) confirm such notice in writing no later
than two Trading Days thereafter, of any of the following events: (i) the Commission notifies the Company whether there will be a &ldquo;review&rdquo;
of any Registration Statement; (ii) the Commission comments in writing on any Registration Statement; (iii) any Registration Statement
or any post-effective amendment is declared effective; (iv) the Commission or any other Federal or state governmental authority requests
any amendment or supplement to any Registration Statement or Prospectus or requests additional information related thereto; (v) the Commission
issues any stop order suspending the effectiveness of any Registration Statement or initiates any Proceedings for that purpose; (vi)
the Company receives notice of any suspension of the qualification or exemption from qualification of any Warrant Shares for sale in
any jurisdiction, or the initiation or threat of any Proceeding for such purpose; or (vii) the financial statements included in any Registration
Statement become ineligible for inclusion therein or any Registration Statement or Prospectus or other document contains any untrue statement
of a material fact or omits to state any material fact required to be stated therein or necessary to make the statements therein, in
the light of the circumstances under which they were made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Use its commercially reasonable efforts to avoid the issuance of or, if issued, obtain the withdrawal of (i) any order suspending the
effectiveness of any Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of
the Warrant Shares for sale in any jurisdiction, as soon as possible.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
If requested by any Purchaser, provide such Purchaser without charge, at least one conformed copy of each Registration Statement and
each amendment thereto, including financial statements and schedules, and all exhibits to the extent requested by such Person (including
those previously furnished or incorporated by reference) promptly after the filing of such documents with the Commission.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
Promptly deliver to each Purchaser, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus)
and each amendment or supplement thereto as such Persons may reasonably request. The Company hereby consents to the use of such Prospectus
and each amendment or supplement thereto by each of the selling Purchasers in connection with the offering and sale of the Warrant Shares
covered by such Prospectus and any amendment or supplement thereto to the extent permitted by federal and state securities laws and regulations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
Prior to any public offering of Warrant Shares, use its commercially reasonable efforts to register or qualify or cooperate with the
selling Purchasers in connection with the registration or qualification (or exemption from such registration or qualification) of such
Warrant Shares for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States as any Purchaser
requests in writing, to keep each such registration or qualification (or exemption therefrom) effective for so long as required, but
not to exceed the duration of the Effectiveness Period, and to do any and all other acts or things reasonably necessary or advisable
to enable the disposition in such jurisdictions of the Warrant Shares covered by a Registration Statement; <U>provided</U>, <U>however</U>,
that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as
a dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business
in any jurisdiction in which it is not otherwise so subject.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
Cooperate with the Purchasers to facilitate the timely preparation and delivery of certificates representing the Warrant Shares, as applicable,
to be delivered to a transferee pursuant to a Registration Statement, which certificates shall be free, to the extent permitted by this
Agreement and under law, of all restrictive legends, and to enable such certificates to be in such denominations and registered in such
names as any such Purchaser may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
Upon the occurrence of any event described in <U>Section 6.3(c)(vii</U>), as promptly as reasonably possible, prepare a supplement or
amendment, including a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document
incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered,
neither the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(j)
Cooperate with any reasonable due diligence investigation undertaken by the Purchasers in connection with the sale of Warrant Shares,
including, without limitation, by making available documents and information; provided that the Company will not deliver or make available
to any Purchaser material, nonpublic information unless such Purchaser requests in advance in writing to receive material, nonpublic
information and agrees to keep such information confidential.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(k)
Comply with all rules and regulations of the Commission applicable to the registration of the securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(l)
It shall be a condition precedent to the obligations of the Company to complete the registration pursuant to this Agreement with respect
to the Warrant Shares of any particular Purchaser that such Purchaser furnish to the Company the information specified in <U>Exhibits
C-1</U>, <U>C-2</U> and <U>C-3</U> hereto and such other information regarding itself, the Warrant Shares and other shares of Common
Stock held by it and the intended method of disposition of the Warrant Shares held by it (if different from the Plan of Distribution
set forth on <U>Exhibit K</U> hereto) as shall be reasonably required to effect the registration of such Warrant Shares and shall complete
and execute such documents in connection with such registration as the Company may reasonably request.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(m)
The Company shall comply with all applicable rules and regulations of the Commission under the Securities Act and the Exchange Act, including,
without limitation, Rule 172 under the Securities Act, file any final Prospectus, including any supplement or amendment thereof, with
the Commission pursuant to Rule 424 under the Securities Act, promptly inform the Purchaser in writing if, at any time during the Effectiveness
Period, the Company does not satisfy the conditions specified in Rule 172 and, as a result thereof, the Purchaser are required to make
available a Prospectus in connection with any disposition of Warrant Shares and take such other actions as may be reasonably necessary
to facilitate the registration of the Warrant Shares hereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.4
<U>Registration Expenses &ndash; Registration Required by Section 6.1</U>. The Company shall pay all fees and expenses incurred by the
Company in connection with (and incident to) the performance of its obligations under <U>Section 6.1</U> of this Agreement by the Company,
including without limitation (a) all registration and filing fees and expenses, including without limitation those related to filings
with the Commission, any Trading Market and in connection with applicable state securities or Blue Sky laws, (b) printing expenses (including
without limitation expenses of printing certificates for Warrant Shares, if any), (c) messenger, telephone and delivery expenses, and
(d) fees and disbursements of counsel for the Company. The fees and expenses incurred by the Company in connection with (and incident
to) the performance of its obligations under <U>Section 6.1</U> of this Agreement shall be borne by the Company regardless of whether
or not any registration statement is filed or becomes effective. The Company will pay its internal expenses (including all salaries and
expenses of its officers and employees performing legal or accounting duties, the expense of any annual audit and the expense of any
liability insurance), the expenses and fees for listing the securities to be registered on each securities exchange and included in each
established over-the-counter market on which similar securities issued by the Company are then listed or traded and any expenses of the
Company incurred in connection with any &ldquo;road show&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 49.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.5
<U>Indemnification</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 13.5pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Indemnification by the Company</U>. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless
each Purchaser, the officers, directors, partners, members, agents and employees of each of them, each Person who controls any such Purchaser
(within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, partners, members,
agents and employees of each such controlling Person (each, a &ldquo;<I>Purchaser Party</I>&rdquo;), to the fullest extent permitted
by applicable law, from and against any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses,
including all judgments, amounts paid in settlements, court costs and reasonable attorneys&rsquo; fees and costs of investigation (collectively,
&ldquo;<I>Losses</I>&rdquo;) that any such Purchaser Party may suffer or incur as a result of or relating to (i) any misrepresentation
or breach of any representation or warranty made by the Company in the Transaction Documents or any other certificate, instrument or
document contemplated hereby or thereby, (ii) any breach of any covenant, agreement or obligation of the Company contained in the Transaction
Documents or any other certificate, instrument or document contemplated hereby or thereby, (iii) any cause of action, suit or claim brought
or made against such Indemnified Party (as defined in <U>Section 6.5(c)</U> below) by a third party (including for these purposes a derivative
action brought on behalf of the Company), arising out of or resulting from (x) the execution, delivery, performance or enforcement of
the Transaction Documents or any other certificate, instrument or document contemplated hereby or thereby, (y) any transaction financed
or to be financed in whole or in part, directly or indirectly, with the proceeds of the issuance of the Securities, or (z) the status
of Indemnified Party as holder of the Securities (unless, and only to the extent that, such action, suit or claim is based upon a breach
of such Investor&rsquo;s representations, warranties or covenants under the Transaction Documents or any conduct by such Investor that
constitutes fraud, gross negligence or willful misconduct) or (iv) any untrue or alleged untrue statement of a material fact contained
in the Registration Statement, any Prospectus or any form of Company prospectus or in any amendment or supplement thereto or in any Company
preliminary prospectus, or arising out of or relating to any omission or alleged omission of a material fact required to be stated therein
or necessary to make the statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light
of the circumstances under which they were made) not misleading, except to the extent, but only to the extent, that (A) such untrue statements,
alleged untrue statements, omissions or alleged omissions are based solely upon information regarding such Purchaser furnished in writing
to the Company by or on behalf of such Purchaser for use therein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Indemnification by Purchasers</U>. Each Purchaser shall, severally and not jointly, indemnify and hold harmless the Company and its
directors, officers, agents and employees to the fullest extent permitted by applicable law, from and against all Losses (as determined
by a court of competent jurisdiction in a final judgment not subject to appeal or review) arising solely out of any untrue statement
of a material fact contained in the Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement
thereto, or arising out of or relating to any omission of a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they
were made) not misleading, but only to the extent that such untrue statements or omissions are based solely upon information regarding
such Purchaser furnished to the Company by or on behalf of such Purchaser in writing expressly for use therein (it being understood that
the information provided by the Purchaser to the Company in (A) <U>Exhibits C-1</U>, <U>C-2</U> and <U>C-3</U>, as the same may be modified
by such Purchaser or (B) in writing constitutes information reviewed and expressly approved by such Purchaser in writing expressly for
use in the Registration Statement), such Prospectus or such form of prospectus or in any amendment or supplement thereto. In no event
shall the liability of any selling Purchaser hereunder be greater in amount than the dollar amount of the net proceeds received by such
Purchaser upon the sale of the Securities giving rise to such indemnification obligation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Conduct of Indemnification Proceedings</U>. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an &ldquo;<I>Indemnified Party</I>&rdquo;), such Indemnified Party shall promptly notify the Person from whom indemnity is
sought (the &ldquo;<I>Indemnifying Party</I>&rdquo;<I>)</I> in writing, and the Indemnifying Party shall assume the defense thereof,
including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees and expenses incurred
in connection with defense thereof; provided, that the failure of any Indemnified Party to give such notice shall not relieve the Indemnifying
Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the extent that it shall be finally determined
by a court of competent jurisdiction (which determination is not subject to appeal or further review) that such failure shall have proximately
and materially adversely prejudiced the Indemnifying Party.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
Indemnified Party shall have the right to employ separate counsel (including local counsel) in any such Proceeding and to participate
in the defense thereof, but the fees and expenses of such counsel (including local counsel) shall be at the expense of such Indemnified
Party or Parties unless: (i) the Indemnifying Party has agreed in writing to pay such fees and expenses; or (ii) the Indemnifying Party
shall have failed promptly to assume the defense of such Proceeding and to employ counsel (including local counsel) reasonably satisfactory
to such Indemnified Party in any such Proceeding; or (iii) the named parties to any such Proceeding (including any impleaded parties)
include both such Indemnified Party and the Indemnifying Party, and such Indemnified Party shall have been advised by counsel that a
conflict of interest is likely to exist if the same counsel were to represent such Indemnified Party and the Indemnifying Party (in which
case, if such Indemnified Party notifies the Indemnifying Party in writing that it elects to employ separate counsel (including local
counsel) at the expense of the Indemnifying Party, the Indemnifying Party shall not have the right to assume the defense thereof and
the reasonable fees and expenses of separate counsel (including local counsel) shall be at the expense of the Indemnifying Party). It
shall be understood, however, that the Indemnifying Party shall not, in connection with any one such Proceeding (including separate Proceedings
that have been or will be consolidated before a single judge) be liable for the fees and expenses of more than one separate firm of attorneys
at any time for all Indemnified Parties, which firm shall be appointed by a majority of the Indemnified Parties. The Indemnifying Party
shall not be liable for any settlement of any such Proceeding effected without its written consent, which consent shall not be unreasonably
withheld. No Indemnifying Party shall, without the prior written consent of the Indemnified Party, effect any settlement of any pending
Proceeding in respect of which any Indemnified Party is a party, unless such settlement includes an unconditional release of such Indemnified
Party from all liability on claims that are the subject matter of such Proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
reasonable fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred in connection with
investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section) shall be paid to the Indemnified
Party, as incurred, within 20 Trading Days of written notice thereof to the Indemnifying Party (regardless of whether it is ultimately
determined that an Indemnified Party is not entitled to indemnification hereunder; provided, that the Indemnifying Party may require
such Indemnified Party to undertake to reimburse all such fees and expenses to the extent it is finally judicially determined that such
Indemnified Party is not entitled to indemnification hereunder).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Contribution</U>. If a claim for indemnification under <U>Section 6.5(a</U>) or <U>(b</U>) is unavailable to an Indemnified Party
(by reason of public policy or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute
to the amount paid or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the
relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted
in such Losses as well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified
Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information
supplied by, such Indemnifying Party or Indemnified Party, and the parties&rsquo; relative intent, Knowledge, access to information and
opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses
shall be deemed to include, subject to the limitations set forth in <U>Section 6.5(c</U>), any reasonable attorneys&rsquo; or other reasonable
fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such
fees or expenses if the indemnification provided for in this Section was available to such party in accordance with its terms.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 85.5pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
parties hereto agree that it would not be just and equitable if contribution pursuant to this <U>Section 6.5(d</U>) were determined by
pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in
the immediately preceding paragraph. Notwithstanding the provisions of this <U>Section 6.5(d</U>), no Purchaser shall be required to
contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received by such Purchaser from the
sale of the Warrant Shares subject to the Proceeding exceed the amount of any damages that such Purchaser has otherwise been required
to pay by reason of such untrue or alleged untrue statement or omission or alleged omission. No Person guilty of fraudulent misrepresentation
(within the meaning of <U>Section 11(f</U>) of the Securities Act) shall be entitled to contribution from any Person who was not guilty
of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties may have
to the Indemnified Parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.6
<U>Dispositions</U>. Each Purchaser agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable
to it in connection with sales of Warrant Shares pursuant to the Registration Statement and shall sell its Warrant Shares in accordance
with the Plan of Distribution set forth in the Prospectus. Each Purchaser further agrees that, upon receipt of a notice from the Company
of the occurrence of any event of the kind described in <U>Sections 6.3(c)(v</U>), <U>(vi</U>) or <U>(vii</U>), such Purchaser will discontinue
disposition of such Warrant Shares under the Registration Statement until such Purchaser is advised in writing by the Company that the
use of the Prospectus, or amended Prospectus, as applicable, may be resumed. The Company may provide appropriate stop orders to enforce
the provisions of this paragraph. Each Purchaser, severally and not jointly with the other Purchasers, agrees that the removal of the
restrictive legend from certificates representing Warrant Shares as set forth in <U>Section 4.1</U> is predicated upon the Company&rsquo;s
reliance that the Purchaser will comply with the provisions of this subsection. Both the Company and the Transfer Agent, and their respective
directors, officers, employees and agents, may rely on this subsection</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ARTICLE
VII.<BR>
MISCELLANEOUS</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.1
<U>Fees and Expenses</U>. Except as provided in <U>Section 6.4</U>, the Company and the Purchasers shall each pay the fees and expenses
of their respective advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party in connection
with the negotiation, preparation, execution, delivery and performance of this Agreement. The Company shall pay all Transfer Agent fees,
stamp taxes and other taxes and duties levied in connection with the sale and issuance of the Securities to the Purchasers.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.2
<U>Entire Agreement</U>. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.
At or after the Closing, and without further consideration, the Company and the Purchasers will execute and deliver to the other such
further documents as may be reasonably requested in order to give practical effect to the intention of the parties under the Transaction
Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.3
<U>Notices</U>. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered
via facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the facsimile number specified
in this <U>Section 7.3</U> or email at the email address specified in this <U>Section 7.3</U> prior to 5:00 P.M., New York City time,
on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile
at the facsimile number specified in this <U>Section 7.3</U> or email at the email address specified in this <U>Section 7.3</U> on a
day that is not a Trading Day or later than 5:00 P.M., New York City time, on any Trading Day, (c) the Trading Day following the date
of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified, or (d) upon actual receipt
by the party to whom such notice is required to be given. The address for such notices and communications shall be as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 93%; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left; width: 25%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to the Company:</FONT></TD>
  <TD STYLE="text-align: left; width: 75%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline Health
  Solutions, Inc.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2400 Old Milton Pkwy., Box 1353</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alpharetta, Georgia 30009</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone No.: (888) 997-8732</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: Bryant J. Reeves,
  III</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail: bj.reeves@streamlinehealth.net</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">With a copy to:</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">Troutman Pepper Hamilton Sanders LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">600 Peachtree Street NE, Suite
  3000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Atlanta, Georgia 30308</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone No.: (404) 885-3000</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention: <FONT STYLE="background-color: white">David
  W. Ghegan</FONT></FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail: david.ghegan@troutman.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">If to a Purchaser:</FONT></TD>
  <TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">To the address set forth under such Purchaser&rsquo;s
  name on the signature page hereto;</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">or
such other address as may be designated in writing hereafter, in the same manner, by such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.4
<U>Amendments; Waivers; No Additional Consideration</U>. No provision of this Agreement may be waived, modified, supplemented or amended
except in a written instrument signed, in the case of an amendment, by the Company and the Purchasers of at least a majority in interest
of the Securities subscribed for purchase pursuant to this Agreement or, in the case of a waiver, by the party against whom enforcement
of any such waiver is sought; <I>provided, however</I>, that the Purchase Price shall not be modified except in a written instrument
signed by the Company and each Purchaser; <I>provided, further</I>, that no waiver, modification, supplementation or amendment that (i)
alters the Securities allocated to a Purchaser or (ii) is unduly burdensome to a Purchaser shall be valid and enforceable against such
Purchaser without the prior written consent of such Purchaser. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other
provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner
impair the exercise of any such right. No consideration shall be offered or paid to any Purchaser to amend or consent to a waiver or
modification of any provision of any Transaction Document unless the same consideration is also offered to all Purchasers who then hold
Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.5
<U>Construction</U>. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed
to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the
parties to express their mutual intent, and no rules of strict construction will be applied against any party. This Agreement shall be
construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by
virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.6
<U>Successors and Assigns</U>. The provisions of this Agreement shall inure to the benefit of and be binding upon the parties and their
successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the Company without
the prior written consent of each Purchaser. Any Purchaser may assign its rights hereunder in whole or in part to any Person to whom
such Purchaser assigns or transfers any Securities in compliance with the Transaction Documents and applicable law, provided such transferee
shall agree in writing to be bound, with respect to the transferred Securities, by the terms and conditions of this Agreement that apply
to the &ldquo;Purchasers&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.7
<U>No Third-Party Beneficiaries</U>. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except each Purchaser
Party is an intended third-party beneficiary of <U>Section 4.6</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.8
<U>Governing Law</U>. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles
of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and defense of the transactions
contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates,
employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto hereby irrevocably submits to the exclusive
jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated
hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives,
and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such New York Court,
or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal
service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall
be deemed to limit in any way any right to serve process in any manner permitted by law. <B>EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES,
TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.9
<U>Survival</U>. Subject to applicable statute of limitations, the representations, warranties, agreements and covenants contained herein
shall survive the Closing and the delivery of the Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.10
<U>Execution</U>. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. Counterparts may be delivered via facsimile, electronic mail
(including pdf or any electronic signatures complying with the U.S. federal ESIGN Act of 2000, e.g., www.docusign.com) or other transmission
method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.11
<U>Severability</U>. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and enforceability
of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt
to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so agreeing, shall incorporate such
substitute provision in this Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.12
<U>Rescission and Withdrawal Right</U>. Notwithstanding anything to the contrary contained in (and without limiting any similar provisions
of) the Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and
the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw,
in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part
without prejudice to its future actions and rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.13
<U>Remedies</U>. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties hereto agree
that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the
foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection
with any action for a temporary restraining order) the defense that a remedy at law would be adequate.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.14
<U>Payment Set Aside</U>. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document
or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise
or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by
or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including,
without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action), then to the extent of any such
restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect
as if such payment had not been made or such enforcement or setoff had not occurred.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.15
<U>Adjustments in Share Numbers and Prices</U>. In the event of any stock split, subdivision, dividend or distribution payable in shares
of Common Stock (or other securities or rights convertible into, or entitling the holder thereof to receive directly or indirectly shares
of Common Stock), combination or other similar recapitalization or event occurring after the date hereof and prior to the Closing, each
reference in any Transaction Document to a number of shares or a price per share shall be deemed to be amended to appropriately account
for such event.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.16
<U>Independent Nature of Purchasers&rsquo; Obligations and Rights</U>. The obligations of each Purchaser under any Transaction Document
are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
of the obligations of any other Purchaser under any Transaction Document. The decision of each Purchaser to purchase Securities pursuant
to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of any information,
materials, statements or opinions as to the business, affairs, operations, assets, properties, liabilities, results of operations, condition
(financial or otherwise) or prospects of the Company or any Subsidiary which may have been made or given by any other Purchaser or by
any agent or employee of any other Purchaser, and no Purchaser and any of its agents or employees shall have any liability to any other
Purchaser (or any other Person) relating to or arising from any such information, materials, statement or opinions. Nothing contained
herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers
as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any
way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each
Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser in connection with making its investment hereunder
and that no Purchaser will be acting as agent of such Purchaser in connection with monitoring its investment in the Securities or enforcing
its rights under the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including
without limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary
for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser has been represented by
its own separate legal counsel in its review and negotiation of the Transaction Documents. For reasons of administrative convenience
only, Purchasers and their respective counsels have chosen to communicate with the Company through Troutman Pepper Hamilton Sanders LLP,
counsel to the Company. Each Purchaser acknowledges that Troutman Pepper Hamilton Sanders LLP has rendered legal advice to the Company
and not to such Purchaser in connection with the transactions contemplated hereby, and that each such Purchaser has relied for such matters
on the advice of its own respective counsel.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.17
<U>Termination</U>. This Agreement may be terminated and the sale and purchase of the Securities abandoned at any time prior to the Closing
by either the Company or any Purchaser (with respect to itself only) upon written notice to the other, if the Closing has not been consummated
on or prior to 5:00 P.M., New York City time, on the Outside Date; <I>provided, however</I>, that the right to terminate this Agreement
under this <U>Section 7.17</U> shall not be available to any Person whose failure to comply with its obligations under this Agreement
has been the cause of or resulted in the failure of the Closing to occur on or before such time. Nothing in this <U>Section 7.17</U>
shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or
the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents. In the event of a termination pursuant to this <U>Section 7.17</U>, the Company
shall promptly notify all non-terminating Purchasers. Upon a termination in accordance with this <U>Section 7.17</U>, the Company and
the terminating Purchaser(s) shall not have any further obligation or liability (including arising from such termination) to the other,
and no Purchaser will have any liability to any other Purchaser under the Transaction Documents as a result therefrom.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">STREAMLINE
    HEALTH SOLUTIONS, INC.</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bryant
    J. Reeves, III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NAME
    OF PURCHASER: _________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Original
    Principal Amount of Note:</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$____________________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number
    of Warrants to be Acquired:____________________ </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax
    ID No. or SSN (as applicable): _____________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address
    for Notice: </FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________________________________</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif">____________________________________</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2in; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Telephone
    No.: _______________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E-mail
    Address: ___________________________________</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: left; layout-grid-mode: line"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:_________________________________
    </FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>EXHIBITS</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form of Subordinated Note</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">B:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Warrant</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-1:
</FONT></P>

</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Accredited Investor Questionnaire</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C-2:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">DRS Book-Entry Questionnaire</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">C-3:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Selling Stockholder Questionnaire</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D:
</FONT></P>

</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Irrevocable Transfer Agent Instructions</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">E:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Secretary&rsquo;s Certificate</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">F:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Officer&rsquo;s Certificate</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">G:
</FONT></P>

</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Wire Instructions</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">H:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Lock-Up Agreement</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">I:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">List of Directors and Executive Officers Executing
  Lock-Up Agreements</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">J:
</FONT></P>

</TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Form of Subordination Agreement</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>SCHEDULES</U>:</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(a)
Subsidiaries</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(g)
Capitalization</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1(x)
Registration Rights</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 30; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>4
<FILENAME>ex10-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><B>The
rights of the holder of this instrument to receive payment hereunder and other rights of the holder of this instrument are subject and
subordinate to the rights of the Senior CREDITOR (as defined in the Subordination Agreement DEFINED BELOW) pursuant to the terms of a
Subordination Agreement, DATED AS OF THE DATE HEREOF (THE &ldquo;<I>SUBORDINATION aGREEMENT</I>&rdquo;), among WESTERN ALLIANCE BANK,
the HOLDER of this instrument, the maker of this instrument and the other parties thereto.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PROMISSORY
NOTE</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$[&#9679;]</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">February
    [&#9679;], 2024</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FOR
VALUE RECEIVED, <FONT STYLE="text-transform: uppercase"><B>Streamline Health Solutions, Inc.</B></FONT>, a Delaware corporation having
an address at 2400 Old Milton Pkwy., Box 1353 Alpharetta, Georgia 30009 (&ldquo;<B><I>Borrower</I></B>&rdquo;), promises to pay to promises
to pay to [&#9679;], having an address at [&#9679;] (the &ldquo;<B><I>Holder</I></B>&rdquo;) the principal amount of [&#9679;] Dollars
($[&#9679;]), in lawful currency of the United States of America (together with any interest capitalized and added to the principal balance
in accordance with <U>Section 2</U> below) the &ldquo;<B><I>Holder Loan</I></B>&rdquo;), and together with any other interest on the
unpaid principal balance of the Holder Loan at the rate set forth in <U>Section 3</U> of this Promissory Note (this &ldquo;<B><I>Note</I></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a statement of the rights of Holder and the conditions to which this Note is subject, and to which Holder, by its acceptance
of this Note, agrees:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<B><U>Definitions</U></B>. As used in this Note, the following capitalized terms have the following meanings:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Additional
Loans</I></B>&rdquo; means each of the loans made to the Borrower contemporaneously with the Holder Loan.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Additional
Notes</I></B>&rdquo; means each of the respective Promissory Notes evidencing the Additional Loans issued by the Borrower contemporaneously
with this Note to the Noteholders who made such Additional Loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Additional
Noteholders</I></B>&rdquo; means, collectively, the holders of any Additional Notes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Business
Day</I></B>&rdquo; means any day other than a Saturday, a Sunday or a day on which banking institutions in Atlanta, Georgia are authorized
or obligated to close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Change
of Control</I></B>&rdquo; shall mean a transaction in which any &ldquo;person&rdquo; or &ldquo;group&rdquo; (within the meaning of Section
13(d) and 14(d)(2) of the Securities Exchange Act of 1934) becomes the &ldquo;beneficial owner&rdquo; (as defined in Rule 13d-3 under
the Securities Exchange Act of 1934), directly or indirectly, of a sufficient number of shares of all classes of stock or other equity
securities, as applicable, then outstanding of Borrower ordinarily entitled to vote in the election of directors, empowering such &ldquo;person&rdquo;
or &ldquo;group&rdquo; to elect a majority of the Board of Directors of Borrower, who did not have such power before such transaction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Closing
Date</I></B>&rdquo; means February [&#9679;], 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Debt</I></B>&rdquo;
means, of any Person as of any date of determination (without duplication): (a) all obligations of such Person for borrowed money; (b)
all obligations of such Person evidenced by bonds, notes, debentures, or other similar instruments; (c) all obligations of such Person
to pay the deferred purchase price of property or services (except trade accounts payable); (d) all capitalized lease obligations of
such Person; (e) all debt or other obligations of others guaranteed by such Person; (f) all obligations secured by a Lien existing on
property owned by such Person, whether or not the obligations secured thereby have been assumed by such Person or are non-recourse to
the credit of such Person; and (g) any other obligation for borrowed money or other financial accommodations which in accordance with
GAAP would be shown as a liability on the balance sheet of such Person.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Event
of Default</I></B>&rdquo; has the meaning given in <U>Section 10</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>GAAP</I></B>&rdquo;
means Generally Accepted Accounting Principles.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Governmental
Authority</I></B>&rdquo; means any nation or government, any state or political subdivision thereof and any entity exercising executive,
legislative, judicial, regulatory, or administrative functions of or pertaining to government.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Lien</I></B>&rdquo;
means any lien, mortgage, security interest, tax lien, pledge, charge, hypothecation, assignment, preference, priority, or other encumbrance
of any kind or nature whatsoever (including, without limitation, any conditional sale or title retention agreement), whether arising
by contract, operation of law, or otherwise.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Loans</I></B>&rdquo;
means, collectively, the Holder Loan and any Additional Loans.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Material
Adverse Effect</I></B>&rdquo; means any act, event, condition, or circumstance which materially and adversely affects: (a) the operations,
business, properties, liabilities and financial condition of Borrower and its Subsidiaries, taken as a whole; (b) the ability of Borrower
to perform its obligations under this Note; and (c) the legality, validity, binding effect or enforceability against Borrower of this
Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Maturity
Date</I></B>&rdquo; means the earlier of: (i) the close of business on August [&#9679;], 2027, or (ii) the date upon which, following
the occurrence of an Event of Default, the Obligations become due and payable in accordance with the terms hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Noteholders</I></B>&rdquo;
means, collectively, Holder and any Additional Noteholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Obligations</I></B>&rdquo;
means and includes all loans, advances, Debts, liabilities and obligations, howsoever arising, owed by the Borrower to Holder of every
kind and description (whether or not evidenced by any note or instrument and whether or not for the payment of money), now existing or
hereafter arising under or pursuant to the terms of this Note, including, all interest, fees, charges, expenses, attorneys&rsquo; fees
and costs and accountants&rsquo; fees and costs chargeable to and payable by Borrower hereunder and thereunder, in each case, whether
direct or indirect, absolute or contingent, due or to become due, and whether or not arising after the commencement of a proceeding under
Title 11 of the United States Code (11 U. S. C. Section 101 <I>et seq</I>.), as amended from time to time (including post-petition interest)
and whether or not allowed or allowable as a claim in any such proceeding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Person</I></B>&rdquo;
means and includes an individual, a partnership, a corporation (including a business trust), a joint stock company, a limited liability
company, an unincorporated association, a joint venture or other entity or a Governmental Authority.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Register</I></B>&rdquo;
has the meaning given in <U>Section 14</U> hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Value: 2; Name: PageNo -->2<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Required
Noteholders</I></B>&rdquo; means, at any time, one or more Noteholders holding in the aggregate more than fifty percent (50%) of the
aggregate principal amount of the Loans outstanding at such time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>SEC</I></B>&rdquo;
means the Securities and Exchange Commission of the U.S.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><I>Subsidiary</I></B>&rdquo;
means (a) any corporation of which at least a majority of the outstanding shares of stock having by the terms thereof ordinary voting
power to elect a majority of the board of directors of such corporation (irrespective of whether or not at the time stock of any other
class or classes of such corporation shall have or might have voting power by reason of the happening of any contingency) is at the time
directly or indirectly owned or controlled by Borrower or one or more of other Subsidiaries or by Borrower and one or more of such Subsidiaries,
and (b) any other entity (i) of which at least a majority of the ownership, equity or voting interest is at the time directly or indirectly
owned or controlled by Borrower and other Subsidiaries and (ii) which is treated as a subsidiary in accordance with GAAP.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<B><U>Interest</U></B>. Interest shall accrue on the outstanding principal balance of this Note at a rate per annum equal to fifteen
percent (15.0%). At the end of each month, commencing with the first month ending after the Closing Date, all accrued and unpaid interest
shall be capitalized and added to the outstanding principal balance and such interest so capitalized shall for all purposes be deemed
to constitute a portion of the principal balance of the Holder Loan hereunder. All accrued and unpaid interest shall be due and payable
in cash on the Maturity Date. Upon the occurrence and during the continuance of an Event of Default, at the election of the Required
Noteholders, the outstanding principal balance of this Note shall bear interest at a rate equal to two (2%) per annum above the rate
otherwise applicable hereunder from the date of such Event of Default until the same is paid in full or such Event of Default is waived
by the Required Noteholders. All interest hereunder shall be computed on the basis of a 365/366-day year for the actual number of days
elapsed.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<B><U>Payments of Principal</U></B>. The entire outstanding principal balance of this Note, together with any then accrued and unpaid
interest thereon and any other amounts payable hereunder, shall be due and payable on the Maturity Date. This Note will not be subject
to principal amortization payments prior to the Maturity Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<B><U>Prepayment and Redemption</U></B>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
Except as provided in <U>Section 4(b)</U> below, this Note and the obligations evidenced by this Note may prepaid, in whole or part,
without any premium or penalty.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
In that event that Borrower prepays any portion of the then outstanding principal balance of the Holder Loan on or before the twelve
(12) month anniversary of the Closing Date, in addition to such prepayment of the principal balance the Borrower shall pay to the Noteholders
a prepayment fee (in accordance with the each Noteholder&rsquo;s pro-rata share of the Loans) in an amount equal to the amount of interest
that would have accrued but for the prepayment from the date of such prepayment through such twelve (12) month anniversary of the Closing
Date.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.
<B><I><U>Pari Passu </U></I><U>Notes</U></B>. Holder acknowledges and agrees that the payment of all or any portion of the outstanding
principal amount of this Note and all interest hereon shall be <I>pari passu</I> in right of payment (and in all other respects) to the
Additional Notes. All payments of principal and accrued and outstanding interest on this Note shall be made <I>pro rata</I> based on
the unpaid portion of the principal balance of the Loans held by each Noteholder. If any Noteholder receives any payment or other amount
in excess of that which he, she or it is entitled to under this Note (whether voluntary, involuntary, through the exercise of any right
of set-off, or otherwise), he, she or it shall, and shall be deemed to, hold such excess amount in trust for the benefit of the Noteholders
who are entitled thereto and shall pay such excess amount over to such other Noteholders as promptly as practicable..</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<B><U>Subordination</U></B>. Holder acknowledges and agrees that, in accordance with the Subordination Agreement, the payment of all
or any portion of the outstanding principal balance and all interest hereon shall be subordinated in right of payment (and in all other
respects) to the Obligations (as defined in the Senior Loan Agreement referenced below) of the Borrower owing to Western Alliance Bank
(&ldquo;<B><I>Senior Creditor</I></B>&rdquo;) pursuant to that certain Amended and Restated Loan and Security Agreement, dated as of
March 2, 2021 (as amended, restated, supplemented or otherwise modified from time to time, the &ldquo;<B><I>Senior Loan Agreement</I></B>&rdquo;),
by and between Borrower and Senior Creditor. To the extent of any conflict between this Note and the terms of the Subordination Agreement,
the terms of the Subordination Agreement shall govern.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<B><U>Representations and Warranties</U></B>. The Borrower represents and warrants to Holder on the Closing Date that:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Entity Existence; Authority</U>. Borrower (a) is duly incorporated, validly existing, and in good standing under the laws of the jurisdiction
of its incorporation; (b) has all requisite power and authority to own its assets and carry on its business as now being or as proposed
to be conducted; and (c) is qualified to do business in all jurisdictions in which the nature of its business makes such qualification
necessary and where failure to so qualify would result in a Material Adverse Effect. Borrower has the power and authority to execute,
deliver, and perform its obligations under this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Enforceability</U>. This Note constitutes a legal, valid, and binding obligations of Borrower, enforceable against Borrower in accordance
with its terms, except as limited by bankruptcy, insolvency, or other laws of general application relating to the enforcement of creditors&rsquo;
rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>No Violations</U>. The execution, delivery and performance by Borrower of this Note will not (a) violate the governing or organizational
documents of Borrower, (b) violate any applicable law or order applicable to Borrower, (c) result in a violation or breach of, conflict
with, constitute (with or without due notice or lapse of time or both) a default under, or give rise to any right of termination, cancellation,
or acceleration of any right or obligation of Borrower under any material agreement or other material instrument binding upon or providing
rights to the Borrower, or (d) result in the creation or imposition of any lien on any material asset of Borrower, in each case with
respect to the foregoing clauses (b), (c) and (d), to the extent such violation, breach, conflict or lien would not reasonably be expected
to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Litigation</U>. As of the date hereof, there is no action, suit, investigation, or proceeding before or by any Governmental Authority
or arbitrator pending, or to the knowledge of Borrower after reasonable investigation, threatened against or affecting Borrower, or any
of its Subsidiaries, that would reasonably be expected to result in a Material Adverse Effect.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 66pt; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>No Default</U>. No Default or Event of Default exists or would result from the incurring of any Obligations of Borrower pursuant to
the terms of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(f)
</B><U>Full Disclosure</U>. No representation, warranty or other statement of Borrower in any certificate or written statement given
to the Holder, as of the date such representation, warranty, or other statement was made, taken together with all such certificates and
statements given to Holder contains any untrue statement of a material fact or omits to state a material fact necessary to make the statements
contained in the certificates or statements not materially misleading.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<B><U>Affirmative Covenants</U></B>: Borrower covenants and agrees that, as long as the Obligations or any part thereof are outstanding
(other than contingent obligations for which no claim exists):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Annual Financial Statements</U>. Borrower will furnish to Lender within thirty (30) days after the filing thereof with the SEC is
required, beginning with the annual report of the Borrower for the fiscal year ending January 31, 2024, a copy of the annual financial
statements and report of Borrower and its Subsidiaries for such fiscal year containing, on a consolidated basis, balance sheets and statements
of income, retained earnings, and cash flow as of the end of such fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Quarterly Financial Statements</U>. Borrower will furnish to Lender within thirty (30) days after the filing thereof with the SEC
is required, beginning with the quarterly report of the Borrower for the fiscal quarter ending January 31, 2024, a copy of an unaudited
financial report of Borrower and its Subsidiaries as of the end of such fiscal quarter and for the portion of the fiscal year then ended,
containing, on a consolidated basis, balance sheets and statements of income, retained earnings, and cash flow, in each case setting
forth in comparative form the figures for the corresponding period of the preceding fiscal year.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Documents
required to be delivered pursuant to Section 8(a) or (b) (to the extent any such documents are included in materials otherwise filed
with the SEC) may be delivered electronically and, if so delivered, shall be deemed to have been delivered on the date on which such
materials are publicly available as posted on the Electronic Data Gathering, Analysis and Retrieval system (EDGAR).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<B><U>Negative Covenants</U></B>. Borrower covenants and agrees that, as long as the Obligations or any part thereof are outstanding
(other than contingent obligations for which no claim exists):</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Disposition of Assets</U>. Borrower shall not, nor shall it permit any of its Subsidiaries to, directly or indirectly, sell, lease,
assign, transfer, or otherwise dispose of all or substantially all of its assets.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Nature of Business</U>. Borrower shall not, nor shall it permit any of its Subsidiaries to, engage in any business other than the
businesses in which they are engaged as of the date hereof and any business similar, related, incidental, or ancillary thereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<B><U>Events of Default</U></B>. The occurrence of any of the following shall constitute an &ldquo;<B><I>Event of Default</I></B>&rdquo;
under this Note:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Failure to Pay</U>. Borrower shall fail to pay when due any payment required under the terms of this Note on the date due and such
payment shall not have been made within five (5) days of the due date; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Representation and Warranties</U><I>. </I>Any representation or warranty made by in this Note shall be false, misleading, or erroneous
in any material respect when made; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Covenants</U>. Borrower shall fail to timely and properly observe, keep or perform, any term, covenant, agreement or condition in
this Note and such failure continues for a period of 30 days after Borrower&rsquo;s receipt of notice thereof from the Required Noteholders;
or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Voluntary Bankruptcy or Insolvency Proceedings</U>. Borrower shall (i) apply for or consent to the appointment of a receiver, trustee,
liquidator or custodian of Borrower or of all or a substantial part of its property, (ii) be unable, or admit in writing its present
inability, to pay its Debts generally as they mature, (iii) make a general assignment for the benefit of its or any of its creditors,
(iv) be dissolved or liquidated, (v) become insolvent (as such term may be defined or interpreted under any applicable statute) as determined
by a court of competent jurisdiction, (vi) commence a voluntary case or other proceeding seeking liquidation, reorganization or other
relief with respect to itself or its Debts under any bankruptcy, insolvency or other similar law now or hereafter in effect or consent
to any such relief or to the appointment of or taking possession of its property by any official in an involuntary case or other proceeding
commenced against it, or (vii) take any action for the purpose of effecting any of the foregoing; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Involuntary Bankruptcy or Insolvency Proceedings</U><I>. </I>Proceedings for the appointment of a receiver, trustee, liquidator or
custodian of Borrower or of all or a substantial part of the property thereof, or an involuntary case or other proceedings seeking liquidation,
reorganization or other relief with respect to Borrower or the Debts thereof under any bankruptcy, insolvency or other similar law now
or hereafter in effect shall be commenced and an order for relief entered or such proceeding shall not be dismissed or discharged within
90 days of commencement; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Senior Loan Agreement</U>. Any default (beyond all applicable grace or cure period) shall occur, and as a result of such default the
Senior Creditor accelerates the Obligations (as defined in the Senior Loan Agreement); or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Judgments</U>. A final judgment or judgments for the payment of money in excess of $1,000,000 in the aggregate that is not covered
by insurance shall be rendered by a court or courts against Borrower and the same shall not be discharged (or provision shall not be
made for such discharge), or a stay of execution thereof shall not be procured, within thirty (30) days from the date of entry thereof
and Borrower shall not, within such period of thirty (30) days, or such longer period during which execution of the same shall have been
stayed, appeal therefrom and cause the execution thereof to be stayed during such appeal; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
<U>Change of Control</U>. The occurrence of a Change of Control.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<B><U>Rights of Holder upon Event of Default</U></B>. Upon the occurrence of any Event of Default (other than an Event of Default described
in <U>Sections 10(d)</U> and <U>10(e)</U> and at any time thereafter during the continuance of such Event of Default, the Required Noteholders
may, by written notice to Borrower, declare all outstanding Obligations to be immediately due and payable without presentment, demand,
protest or any other notice of any kind, all of which are hereby expressly waived. Upon the occurrence of any Event of Default described
in <U>Sections 10(d)</U> and <U>10(e)</U>, immediately and without notice, all outstanding Obligations shall automatically become immediately
due and payable, without presentment, demand, protest or any other notice of any kind, all of which are hereby expressly waived. In addition
to the foregoing remedies, upon the occurrence and during the continuance of any Event of Default, the Required Noteholders may exercise
any other right, power or remedy granted by this Note or any Additional Note or otherwise permitted by law, either by suit in equity
or by action at law, or both.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12.
<B><U>Coordinated Action; Expenses</U></B>. Holder may not institute any action to collect or convert this Note or any other action with
respect to this Note or the Obligations without the prior written consent of the Required Noteholders. The Required Noteholders may designate
a single Noteholder to institute any such action on behalf of all Noteholders, and Holder agrees and acknowledges that such designated
Noteholder shall serve as the representative of all Noteholders in a single action. Each Noteholder shall indemnify and hold harmless
such designated Noteholder from and against any and all costs, expenses, fees and liabilities which it may incur in connection with pursuing
such action, and such designated Noteholder shall have no liability whatsoever to the other Noteholders for any actions taken or omitted
in good faith in connection therewith. If the Required Noteholders or any Noteholder designated by the Required Noteholders institutes
an action to collect any obligations arising under this Note or any of the Additional Notes, or to enforce any terms hereof, the Borrower
shall pay all costs and expenses incurred by such designated Noteholder in connection therewith, including, without limitation, reasonable
attorneys&rsquo; fees and costs.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13.
<B><U>Successors and Assigns</U></B>. Subject to the restrictions on transfer described in <U>Section 16</U> below, the rights and obligations
of the Borrower and Holder shall be binding upon and benefit their respective successors, assigns, heirs, administrators and transferees.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">14.
<B><U>Register</U></B>. Borrower shall maintain a register for the recordation of the names and addresses of Holder, and the aggregate
original principal amount of the Loan owing to each Holder (the &ldquo;<B><I>Register</I></B>&rdquo;). The Register shall be available
for inspection by any Noteholder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15.
<B><U>Waiver and Amendment</U></B>. No waiver, termination or discharge of this Note, or any of the terms or provisions hereof, shall
be binding upon Borrower or Holder unless set forth in writing and signed by (or with the written consent of) Borrower and the Required
Noteholders; provided, that any waiver, termination or discharge of this Note or any Additional Note, or any of the terms or provisions
hereof, that by its terms disproportionately and adversely affects Holder relative to the other Noteholders (giving effect to any concurrent
amendments to the Additional Notes) shall require the written consent of Holder. Any waiver of any term or condition shall not be construed
as a waiver of any subsequent breach or a subsequent waiver of the same term or condition, or a waiver of any term or condition of this
Note. No failure to exercise, or delay in exercising, any right, remedy, power or privilege arising from this Note shall operate or be
construed as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any
other or further exercise thereof or the exercise of any other right, remedy, power or privilege.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16.
<B><U>Assignment by Borrower or Holder</U></B>. Neither this Note nor any of the rights, interests or obligations hereunder may be assigned,
by operation of law or otherwise, in whole or in part, by Borrower or Holder without the prior written consent of the Borrower and the
Required Noteholders.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">17.
<B><U>Notices</U></B>. All notices, requests, demands, consents, instructions or other communications required or permitted hereunder
shall be in writing and faxed, mailed or delivered to each party at the respective addresses of the parties set forth in in the opening
paragraph of this Note. All such notices and communications will be deemed effectively given the earlier of (i) when received, (ii) when
delivered personally, (iii) one Business Day after being delivered by facsimile (with receipt of appropriate confirmation), (iv) one
Business Day after being deposited with an overnight courier service of recognized standing or (v) four days after being deposited in
the U.S. mail, first class with postage prepaid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18.
<B><U>Usury</U></B>. In the event any interest is paid on this Note which is deemed to be in excess of the then legal maximum rate, then
that portion of the interest payment representing an amount in excess of the then legal maximum rate shall be deemed a payment of principal
and applied against the principal of this Note.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">19.
<B><U>Governing Law</U></B>. This Note and all actions arising out of or in connection with this Note shall be governed by and construed
in accordance with the laws of the State of New York, without regard to the conflicts of law provisions of the State of New York or of
any other state.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">20.
<B><U>WAIVER OF JURY TRIAL</U></B>. BORROWER AND, BY ITS ACCEPTANCE HEREOF, HOLDER, IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED
BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF THIS NOTE OR
THE TRANSACTIONS CONTEMPLATED HEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). BORROWER AND, BY ITS ACCEPTANCE HEREOF, HOLDER,
(A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER SUCH PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER
PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, AND (B) ACKNOWLEDGES THAT IT HAS BEEN INDUCED TO
ENTER INTO OR ACCEPT, AS APPLICABLE, THIS NOTE BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.
<B><U>Time Is of the Essence</U></B>. Time is of the essence of this Note, and of each provision hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">22.
<B><U>Formalities</U></B>. Borrower waives presentment, demand, notice of dishonor, notice of acceptance, default, protest and any other
notices whatever. Additionally, Borrower, without affecting its liability hereunder, consents to and waives the withdrawal or extension
of credit or time to pay, the release of the whole or any part of the obligations of any Person under or in connection with this Note,
renewal, indulgence, settlement, compromise or failure to exercise due diligence in collection, the acceptance or release of security,
extension of the time to pay or perform for any period or periods whether or not longer than the original period, or any surrender, substitution
or release of any other Person directly or indirectly liable for payment or performance of any of the obligations arising under or in
connection with this Note or any collateral security for the obligations hereunder. Borrower agrees that he or she shall not exercise
any right of subrogation, reimbursement or indemnity whatsoever or any right of recourse to or with respect to any assets or property
of the other or to any collateral for their respective obligations arising under or in connection with this Note, except following payment
and performance of all of the Obligations.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">- <!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --> -</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Borrower
has duly executed this Promissory Note as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>STREAMLINE
    HEALTH SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bryant
    J. Reeves, III</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interim
    Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature Page to Promissory Note</I>]</FONT></TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>5
<FILENAME>ex10-3.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
10.3</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">THIRD
MODIFICATION AND WAIVER</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">TO</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">SECOND
AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
THIRD MODIFICATION TO SECOND AMENDED AND RESTATED LOAN AND SECURITY AGREEMENT <FONT STYLE="letter-spacing: -0.1pt">(this &ldquo;<U>Modification</U>&rdquo;)
is entered into as of February 7, 2024 by and among STREAMLINE HEALTH SOLUTIONS, INC., a Delaware corporation (&ldquo;<U>Streamline</U>&rdquo;),
STREAMLINE HEALTH, LLC, a Delaware limited liability company (f/k/a STREAMLINE HEALTH, INC., an Ohio corporation) (&ldquo;<U>Streamline
Health</U>&rdquo;), STREAMLINE PAY &amp; BENEFITS, LLC, a Delaware limited liability company (&ldquo;<U>Streamline Pay</U>&rdquo;), AVELEAD
CONSULTING, LLC, a Georgia limited liability company (&ldquo;<U>Avelead Consulting</U>&rdquo;), STREAMLINE CONSULTING SOLUTIONS, LLC,
a Delaware limited liability company (&ldquo;<U>Streamline Consulting</U>&rdquo; and, together with Streamline, Streamline Health, Streamline
Pay, Avelead Consulting and any other Person who, from time to time, becomes a Borrower under the Loan Agreement (as defined below),
collectively, the &ldquo;<U>Borrowers</U>&rdquo; and each individually, a &ldquo;<U>Borrower</U>&rdquo;) and WESTERN ALLIANCE BANK, an
Arizona corporation (&ldquo;<U>Bank</U>&rdquo;).</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">RECITALS</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-decoration: none">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A.
Bank and Borrower have previously entered into that certain Second Amended and Restated Loan and Security Agreement dated as of August
26, 2021 (as amended, restated, supplemented and otherwise modified from time to time, the &ldquo;<U>Loan Agreement</U>&rdquo;), pursuant
to which Bank has made certain loans and financial accommodations available to Borrower.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">B.
It has come to the attention of Bank that certain Events of Default have occurred and are continuing pursuant to Section 8.2(a) of the
Loan Agreement due to the failure of the Borrower to maintain a Maximum Debt to ARR Ratio of not greater than 0.50 to 1.00 for the period
ended January 31, 2024, in violation of Section 6.9(b) as in effect immediately prior to the date hereof (the &ldquo;<U>Specified Default</U>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">C.
Bank and Borrower now wish to waive the Specified Default and modify the Loan Agreement on the terms and conditions set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">D.
Borrower is entering into this Modification with the understanding and agreement that, except as specifically provided herein, none of
Bank&rsquo;s rights or remedies as set forth in the Loan Agreement or any other Loan Document is being waived or modified by the terms
of this Modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>AGREEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NOW,
THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
<FONT STYLE="text-transform: uppercase"><U>MODIFICATIONS</U>.</FONT></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Additional Definitions</U>. Section 1.1 of the Loan Agreement is hereby amended to add the following new definitions in the appropriate
alphabetical order:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;&ldquo;<U>ARR
Net Leverage Ratio</U>&rdquo; means, as of any date of determination (a) (i) the Obligations, <U>minus</U> (ii) Qualified Cash, divided
by (b) Annualized Recurring Revenue.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;&ldquo;<U>Third
Modification Closing Date</U>&rdquo; means February 7, 2024.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;&ldquo;<U>Qualified
Cash</U>&rdquo; means, as of any date of determination, the aggregate amount of Borrower&rsquo;s cash maintained with Bank that is in
excess of Two Million Dollars ($2,000,000).&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Minimum Cash</U>. Section 6.9(a) of the Loan Agreement is hereby deleted in its entirety and the following substituted therefor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(a)
<B>[Intentionally omitted]</B>.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Maximum ARR Net Leverage Ratio</U>. Section 6.9(b) of the Loan Agreement is hereby deleted in its entirety and the following substituted
therefor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(b)
<B>Maximum ARR Net Leverage Ratio</B>. Borrowers&rsquo; ARR Net Leverage Ratio, measured on a quarterly basis as of the last day of each
fiscal quarter, shall not be greater than the amount set forth under the heading &ldquo;Maximum ARR Net Leverage Ratio&rdquo; as of,
and for each of the dates appearing adjacent to such &ldquo;Maximum ARR Net Leverage Ratio.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quarter
    Ending</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    ARR Net Leverage Ratio</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.50
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.45
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.40
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.35
    to 1.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Maximum Debt to Adjusted EBITDA Ratio</U>. Section 6.9(c) of the Loan Agreement is hereby deleted in its entirety and the following
substituted therefor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(c)
<B>Maximum Debt to Adjusted EBITDA Ratio.</B> Commencing with the quarter ending April 30, 2025, Borrowers&rsquo; Maximum Debt to Adjusted
EBITDA Ratio, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four (4) quarter period then ended,
shall not be greater than the amount set forth under the heading &ldquo;Maximum Debt to Adjusted EBITDA Ratio&rdquo; as of, and for each
of the dates appearing adjacent to such &ldquo;Maximum Debt to Adjusted EBITDA Ratio&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quarter
    Ending</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Maximum
    Debt to Adjusted EBITDA Ratio</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, 2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.50
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, 2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.00
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, 2025 </FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.50
    to 1.00</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025 and on the last day of each quarter thereafter</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.00
    to 1.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Fixed Charge Coverage Ratio</U>. Section 6.9(d) of the Loan Agreement is hereby deleted in its entirety and the following substituted
therefor:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(d)
<B>Fixed Charge Coverage Ratio</B>. Commencing with the quarter ending April 30, 2025, Borrowers shall maintain a Fixed Charge Coverage
Ratio of not less than 1.20 to 1.00, measured on a quarterly basis as of the last day of each fiscal quarter for the trailing four (4)
quarter period then ended.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
<U>Minimum Adjusted EBITDA</U>. Section 6.9 of the Loan Agreement is hereby amended to add the following new subsection (e) at the end
thereof:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;(e)
<B>Minimum Adjusted EBITDA</B>. Commencing with the quarter ending January 31, 2024, Borrowers shall maintain Adjusted EBITDA, measured
on a quarterly basis as of the last day of each fiscal quarter, in an amount not less than the amounts (or, in the case of amounts set
forth in parentheses, no worse than the amounts) set forth under the heading &ldquo;Minimum Adjusted EBITDA&rdquo; as of, and for each
of the dates appearing adjacent to such &ldquo;Minimum Adjusted EBITDA&rdquo;.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify; text-indent: 0.75in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Quarter
    Ending</B></FONT></TD>
    <TD STYLE="padding-bottom: 1.5pt; width: 2%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Minimum
    Adjusted EBITDA</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($5,750,000)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">April
    30, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($4,560,000)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
    31, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($2,960,000)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">October
    31, 2024</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">($1,500,000)</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">January
    31, 2025</FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">$430,000</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
<U>Compliance Certificate</U>. <B>Exhibit B</B> to the Loan Agreement is hereby deleted in its entirety and replaced with <B>Exhibit
B</B> attached hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<FONT STYLE="text-transform: uppercase"><U>Waiver of specified Defaults</U></FONT>. Bank hereby waives the Specified Default. This waiver
shall be effective only for the specific defaults comprising the Specified Default, and in no event shall this waiver be deemed to be
a waiver of enforcement of any of Bank&rsquo;s rights with respect to any other defaults or Events of Default now existing or hereafter
arising. Nothing contained in this Modification nor any communications among Borrowers and Bank shall be a waiver of any rights or remedies
Bank has or may have against Borrowers except as specifically provided herein. Except as specifically provided herein, Bank hereby reserves
and preserves all of its rights and remedies against Borrowers under the Loan Agreement and the other Loan Documents.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
<U>NO DEFENSES OF BORROWER/GENERAL <FONT STYLE="text-transform: uppercase">Release</FONT></U>. Each Borrower agrees that, as of this
date, it has no defenses against the obligations to pay any amounts under the Indebtedness. Each Borrower acknowledges that Bank would
not enter into this Modification without Borrower&rsquo;s assurance that it has no claims against Bank or any of Bank&rsquo;s officers,
directors, employees or agents. Except for any claims or obligations arising after the date of this Modification, each Borrower releases
Bank, and each of Bank&rsquo;s officers, directors and employees from any known or unknown claims that such Borrower now has against
Bank of any nature, including any claims that such Borrower, its successors, counsel, and advisors may in the future discover they would
have now had if they had known facts not now known to them, whether founded in contract, in tort or pursuant to any other theory of liability,
including but not limited to any claims arising out of or related to the Loan Agreement or the transactions contemplated thereby. Each
Borrower acknowledges and agrees that they have been informed by their attorneys and advisors of, and are familiar with, and do hereby
expressly waive, the provisions of Section 1542 of the California Civil Code, and any similar statute, code, law, or regulation of any
state or the United States, to the full extent that they may waive such rights and benefits. Civil Code section 1542 provides:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.5in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR A BORROWER DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE
TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR
RELEASED PARTY.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
provisions, waivers and releases set forth in this section are binding upon each Borrower and its shareholders, agents, employees, assigns
and successors in interest. The provisions, waivers and releases of this section shall inure to the benefit of Bank and its agents, employees,
officers, directors, assigns and successors in interest. The provisions of this section shall survive payment in full of the Obligations,
full performance of all the terms of this Modification and the Loan Agreement, and/or Bank&rsquo;s actions to exercise any remedy available
under the Loan Agreement or otherwise.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">4.
<U>CONTINUING VALIDITY</U>. Borrowers understand and agree that in modifying the existing Indebtedness, Bank is relying upon Borrowers&rsquo;
representations and warranties set forth in this Modification and the reaffirmation of Borrowers&rsquo; performance obligations under
the Loan Documents, subject to the modifications set forth herein. Except as expressly modified pursuant to this Modification, the terms
of the Loan Documents remain unchanged and in full force and effect. Bank&rsquo;s agreement to modifications to the existing Indebtedness
pursuant to this Modification in no way shall obligate Bank to make any future modifications to the Indebtedness. Nothing in this Modification
shall constitute a satisfaction of the Indebtedness. It is the intention of Bank and Borrowers to retain as liable parties all makers
and endorsers of Loan Documents, unless the party is expressly released by Bank in writing. No maker, endorser, or guarantor will be
released by virtue of this Modification. The terms of this paragraph apply not only to this Modification, but also to any subsequent
modification agreements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">5.
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>AMENDMENT FEE</U>. In consideration of the agreements
set forth herein, Borrowers hereby agree to pay to Bank an amendment fee in the amount of $10,000 (the &ldquo;<U>Amendment Fee</U>&rdquo;),
which Amendment Fee shall be nonrefundable when paid and fully-earned, due and payable on the date of this Modification.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<FONT STYLE="text-transform: uppercase"><U>Effectiveness of this Modification</U></FONT>. This Modification, and the waivers provided
for herein, shall become effective upon the satisfaction, as determined by Bank, of the following conditions.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
<U>Modification</U>. Bank shall have received this Modification fully executed in a sufficient number of counterparts for distribution
to all parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
<U>Amendment Fee</U>. Bank shall have received the Amendment Fee by wire transfer in immediately available funds, by autodebit to any
of Borrower&rsquo;s bank accounts maintained at Bank or charged as a Credit Extension.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
<U>Equity Raise</U>. Bank shall have received evidence, in form and substance reasonably acceptable to Bank, that Borrower has received
gross proceeds from an equity investment in borrower or from the raise of Subordinated Debt, in each case, in an amount equal to or greater
than Four Million Dollars ($4,000,000).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
<U>Representations and Warranties</U>. The representations and warranties set forth herein and in the Loan Agreement are true and correct
in all material respects (except for such representations and warranties qualified by materiality, which shall be true and correct in
all respects).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
<U>Other Required Documentation.</U> All other documents and legal matters in connection with the transactions contemplated by this Modification
shall have been delivered or executed or recorded, as required by Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bank
shall provide prompt written notice (e-mail to suffice) to Borrowers confirming the satisfaction of the conditions in this Section 6
and the effectiveness of this Modification, which confirmation shall be binding on Bank.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">7.
<U>CHOICE OF LAW AND VENUE; JURY TRIAL WAIVER; REFERENCE PROVISION</U>. This Modification constitutes a &ldquo;Loan Document&rdquo; as
defined and set forth in the Loan Agreement, and is subject to Sections 11 and 12 of the Loan Agreement, which are incorporated by reference
herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.
<U>NOTICE OF FINAL AGREEMENT</U>. By signing this document each party represents and agrees that: (A) this written agreement represents
the final agreement between the parties, (B) there are no unwritten oral agreements between the parties, and (C) this written agreement
may not be contradicted by evidence of any prior, contemporaneous, or subsequent oral agreements or understandings of the parties.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9.
<FONT STYLE="text-transform: uppercase"><U>Counterparts; Facsimile Signatures</U></FONT>. This Modification may be executed in any number
of and by different parties hereto on separate counterparts, all of which, when so executed, shall be deemed an original, but all such
counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or other similar form of electronic
transmission shall be deemed to be an original signature hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.
<FONT STYLE="text-transform: uppercase"><U>Ratification</U></FONT>. Borrowers hereby covenant and agree to comply with each and every
term and condition set forth in the Loan Agreement, as amended hereby, and the other Loan Documents effective as of the date hereof,
and hereby reaffirm their various obligations thereunder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<FONT STYLE="text-transform: uppercase"><U>Integration</U></FONT>. This Modification, together with the Loan Agreement and the other
Loan Documents, incorporates all negotiations of the parties hereto with respect to the subject matter hereof and is the final expression
and agreement of the parties hereto with respect to the subject matter hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.1pt">[Signature
Page Follows]</FONT></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><U>BORROWER</U>:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 45%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>STREAMLINE HEALTH SOLUTIONS, INC.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none">/<I>s/ Bryant J. Reeves, III</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Bryant J. Reeves, III&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Interim Chief Financial Officer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>STREAMLINE HEALTH, LLC (F/K/A STREAMLINE HEALTH, INC.)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><I>/s/ Bryant J. Reeves, III</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Bryant J. Reeves, III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title : </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Treasurer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>STREAMLINE PAY &amp; BENEFITS, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><I>/s/ Bryant J. Reeves, III</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Bryant J. Reeves, III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Treasurer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>AVELEAD CONSULTING, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none">/<I>s/ Bryant J. Reeves, III</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Bryant J. Reeves, III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Treasurer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt"><B>STREAMLINE CONSULTING SOLUTIONS, LLC</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none">/<I>s/ Bryant J. Reeves, III</I></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Bryant J. Reeves, III</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Treasurer</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: -3in"><FONT STYLE="font-size: 10pt; letter-spacing: -0.1pt"><U>BANK</U>:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: -3in"><FONT STYLE="font-size: 10pt"><B>WESTERN
ALLIANCE BANK</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: -3in"><FONT STYLE="font-size: 10pt; text-decoration: none"><I>/s/
                                            Blake Reid</I></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 3in; text-align: justify; text-indent: -3in"></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Blake Reid</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Senior Director</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt">[Signature Page to Third Modification and Waiver to 2nd A&amp;R LSA]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
b</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><BR>Compliance
Certificate</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify; width: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">TO:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WESTERN ALLIANCE BANK, an
  Arizona corporation</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">FROM:</FONT></TD>
  <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Streamline Health Solutions, Inc., a Delaware corporation and Streamline
  Health, Inc., an Ohio corporation, Streamline Pay &amp; Benefits, LLC, a Delaware limited liability company, Avelead Consulting, LLC,
  Streamline Consulting Solutions, LLC</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: -1in"></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
undersigned authorized officer of Borrower hereby certifies that in accordance with the terms and conditions of the Amended and Restated
Loan and Security Agreement between Borrower and Bank (the &ldquo;Agreement&rdquo;), (i) Borrower is in complete compliance for the period
ending _______________ with all required covenants except as noted below and (ii) all representations and warranties of Borrower stated
in the Agreement are true and correct as of the date hereof. Attached herewith are the required documents supporting the above certification.
The Officer further certifies that these are prepared in accordance with Generally Accepted Accounting Principles (GAAP) and are consistently
applied from one period to the next except as explained in an accompanying letter or footnotes.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Please
indicate compliance status by circling Yes/No under &ldquo;Complies&rdquo; column.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Reporting Covenant</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Required</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1.5pt solid; text-align: center"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Complies</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 40%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 2%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 8%; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Annual financial statements (CPA Audited)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">FYE within 180 days</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Monthly financial statements and a Compliance Certificate</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Monthly within 30 days </FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">10K and 10Q</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(as applicable)</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Annual operating budget, sales projections and operating plans approved
    by board of directors</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Annually no later than 30 days prior to the beginning of each fiscal
    year</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A/R &amp; A/P Agings, Borrowing Base Certificate, Deferred Revenue
    Schedule and Monthly Recurring Revenue Report</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Monthly within 30 days</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">A/R Audit</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Initial and Annual</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deposit balances with Bank</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$ ___________________</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Deposit balance outside Bank</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">$ ___________________</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 12pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Financial
    Covenant</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Required</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Actual</B></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="3" STYLE="text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt; text-decoration: none"><B>Complies</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 2in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.5in"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0.1in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center; width: 0.5in"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Maximum ARR Net Leverage Ratio</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(a) January 31, 2024, 0.50 to 1.00, (b) April 30, 2024, 0.50 to 1.00,
    (c) July 31, 2024, 0.45 to 1.00, (d) October 31, 2024, 0.40 to 1.00, and (e) January 31, 2024, 0.35 to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">___ to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Maximum Debt to Adjusted EBITDA Ratio</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(a) April 30, 2025, 3.50 to 1.00, (b) July 31, 2025, 3.00 to 1.00,
    (c) October 31, 2025, 2.50 to 1.00 and (d) January 31, 2025, and the last day of each quarter thereafter, 2.00 to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">___ to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Fixed Charge Coverage Ratio</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">April 30, 2025, and the last date of each quarter thereafter, 1.20
    to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">___ to 1.00</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Minimum Adjusted EBITDA</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">(a) January 31, 2024, ($5,750,000), (b) April 30, 2024, ($4,560,000),
    (c) July 31, 2024, ($2,960,000), (d) October 31, 2024, ($1,500,000) and (e) January 31, 2025, $430,000</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">$_____</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">Yes</FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">No</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Intellectual
                           Property Updates</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Attached as Exhibit
    A is a listing of listing of any applications or registrations of intellectual property rights filed with the United States Patent
    and Trademark Office, including the date of such filing and the registration or application numbers, if any, since the date of the
    last such Compliance Certificate delivered to Bank.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B><U>Updates to
    Schedules</U></B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-size: 10pt"><B>&nbsp;</B></FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></P>
    <P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">Attached as Exhibit
    A are updated Schedules updating any information set forth in such Schedules since the date of the last such Compliance Certificate
    delivered to Bank.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P></TD>
    <TD STYLE="width: 50%; text-align: justify"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD><FONT STYLE="font-size: 10pt"><B>Comments Regarding Exceptions:</B> See Attached.</FONT></TD>
    <TD STYLE="border-top: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-top: Black 1pt solid; border-right: Black 1pt solid"><P STYLE="margin-top: 0; margin-bottom: 0; font-size: 2pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt"><B>BANK
                                            USE ONLY</B></FONT></P></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">Received by: __________________________________</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">AUTHORIZED SIGNER</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">Date: ________________________________________</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">___________________________________________</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">Verified: ____________________________________</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">SIGNATURE</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">AUTHORIZED SIGNER</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">___________________________________________</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">Date: ________________________________________</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">TITLE</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-right: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">___________________________________________</FONT></TD>
    <TD STYLE="border-left: Black 1pt solid; width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 22%"><FONT STYLE="font-size: 10pt">Compliance Status</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; width: 27%; text-align: center"><FONT STYLE="font-size: 10pt">Yes No</FONT></TD></TR>
  <TR>
    <TD><FONT STYLE="font-size: 10pt">DATE</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; border-left: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="border-right: Black 1pt solid; border-bottom: Black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>ex99-1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibit
99.1</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 49px; width: 180px"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health&reg; Improves Liquidity Position and Appoints New Directors</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>Streamline
expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million
of installed SaaS ARR during the second half of fiscal 2024</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="width: 0.25in">&nbsp;</TD>
    <TD STYLE="width: 0.25in">&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expanded
    board of directors with appointment of CEO Benjamin Stilwill and Matthew Etheridge </FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closed
    private placement of unsecured subordinated notes and warrants and private placement of common stock resulting in aggregate gross
    proceeds of approximately $4.5 million</FONT></TD>
    </TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&#9679;</TD>
    <TD STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Modified
    existing senior loan covenants</FONT></TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Atlanta,
GA &ndash; February 7, 2023 &ndash; </B><U>Streamline Health Solutions, Inc.</U> (NASDAQ: STRM) (&ldquo;Streamline&rdquo; or &ldquo;the
Company&rdquo;), a leading provider of solutions that enable healthcare providers to improve financial performance, announced today that
it has entered into a securities purchase agreement with accredited investors in a private placement of unsecured subordinated notes
and warrants and issued common stock to a single accredited investor in a private placement, for aggregate gross proceeds of approximately
$4.5 million. The Company also announced the appointment of two new members to serve on the board of directors of the Company.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Appointment
of New Directors</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company announced the appointment of CEO Benjamin Stilwill and Matthew Etheridge to its board of directors, effective February 7, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
Stilwill has been an employee of Streamline since 2013 and has served as the Company&rsquo;s CEO since October 2024. Prior to his appointment
as CEO in October 2024, Mr. Stilwill held various senior roles across the organization, including as President of the Company and as
CEO of the Company&rsquo;s eValuator business. Prior to joining Streamline Health, Mr. Stilwill was a financial analyst in BMO Capital
Markets&rsquo; M&amp;A Practice. Mr. Stilwill holds an Executive MBA from Villanova University and a Bachelor of Arts degree in Economics
from DePauw University.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Matthew <FONT STYLE="background-color: white">W.
Etheridge is a private investor with over 20 years of investment management experience, with a primary focus on healthcare services
and information technology. Previously, Mr.&nbsp;Etheridge was a Managing Partner of Perry Capital LLC, a private investment
management firm, where he was Co-Portfolio&nbsp;Manager of the firm&rsquo;s healthcare group, which managed public and private
investments in healthcare and other industries. Prior to joining Perry Capital in 2001, Mr. Etheridge was an investment analyst
for Stanford Management Company, the investment manager of Stanford University&rsquo;s endowment. Prior to joining Stanford
Management in 1997, Mr. Etheridge was a consultant with McKinsey &amp; Company. Mr. Etheridge received his J.D. from
Stanford Law School and his A.B. in Economics from Stanford University. Mr. Etheridge currently serves on the boards of Lightbeam
Health Solutions, Conversio Health, and Healthmine. He previously served on the boards of Universal American Corp,
naviHealth, and S.A.C. Re.</FONT></FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
am thrilled to welcome these talented leaders to Streamline&rsquo;s board. I believe Mr. Etheridge&rsquo;s demonstrated track record
of supporting leading healthcare technology businesses and wide-ranging experience will add significant value as Streamline continues
its evolution,&rdquo; said Tee Green, Executive Chairman. &ldquo;Similarly, Mr. Stilwill&rsquo;s leadership within Streamline has enabled
the Company to provide significant value to its clients and led to key advancements of the Company&rsquo;s team members.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
look forward to partnering with my fellow board members and Streamline&rsquo;s leadership team to maximize the value of the Company and
advance its mission to ensure our nation&rsquo;s health systems are <FONT STYLE="background-color: white">accurately</FONT><FONT STYLE="background-color: white">
</FONT> paid for all of the care they provide,&rdquo; said Mr. Etheridge.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Private
Placements of Debt and Equity Securities</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company announced the closing of a private placement of unsecured subordinated promissory notes (the &ldquo;Notes&rdquo;) in the aggregate
principal amount of $4.4 million and warrants with a strike price of $0.38 (the &ldquo;Warrants&rdquo;) to purchase up to an aggregate
of 4,052,631 shares of the Company&rsquo;s common stock, par value $0.01 per share (the &ldquo;Common Stock&rdquo;), to certain accredited
investors. The Company also announced the closing of a private placement of Common Stock to a single accredited investor for aggregate
gross proceeds of approximately $100,000 (collectively, the &ldquo;Private Placements&rdquo;). The Private Placements closed on February
7, 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
connection with closing of the Private Placements, the Company also announced it had entered into a modification to its existing senior
credit facility with Western Alliance Bank to amend certain financial covenants and thresholds.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects the proceeds from the Private Placements will be sufficient to achieve the previously announced adjusted EBITDA breakeven
run rate of $15.5 million of installed SaaS ARR, which it reiterated is expected to occur during the second half of fiscal 2024.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additional
details regarding the Private Placements will be included in a Form 8-K to be filed by the Company with the Securities and Exchange Commission
(&ldquo;SEC&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Notes, the Warrants and the Common Stock described above were offered in private placements under Section 4(a)(2) of the Securities Act
of 1933, as amended (the &ldquo;Securities Act&rdquo;), and/or Regulation D promulgated thereunder and, along with the Common Stock underlying
the Warrants, have not been registered under the Securities Act or applicable state securities laws. Accordingly, the Notes, the Warrants,
the Common Stock and the Common Stock underlying the Warrants may not be offered or sold in the United States absent registration with
the SEC or an applicable exemption from such registration requirements and in accordance with applicable state securities laws. The securities
were offered and sold to &ldquo;accredited investors&rdquo; as that term is defined in Rule 501(a) under the Securities Act.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities
in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the
securities laws of any such jurisdiction.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Management
Commentary</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;I
look forward to working alongside our board and talented team members as we accelerate Streamline&rsquo;s growth,&rdquo; stated Benjamin
Stilwill, Chief Executive Officer. &ldquo;Our improved liquidity position will allow the business to continue supporting our healthcare
system clients through our unique pre-bill revenue cycle solutions.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>About
Streamline Health</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Streamline
Health Solutions, Inc. (Nasdaq: STRM) enables healthcare organizations to proactively address revenue leakage and improve financial performance.
We deliver integrated solutions, technology-enabled services and analytics that drive compliant revenue leading to improved financial
performance across the enterprise. For more information, visit <U>www.streamlinehealth.net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Safe
Harbor Statement under the Private Securities Litigation Reform Act of 1995</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Statements
made by Streamline Health Solutions, Inc. that are not historical facts are forward-looking statements that are subject to certain risks,
uncertainties and important factors that could cause actual results to differ materially from those reflected in the forward-looking
statements included herein. Forward-looking statements contained in this press release include, without limitation, statements regarding
the Company&rsquo;s growth prospects, improved liquidity position, expectations regarding installed SaaS ARR and Adjusted EBITDA, results
of investments in sales and marketing, success of future products and related expectations and assumptions. These risks and uncertainties
include, but are not limited to, the timing of contract negotiations and execution of contracts and the related timing of the revenue
recognition related thereto, the potential cancellation of existing contracts or clients not completing projects included in the backlog
and Booked SaaS ACV, the ability of the Company to achieve Adjusted EBITDA targets, the impact of competitive solutions and pricing,
solution demand and market acceptance, new solution development and enhancement of current solutions, key strategic alliances with vendors
and channel partners that resell the Company&rsquo;s solutions, the ability of the Company to control costs, the effects of cost-containment
measures implemented by the Company, availability of solutions from third party vendors, the healthcare regulatory environment, potential
changes in legislation, regulation and government funding affecting the healthcare industry, healthcare information systems budgets,
availability of healthcare information systems trained personnel for implementation of new systems, as well as maintenance of legacy
systems, fluctuations in operating results, effects of critical accounting policies and judgments, changes in accounting policies or
procedures as may be required by the Financial Accounting Standards Board or other similar entities, changes in economic, business and
market conditions impacting the healthcare industry generally and the markets in which the Company operates and nationally, the Company&rsquo;s
ability to maintain compliance with the terms of its credit facilities, and other risks detailed from time to time in the Streamline
Health Solutions, Inc. filings with the U. S. Securities and Exchange Commission. Readers are cautioned not to place undue reliance on
these forward-looking statements, which reflect management&rsquo;s analysis only as of the date hereof. The Company undertakes no obligation
to publicly release the results of any revision to these forward-looking statements, which may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>Contact</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jacob
Goldberger</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vice
President of Finance</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">303.887.9625</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>jacob.goldberger@streamlinehealth.net</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ex99-1_001.jpg
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !M 90# 2(  A$! Q$!_\0
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MZ8#HB9Z=,L< 9Y-?!'C7_@KAXLO+RY3PKX.TS3K3=B"34I7GEVYZLJE1D\<
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MI:'[6?M=?M+']EWP#I7B5=!'B WVIKIWV<W/D;,Q22;\[6S_ *O&,=Z_-O\
M:V_;H;]J3P+I/AUO""^'_L&I+J'V@7WG[\121[<;%Q_K,Y]J_2[XV?!G3?VL
M/@3::-JTC:3<7T%OJ=I<QKO-I<&/<#@XR,.RGH<$U^3G[1'[&GCS]FO2X-6\
M2OIMUH]S>BQM[NQN-_FR%&?.P@,!A&ZCM7A\*T\K;BJJMB8R=KMZ^FMF<V!5
M#3F^-'@]??OP>_X*D0_#GP/X4\*7G@![FRTBTALIKR#41YCH@"EU0IC/&<%O
MQKX"KZ<\&?\ !.WXP^//">D^(M*LM)?3=4MDN[=I-116,;C(R.QQVK[[.*.6
MUJ<5F32C?2[MK]YZN(C1DE[;8_7/X9_%KP[\7OA[:^,?"]W]NTJXC=EW#8Z.
MOWHW7^%@>U?#;?\ !7:.UUHVUW\-V%K'.8Y9(=4#/M#8)53& 3CL2/K7O?[$
M'P+\6?L__ _7?#OB^*WAU";4)[N-+6X$R^6T**.1T.5;BOQGUS_D-ZA_U\2?
M^A&OS_(LER[&8K%4I+VD(-<KN]G?LU<\G"X:C4G.+U2V/WI^#O[1'@KXX> 9
MO%OA[4PNG6JG[?'=@1RV3!=S+*.V!GYAD'!P37QK\;/^"K\>DZ]=:9\-O#]O
MJME!E!K.J,RK*XR"8XEP=G3!)!// KX \(_%3Q'X&\+>*?#^C7[V>G^)((K>
M_$9(9D1]X (/&>5/J&([TWP?\)?&GQ D5/#GA;5M:+8P;*SDD!STY QVKV\+
MPG@<)6J5L4^:'V4W:R\]NNAU0P%*G)RGJNA^BW['_P"WW\1/CU\7=+\%ZSX?
MT5H+E)I[B^LUEB,,:(6SMRPSD <D<D=*^\M=U[3O#.CW>JZM>PZ=IMI&TL]U
M<.$CC0#)))KXS_X)S_LC^(O@?#K/C#QI;+IVN:M;K:VNG;]TEO!D.QDQP&8A
M?EZC:<]:^;O^"DW[3FH?$#XCW7PZTBXDM_#'A^7R[I8VQ]LNL?,6P>53. #W
M!/I7RN(RO#9MF[PV7)1IQ7O-:KS:^^QP2HPQ&(Y*.B1[?\9/^"L'A[P_J$VG
M_#WPZ_B3RSM.J:A(;>W;IRB %F'7KMKQ;_A[)\4?[4\[^P/#GV'/_'KY4N['
MIOW_ -*^-?#/AG5O&6NV>BZ'I]QJNK7D@BM[.UC+R2,>P KZ,E_X)N_'2+06
MU+_A&[5F S]B6_B-Q_WSGK[9K[=Y-D.71C3Q"BF_YI:O\?R1Z?U?"T4E.WS/
MJ?X,_P#!5[0/$6I0Z=\0O#S>&O-;:NJ:?(9[=?\ KHA 91TY&[\*^[M"UW3_
M !-H]GJVE7D-_IMY$LUO<P,&21",@@U_.SKFA:CX9U>[TK5K*?3M2M)#%/:W
M4922)QU#*>0:^U?^":'[3&I^#_B):_#35[MKCPWKCE;%9G)^R7750G^R_0CU
MP?7/@Y[PMAXX>6+R_3E5VKW37=?UJ<N*P,5!U*1^L%>-_M"?M7> _P!F_3 _
MB._:YUB9-]MHMEA[J8>N,X1?]IL#ZUU/QQ^*]A\$OA;K_C+4(VGBTV M' F,
MRRGY409]6(_#-?@S\0?'VL_$[QCJGB;7[M[W5-0F::61V)"Y/"+GHH' '8"O
MF^',@6;3E5KNU./;J^W^9QX/"_6&Y2V1]G^+/^"MWCJ^GE'AWPCHNE0;_P!V
M;UY+E]OO@H,UU7PM_P""MET^KV]M\0/"4*:<^%DO]%=M\9_O&)SROKAL^F:_
M.W3]-N]6O([6RMIKRYD.$A@0N['T ')KI_''P?\ &_PT6W?Q5X4U;0$N%W1/
M?VCQ*PSC@D5^FU.'LFY50=))O;5W^6MV>T\)A[<MC],_CI_P4XT?X6^-(-*\
M.^'+?QEI-Q8PWL.K0:EY:.) 3M \MN1C!YSGBO</V;/VO/!/[35E<IH+7&G:
MY9H)+K2+Y0)44G&]2"0ZY[@Y]0*_"ROH']@OQ1J'AG]JCP-]@F\H:A=&PN%(
MR'AD4AA^@_$5XF8<)X&G@)2HW52$6[W>ME?5;:^5CEJX"G&DW'='[A5^>>L_
M\%9T\/\ C"_TF\^'3/:V-]):RSP:IERB2%2RJ8P,X&<$_C7Z&5_/#\3O^2D>
M*O\ L*W7_HYJ^5X4RO"9E*LL5#FY4K:M;W[,XL#0IUG)35['[-6?[='PKO/@
MG/\ $L:I*NGP.+>72R@^W)<D$K 8P?O$ D'.W'.:^,O&7_!6SQQ?7DX\,^$]
M'TNT\P^2VH-)<2%.VX*5&?I7P@)I!&8P[",G)3)P3ZXJZ?#^J+9_:SIMV+7;
MO\_R&V;?7=C&*^[PG"F6X64I5(\]WI?HNWF>G3P-&FVY:GWS\/?^"M^NPZI:
M0^-/!]C<Z>S!;BZTF1HY4&>65&R#CTR/K7WIH_[0G@+7?A')\2[77H6\(PP-
M/->,"&BV\%&3[P?/&W&<D>M?@%716?Q"\0Z=X(O_  A;:G-#X=O[I+RZL5/R
M2RH,*3]/\/2L,PX0P6)<989>S=];;-=?1]NA-;+Z<[.&A]Y_$#_@KCJ"ZY<P
M^#/!EJVDQLRQ76K3MYLHSPQ1>%'MDUG>%O\ @KKXCAU*W'B'P-I]SI^X"8Z?
M<O'*!D9*A@02!G@]?45\$V^AZE>6IN8-/NI[=<YFCA9D&.O(&*HUZ<>&<HY.
M3V*?G=W_ #-E@L/:W*?T"?!7XX>%/CYX-A\1^$[[[3;$[+BVD 6>UDQDQR+G
M@_H>U=_7XL_\$\OB[>?#3]HK0]/-XT.B^(6_LZ[A>3;$68?NW()QD,  ?]HC
MO7[35^/Y_E*RC%^R@[PDKKT[?(^?Q5#ZO4Y5L?ST?%K_ )*AXM_["MU_Z-:O
MH#_@F9_R=5I'_8/NO_0!7S_\6O\ DJ'BW_L*W7_HUJ^@/^"9G_)U6D?]@^Z_
M] %?M69_\BBK_P!>W^1]'6_W>7H?K]XT\0_\(CX/UW7/(^T_V983WOD[MOF>
M7&S[<]L[<9KX&\-_\%>M,N-8@BUWX>W-CIC'$MQ8Z@)Y$]"$9%!'XU]P?&;_
M )(_XZ_[ 5]_Z3O7\]U?FW"N48/,Z59XJ%VFK:M6O?L>/@</3KQESH_H:^&?
MQ,\._%[P=8^)_"VH+J6D7@.R4 JRL#AE93R&!Z@UC_'[XJM\$?A!XC\;KIPU
M9M(BCD%F9?*$NZ5(\;L''W\].U?$?_!(7Q=J5Q#\0O#,MP7TJU^RW\$!&=DD
MF]'(/H1&G'M7T[^WQ_R:+\1?^O:W_P#2J&O!Q&64\'G,<!+WH<\5\I-?HSEE
M15/$*D]5='S_ . /^"MWAS6/$$-GXK\&7>@:=,RI]OL[H70B).-SH54[0/[N
M3[5]1?&;]J3P)\&/AE:>-+_5(]3L=2BWZ3#8,)&U E=R^6>FW!&6/ S7X-5T
M&J>+-?\ %^EZ#HMW=7&H6FC0-:Z=:@%O*1I&D*J!ZLQ_0=A7Z1B>#L#4JPG1
MO"*^)7;NO*][:_@>Q/+Z3DG'1=3[*\2_\%:OB%>7^[0_"VA:99AR1'=>9<.5
MSP"P90#^%>D?!O\ X*QVFKZ]#IWQ%\-1Z/93D(-6TMVD6$G',D;<[>O*DD<<
M=Z_-J^T74-+56O;"YM%8X5IX60$^@R*I5ZM3AK*:M/D5)+S3=_OO^9N\%0E&
MRB?T<:3JUEKVEVFI:==17MA=Q+-!<P.&21&&592.H(-6Z^%/^"4OQ>OO%GPU
MU[P1J-R;AO#<R266[)9+:7<=F?0.KX_WL= *^D?VI/CE!^SU\&=9\6E8I=17
M;:Z;;S$A9KIP=BG'4 !F(]$-?BF+RNMA\P>7QUE>R\[[?@?-U*,H5?9+<S_V
MA/VNOA]^S?;+'XCOY+S6Y4$D.BZ>!)=.IZ,02 B\'EB,XXKX<\5_\%</&EY+
M.OA[P;I&F1$_NFOI9+AP/<#:*^'O%7BK5O&WB&_UW7+^;4]6OI3-<75PVYY&
M/?\ H!T  %>F?!C]DOXG?'JR>_\ "GAYYM*60Q'4KN18+<L!DA6;[Q'&<9QD
M5^K87AG*\MH>TQS4GU<G9?)?YZGNPP5"C&]77U/I#PO_ ,%;O'5E)$->\(:+
MJD>[]X;.22V8CVR7 -?;O[.O[9'P^_:/A%MHMX^E>(E4M+H>I;4N, \LA!(D
M7H<J>,C(%?D?\:/V4?B9\ [5+WQ;X?>WTN240KJ5K()[?>1D*77[I/.,XS@U
MYCX>\0:CX4URQUC2+R;3]3LI5GM[F!RKQN#P013Q/#659E0]I@K1?1Q=U\U_
MPS'/!T*T;TM/0_HSHKQ_]EGX[V_Q^^"NA^*Y0EIJ3!K34(2P 6YCP'(_V6X8
M>S45^+UZ%3#U94:BM*+L_D?-RBX2<7NC\N_V]_V=-<^#WQFUO7Q:2S>%/$5Y
M)?65^/F42.=\D3D?=8,S8!ZC!]:^:])U>^T'4(+_ $V\N-/OH&WQ7-K(T<D;
M>H8'(-?K!XC_ ."E7P*\4Z7<:5KFC:MJ=A,"DMK>::DB'@@Y4MUY/O7G/A7]
ME7]F7]J[[==_#3Q+J'AG4U(>;2@V6ASSD0R\E>HR&(X-?M&!SJO@\+&&:X>4
M5%6YK736VO;\;GT=+$RIP2KP:MU/G'X<?\%#OC-\/X([2;7HO$^G*JQ_9]<@
M$QV $;0XPW(/))/2OL?]F/\ ;W^'GQ@U2T\-^,O#&E^$?$MS(L-M*L"/9W3G
M "ABN48GLW'(YKXA_:N_9!UG]EF\T@W^NZ?K=CJSS"U:VW),H0C[Z'IPPY&1
MG(KP!':-E92593D,#@@UW5,GRK.,/[;#I+FVE'3\-/Q1K+#T,1#FAUZH_I 1
M%C1410J*,!5& !Z5\-?\%</^2&>$?^QC3_TFGKZ*_9*^(5Y\4OV<O OB34-Q
MOKBQ\F=W.3))#(T+.3_M&/=^-?.O_!7#_DAGA'_L8T_])IZ_*\DHRP^=TJ,]
MXR:?RNCP\-%QQ,8OHS\HZ_?#]EG_ )-Q^&__ & K7_T6*_ ^OWP_99_Y-Q^&
M_P#V K7_ -%BON>./]UH_P")_D>GF?P1]3TG5/\ D&7?_7%__037\ZFN?\AO
M4/\ KXD_]"-?T5ZI_P @R[_ZXO\ ^@FOYU-<_P"0UJ'_ %\2?^A&N+@7?$?]
MN_\ MQGE?V_D>I?LD_">W^-7[0'A+PM>^6VG37!N+R.3.)((E,DB<=V5"!]:
M_=G3-,M-%T^WL+"UALK*W01PV]N@2.-1P%51P!7Y(_\ !*NRAN/VD+J:2-6D
MM]&N'B8CE26121^!(_&OUXKRN-<1.>/C1O[L8K[W?7\C#,I-U5'LBCKEU)8Z
M+J%Q$<2PV\DB'W"DBOYV-=UJ[\2:YJ&KZA)YU_?W$EU<28QOD=BS'';))K^B
MZ^M$U"RN+63(CGC:)MO7# @_SK^?3XQ> 9?A;\4_%/A217 TG4);>/S#EFB#
M$QL?<H5/XUZ? LX<V(@_B?*_EK?\T;96U>2ZG4_LY_M$ZG^S;XHOO$&BZ+IN
MJZG<VWV5)=10MY"D@L4QR"<8)],CO7T1_P /9_B5_P!"WX?_ .^9?_BJ\$_9
M9M_A+JGCXZ3\7HKJ'1;Z/R[;4K>Y,*6DP.<RX_@(XSV..U?HO9?\$\?V<=2L
MX[JT>XN;:1=RS1:YN0CU!%>]G5?*,/B;X_#RE)KXK73]'?H=6)EAX3_>P;?<
M_-+]H3X]7_[1'C.'Q/JVBZ;I&IBW6WF?3E9?/"GY6?).6 XSZ8]*Y+X;ZG=Z
M-\0O#=]8W$EK=P:C;O%-$<,C"1>0:_4^W_8*_9ANKA((=26:=CM6*/Q$K,3Z
M  YS73Z?_P $U?@AI]]:WMOINK"6"1)HV_M-R-RD,.W(XK!<597AZ*H1IS44
MK)6Z?-D_7J$(\J3L<3_P5D\1WFE_ OP]I<!46NJ:RJW&X9)$<;.N/3G%?DW7
M["_\%0/ )\7?LXG5HDDDN/#^H17@"'@1L#&Y([X#"OQZKKX.E"65I1W4G?U_
MX:QIE[7L-.Y^MW_!,7X'Z+X5^#<'CV>QAF\2Z[)*$O&P[0VRL55$_NY()/<\
M5]@^)O#&E>,M!O=%UNP@U/2[R,Q3VUP@='4C'0]_?M7YB_L!_MQ>&O@WX3E\
M ^.WGLM,^U-<:?JD<9D2+>1O20#D#/((&!SFOK/XK?\ !0KX0?#[PO<7VD^(
M[?Q=JS(PM=.THER\F.-[8PB^Y_"O@,ZRW,ZN:5)*G*3D_=:3M;IKTM^!Y.(H
MUG7;LWKH?DW^T-\.;7X2_&SQCX1L9VN;+2[]XH))!AO+(#*#[@,!^%=1^Q7_
M ,G4_#7_ +"T?\FKS/X@>.-4^)7C76?%&M3>?J>J7+W,S=@2>%'L!@#V%>F?
ML5_\G4_#7_L+1_R:OV#$1J1RV<:KO)4W?UY=?Q/H9)JBU+>WZ'[KU_/#\3O^
M2D>*O^PK=?\ HYJ_H>K^>'XG?\E(\5?]A6Z_]'-7YUP+_$Q'I']3R,KWG\CT
M?]C7X4Q?&+]HCPIH5Y:1WNE1S&]OX)&P&@B&YA[Y.T8[YK]RFT73WTG^RVL;
M9M-\OR?L9A4P^7C&S9C&W';&*_('_@EW_P G46?_ &";S_T%:_8NO/XUK3>/
MA3OHHIKU;9CF4G[5+R/P(_:6\$VGPY^/7CCP[IZ".QL=3E6",'(5"=RKT[ X
M_"L'X1^"/^%D_$[POX7W^6FJZA#;.V[:0C,-Q!]<9KT3]M[_ ).K^(__ &$V
M_P#05JC^QS"+C]J#X;HW3^UHS^08_P!*_4X5YQRQ5[^][._SY;GN*35#FZV_
M0_<+PEX'T+P-X5L_#>B:9;V.BVL(@CM(T&PKC!W?WB1U)ZU^,/[?'PYT3X8?
MM,>(M*\/6BV&FW$4%\+9.$C>5 SA1V7=G [9K]NZ_&__ (*??\G6ZE_V"[+_
M - -?E?!E6H\RFG+XHMOS=UJ>'ETG[9Z[H^?/@W_ ,E=\$?]ARR_]'I7]"=?
MSV?!O_DKO@C_ +#EE_Z/2OZ$Z]#CK^+A_27Z&N:?%#YG\]'Q:_Y*AXM_["MU
M_P"C6KZ _P""9G_)U6D?]@^Z_P#0!7S_ /%K_DJ/BW_L*W7_ *-:OH#_ ()F
M?\G5:1_V#[K_ - %?>YG_P BBK_U[?Y'J5O]WEZ'ZR_&;_DC_CK_ + 5]_Z3
MO7\]U?T(_&;_ )(_XZ_[ 5]_Z3O7\]U?'\"_P:_JOR9P97\,C]"_^"/_ /R-
MGQ+_ .O*R_\ 1DM?7'[?'_)HOQ%_Z]K?_P!*H:^1_P#@C_\ \C9\2_\ KRLO
M_1DM?7'[?'_)HOQ%_P"O:W_]*H:\3-_^2GA_BI_^VG+B/]]7JOT/P\K],O\
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M (JC_A/_  O_ -#)I'_@=%_\57XN?\,+?'__ *)]J7_@5;__ !RC_AA;X_\
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M&KY_.>%L-EN"GBJ=23:MO;JTNQR8C PHTW--GZ'5\P_\%(/^34?$G_7Q;?\
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E_P"22EZ_^WGMK_<'_74_2BBBBORP\0**** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>strm-20240201.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa+GCbP9z5Z8GekhvWBwbZlabywrpB4J8SUWPwwmYWAC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:STRM="http://streamlinehealth.net/20240201" elementFormDefault="qualified" targetNamespace="http://streamlinehealth.net/20240201">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://streamlinehealth.net/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="strm-20240201_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="strm-20240201_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>strm-20240201_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>strm-20240201_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.21a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://streamlinehealth.net/role/Cover" xlink:href="strm-20240201.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://streamlinehealth.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm139926856708208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Feb. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Feb.  01,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-28132<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Streamline
Health Solutions, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001008586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">31-1455414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2400
    Old Milton Pkwy.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Box
    1353<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alpharetta<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(888)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">997-8732<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common
    Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">STRM<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M 0  (@(   \   !X;"]W;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y
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MX_T,:3?D@6)8YL_X>\87_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0
M   ( +V(1U@'04UB@0   +$    0              "  0    !D;V-0<F]P
M<R]A<' N>&UL4$L! A0#%     @ O8A'6)7W?&;O    *P(  !$
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M;',O+G)E;'-02P$"% ,4    " "]B$=8JL0B%C,!   B @  #P
M    @ %S$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ O8A'6"0>FZ*M
M    ^ $  !H              ( !TQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM
M;"YR96QS4$L! A0#%     @ O8A'6&60>9(9 0  SP,  !,
M ( !N!(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @   A0
#

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://streamlinehealth.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>strm-20240201.xsd</File>
    <File>strm-20240201_lab.xml</File>
    <File>strm-20240201_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "STRM",
   "nsuri": "http://streamlinehealth.net/20240201",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "strm-20240201.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "strm-20240201_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "strm-20240201_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://streamlinehealth.net/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-02-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-02-01",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://streamlinehealth.net/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001493152-24-005268-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-24-005268-xbrl.zip
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M'87!\4EP^.[D_/CUT=G!Q?&[$V/JK)NZ 0&)"W"!:&/A0D OBRZ"H'T/H!R
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MD)R(^L*4:8*LZ_3B!NQ0,RQR:R[!,OVW/-8GQ37=4VS;&7+D)57)G RW%';
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M(&)GP>]JX!0NHBJMYKPB%+&D$=./W9I^V]TE+_(GQ*6X*(L/"29ZX%LE$T>
M90RB:4(ZA)ZB#\% %C!QQO/Z3 ZU;=Y*$Z/&;RE#BO]*T:$J*:\C R,#X[@L
M;HA=H6(4&?Q2(Y3GHS;9Y0DY;=*@GR,D'P/\1B9M$-7@DE!+[L#[FB:46'*[
M0 M%I "VH9E?,%])!%+"Q5E> VU'#, Y3HYUXD46\#T6MJ*-FM,/"W>Q1T+
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MLUBMTIC]^XNR:&H87W":;#9PTG[&X=?$&!%A=J(*P!8UWERKN#@PS7PX V(
M;A77/JX+\KH6M\$JB@G#EW#0V]0[V@8[E&0LBSR-38<3X;"+2L968PGFNL%^
MMWCT49Q'4=[A"<UB%F6CH4QHP4AT= E;B !8)\SLWQM?WHFR5RO!C!OF.P2V
M:-T3,_S\?0C/YBY*C#@(UOW@$D>9ZVV5"J>F@;+(I]1Q4UIYD63%S9!BSK&
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MNY2F=RP88JD[E=V1!3H[MYO$[+(3KG ().@)'>C)C3NY0LQF!;L3%)O!32"
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M[6/Y:2_E(U(EGY&MWG\ZIJO'=/68KG[()_PA3VB62^T=B!*A];#JZE2TN=A
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MY#B;IGH8-^- B1J=KA;QE-"V:A%3A&5)3^J;)(.C/-M_-@]@CO55'_^E(9C
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MJ5)-EY$C^UBB">@-&W_5H.N#B%-]S:!K;"!H:[[?5T$G_MHG00/"H]@+Z%Z
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MC.JM0.1Q6W#J%JO2\K_P:ZXS3WVU%1_3K=^X$S'#E8$.'M,>^C!8AM/OP>_
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MO-M9ZX*3V]^:FRM[.NGQW6@QW*WJLG/J8H./O<J:)#C_<,N7G+$!M+-7V0)
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MOHJY;,G-W=Y*S3I-"\:#\M?TAL*OX]OP0(INZG+0865T%Y.]83>[5KW!94J
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M0D7Y*5TT+$P9>-<BHCNM0YFC#LF\*8_TDKNM3PAG:]X^KK5!"<Y:Z8S%RH5
MZ\ZX T1J#JOA+)DGTY3Y;B8HT90219!MS[0M!=(<B3DJ/0J'A8YI//4=9?4+
M\0PN?3WOTAWIU$#)%HFNU71$V0>3SMD6)\QW50GU[4YRN U='[NY>5B>:U&7
M?;;N )';, 2T(=_',X"BT]P11<2#RH/%-J?9@IM<;1=+6" 9H>HU+4P+U\:;
MRWV21(CEB!++%S> 5PM5K&8O"=Q;K@&NA5:GYKE'>C0A>B$O+[3 B'?6#/;*
MTK*P0);S4U@1J[,X:_Y(+W=?<N\$;.9B\HA(&O?08(S3&#HBQ.YXBR MZ7@6
M=KZ:F=$F11C< FW7D;,Q)%W5,#+<$8CFHGD?"C=PGWL>.+=M(8\5QGO$2>D8
MVVA_6PTPWXX(KV>*O.CV,2N<(#ZN[01=U2BVGN_^#2?L02V3![GR7^'*?TN]
M!,9\'L27W#MDC*N0L"*YU9@_@6D?Y77V*;&0(I&_2_'0FH7$DW$1)?G1&LQO
M;YWC$%@^@:RO^*,N8S$)D5I*8UL!Z3QS:#@*E8I;5J17PZD4$-.X' GF:)V/
MTT7&O<TBHX(7,A>D[DJ( (:Q[4/6+!,8GCIAB_IL^;-0-J=)">78$XJY@(EO
M$"@8XDH<A$9XX[9T^&#=$8Y=$:6T@0$_#%LG< ' 1W"F:3"=IAF0>@!&U!%!
M8-<G7%J1Y4%O!T1HF'7+EJ7Y>G8E.1C7+0,J@:4WDWQS^,<\7FH.YHM\3%(_
MR[-96BEV=+[N]I:G+,C35KN'M93Q!!G4O3P%<+- U.C\(')_5$\V_ G75UXX
M^E?U:B+]8DBQDW2+N>>5&^1(_EDHC$,.B5X-DG):$<#T*/8*3!?F9N!%$4\'
MKD\X,DBA)BDJR2.YM4K' ;&)"VT1'S0+/!VPZ:A&)UF??)MW\M\ -O=&BD_2
ML5!::F6W:'!HH*U4Y MY'3;NQV-O.;OALJ%YL ]@7$7NBZ*P%"DYQ<3@_JAR
M^WO2BX8OR)B: BMG5]*J9?&E?-9"@UN!3#Z27F-2&5@AV* &\8#MV[*=64A:
M&27@Z7+/O_RI5R/UY>RWU,N!8Y12%[#:I=6*V*&DIU>;"V]MN%<C$V09UR6K
M<@Z2V=3X#7PP^"I:9G/NR3P@$>LG5JYF7D3>#GB3[2TO24*)&)[O2W9EK+X2
MO@Y[,R\9JIPE\UJ,L=Z-?MG[=3C8?Q=]&!R?_A&]&QX/3X_PG[T_HM'Q\?!?
M1_N#O8,_HM\'HW\-3\PJ-7\^?3>,?OMX<# \.8V&_WDZ-.?KA^'Q^]'IZ?!-
M9+XW^/#A8+2/9=R#P>_]:'!H?G?X)AH<'$3'H[?O3B.XR/%H< "?_L?'8W.K
M0_S4P?"M^>6'XZ/]X1!*O]'@>'0"_QY]/(V.?HN.CJ/CX<'@U/R*1S(ZB09O
MCX?#]S *\V<8V^GQX/!DL'\Z.CH\B?;-\3]\_\%\R0R.'LQX6GN_/BC7Y$%Z
M6S]S9L-L(.,TD:-UXFG?2O +'+E+\EX4+7J?":U\$@6S89"?BO)RCI&4;)RQ
MH+'/3TK[4"+H$D>3:,(#6UVT!JI1-^Q<^S5_I)>[3QX3Z8C0WP1#6"YF,S,%
M9;0OT1-$W30D\#'.:XR,/<C2(WI;EY^L-(*E*5'.(%5TX!"<)W3JV')/',C-
MGR5CJ%TZ5@"\O+Z](O=PV;)$.>2.5".QGGWNBFP@)%[Q^>X$\.@01-E&"=7G
M0) -'A FS521RHYE%QP<-S"+6 OVN?=)N+#(Y^D8_8;M+>40+B93R1BJCUE(
M9\D$<-9WA.%@3_@T@8)9%@U/1F\/D2+2O)FGCQ\_-O?;/=\U1N'R<A<81.!:
M $#N.>H'W<)O_!(B;I= 0CUG5.;JJ0*%5_=*L @-E\!@,+M2W^-LJRH_VY<L
M*GN+9;'(RQ_"JEP#V_M;!]OK8'L=;&^S]_AF/Y+Q'(AL\ 395XFCWFF/U5$>
M52,G#FJA7(=)YV3VC9U?SC7LB(,X3H607RMY1!^CA+>WR+4">%XHLV8+-3>H
M!,YS+[J$FINHI$*F ?$TQ F$V82:$A,5UH&"; 8$*5:)A>A36H!5;I*$72;6
M:D6 />(@&^\Z!50=7 ,O6O(M,$4CQ<QQ;DY)%*\EL):ZA+M9 Y+P YRIF_U(
M9K\1/>!Q4HX9( 8+ 1J8)T5\:9R\8SCZ!)SJZ]N8)4UY%O9X49X"*C*>'L6.
M9K##@%*0%^BDQH7:1+#7>NWY1U1LFX-IJ&'&!(J&"QT&S)XO,V_.8H*3Y0NE
M4QB' 6)6-5LJX4Y"R,PE2/\0=R>GJRDWKNOL2@3&?#3-)TR1F#H]+58KK!6U
MB=;8O <:["6_@SYR=\'=2JB50XJW2)P4#(P*7P#\BQNX+G[J\=6(=!DK\]%G
M]!S)O(6J\\1Y"N]Q4228V4XHX5<*TI%+!T2XB/7^S@:L^2,9&_",;0#H6TF]
M>>2KQE#PJE6)'&K4G!",[?#X^9 :,CJ'])!-D6I-1> 3DPP/2T!!I0?":N&,
M=[A+.18=/B5KZ"0QR=C8H]<-TDLJ3!8!>FJE\G.$>>#A.<OG205&352J-'AF
M8J(G.!0A4D[,Q6E;<E"=Y:5/)>Q$JN#/$!S0HVKKX>D#($H/@H?SG$H#4 H?
M)[H(P[IL#'X61X.?$HG00I.B*R?N[M&.R&-BV;U)=ER[=!R!5Y*CR4=F>W:/
M,!QA%D4N+U*M$ERH9(*5!*AMDHJ<FL?.5JSY(QE;0=TM'^(K/"U/DBH:0+J-
M,WR>+J5MF'"J#9_QB%[PMTG1<R:%,/],UUT@;7!N+//IC@/V@EG=4IP"A3ZK
M% PN%N7RT'BX@FL%\J3EP"N9NIO02!A.:HMR@")V2'^L2:/'#DX#'+ICX_Y8
MJ*Y2:R.E5)2OK=(XZV-[=@SSW!>SF9!T!/(<G^?(. P85AA%D=1)$LVUX)DG
M\&W14G6J>K!W<Y6Y=*Y"5!5F825TUX3A]ZKF3W5.<:CF:.)5S;GO' 9722 /
MY"R>?RZ6BVK,QT))@(G")A?QMU"C-=>'J\)<.[7&F)5%:#V(_+,OBZJ,'"EO
MY(SRQ^RLLWIYX;^TW"P5UC]WV".<1C#P)7;W*'W&"U1+%'DVT%]!VSU=F@_@
M4E&)Q^TM0CA[J^Y3+%*:0!X-.K_"7UE;:V81Y-.I_3S+S4PZJ[GFCV2L)K4>
M#"9P1[(O9HF@IDMTB,RSY.%@0YESP' Q7^BU7.7CS^9(S](*)8PGJ?0%P7]-
MN&MFHG601#*9JM\%XXSV:6.=X/5V;':^=/!9:"\BDXE0".,?T56 Z1WV(OI=
M C."9ACRLG 'H60YVHN(9%VR*XHB[$\M0^GAEC]+YW9G\K@X4C3?CA?&!F3I
M?]M/\ 3A9L#(TJ<-5@SREJ18U1O[6,<!^R!BX>F\];BA/B2F"J86@X(A27#Q
M,49\]-NV7K&9M2=*M@CJ%R18@>X>;_Z++H.R_H]D]C;U#( RYB+!VT2'Q(EB
M5HA&9),R^)%R]F%18GY%]1;H8*"!L%<G;=@=PI5'RE6"C*$V&J5:Y=] 87*=
M^!5WV 3UB,L%%%A5(O42::4+R7A(D.%DT:Z]X36/11-CO"6;^*W-"H"HI"=7
M=0"(!VEA\F&(HD6$X=G;E#U.W9O-KMJ>@""G@0^F<YP0]'P B&6,D_'H2J5Z
M3YT:"Q,[X9JPF,.SI3%020G%[^DT3E$9:R$*U7W$U4%*C%!KA, 075?\ =JC
M,D*2ZN_9WH+MK9VIL;3S<4HR&-8A[)'_2<)L%M(J3CP[@"?&K4TG","FHKQH
MQ?I^#+'N>VK=7B\Q^*P85IZ+0\U(SYNO30M#G:*C3^A0?2EA^\;1U>1O<]UG
MZZZYX[FYA%;O4;J/$Y[H:*<(6;&2S+AP] N/0N];O^X 5HWPG)0\67$6V8G@
MWQ,<@B<Z%$6)3$O@8%*H.S_M@OXJ(77G"?;"P6UAZ>5C$3R*V<# <27-SG;F
M4/,0-BRX"U?H.8R+)*:F2=6_U]2@*ZUV,2@L(BYOC'-/B0D -^*M8'S '+<(
MJ[=XQJ=H8)RC)L2Y-5$TC/TV=:7^4MI6_/H2!^,2CZFA@A>Y/>&UB6E(,IE8
M&9\67<6+A-Q&!QH67 O=M:;<=Y;(9-F;-CKF@_?,YVE%G9&U^W)"^\3S#RD\
M064?%6%?FW"KB6\&)<]]4VIL444]LK;.I6)ZE5,,Q9M4NZ.QR8Z%3P1;..T?
MDE6H=MI[:>4W]YJI--;:&$1RXD(&CYQ V"^\(%R2-<Z<RA@7.@7T:Q<,8U4:
M4VA/, O/XVP 3%)^"6*HJ$F&HI-Q)C)I$=<5((8U#@_:$R=EMKJ5-?H-^0<@
MH4FG^F1F+!K)B%XDNFT:-#^@;[J9S/5;D7A0#+;B5F4T3B+<H)HNG-0HMA5$
M-R&_[4-# SVXG^AHBNDV=O9-KH^OH4!9%S/]--,@3=>HP=#>97C\];MRM<VB
M/+"H:L;<2U6[*HT,&[/M8F)=*Y1D(5RW0*MEU31?3A>.K/DCF7"$&@I/ 9M.
M8?0J\&7%'^,,%B$.60?0NM1-YI[XS'P@1R-&+?Y8?0S%UZCIPH0C 2]2>5SU
MX]NLPB2;(NE";U5A$VTL"M=H&#&L>)M4 _]F.9M1MPQG_&XF6"1$ET?+"K*O
MT1MSC1MQ!-D& CO#C78(U23A*00]>8D20=[9$E_$:89Y'+]!^A+,9&2B@XS;
MS;5H+^YCY?^$NS+LX8$E?$FLHG6'^,%6HNQ=<G^FP1>&Y$O$- R(=N.>:3.%
MSL,-RB'1PPH@W/-*H4@=,RL-'8W6T78.O)RT7$WS!3NEJ>UF<!T@EKGFX(]H
MS2@2''K/0A AC#I8#\S"M3<O%K+CK+TK;W5X'LHU(PSD#>T2Q'1@G5LK\#;Z
M_F'%"J1F[A?@C,'NFUZQL-O\D;VX><-*%S3Z2  E?>]@ ^4-AN P&<&;[=A6
M0-@L-L@3*4,_T^]6CD)">X$<K5PW[)YO:.3PKOO<UP27C61'>SXB)K@6;#[&
M9YEAW=[)^\,H6Z\BDWVH=[[]-_9?Q\/W@]'AF^'Q]M;1;]&'P=MA-#J$-K71
MT>'@X #:S'X[C?8.!H?__'\/>)%> YY_V8'G._#\CP&>7^O#X%ZBKM'A]M;O
MH]/#X<E)]#MTQ1[]UO= W-(PCIF-&/G;T/-1(94E%55$/Y@MPO8FVR1'*4H_
M<T),92#,2;2B,>3P$G0DV /&2N@T+<H*B[!$[!F?Y1<_!.3*V0.]_^OVX:L?
MVS,/K69$Q"2.O_X&K=(4GB;$S:]WAWN9I2MHH/M',/&'__[3TV^8Y>\YZ)/3
MX^'@_<'H<$B#?3<<')R^BTZ.#CYBNWO?>#K[(>G,-7VA=DV^>'RK J.K7NXM
M#GH#Q_S\>P]ZO1?<QKRPVQSH7E/TUQOE=>X\7?+^GZ-;;!NPV [C6?*:Q[;^
MHR5U5QJ<DWAMT7?MEMGZ#/04*N^;L\Y&$#&G,QK=_J<TF9HX6*!,1T 7!069
MT(JS.F0/*3=UVT$;\=3FA7FD)92[06KC8>89U^?YOR7I^*I+.G9)QP>>=.3,
MT<;9T,;PO[\2X$]=RFM=G+NU37D=#MYSL@L.V8_'^^\&)\/CU]'_;_O?#^"X
M;\*KW+QPO4M&KD?*Z/OF*KO_W[1]N3%[\=;3:!LPSFXQ;<!+HF39!@QTU6JZ
MA438>L1M7:CS(/VOVQWT$7-ZT% _D.A*G$6#&73=HU!+7OE[NC.\&S#0[B6M
MW4#_5VLJX<?,+FSRN^PVW :\)"(0HL&9@^QW4N0H&3XZ&!,3V.O0]HM^@%>[
MKF^RVUWK]TY"P5[\A48V>F-\Q%WH(3LY.8QVH$O+:N;T6A+HW;M=ZW?;;< -
M>$D#TINCT4&[[R&V?[_NSJ[['%?GW'<OJ'M!]_.";CUU^S2=WQ]JI>L)^UX;
M;0Z4$]DWYF&S^"I?5H_.BW3R:)9/S.BS=)[<>U)Y@Y[I-,F2Q2?4((1',<'#
M"IA-<[\+&/NNS/)WF-F[L-H;,NP?\C6NV4:_S><8/B(]31@[1RC7[NYNA_\0
M2Z.S 3_(BQX &QV0-P5SZ][_6CNK'AP>XYJ6E9^[EI6N9>6!MZS(0 /L7[>V
M]W[9LX^^]^O=M++<T6.!;OQ_OAOMC4Y/@ GP]8-[P/;W=K,-N7=T_&9XK/>F
MMP%OU*1ZTWD#%V/U!I9<1G#+6MH?'N&M)W<&#1CFZI'<YKU_ Q70? I*",8V
M,HLNP,@"6;N_/H=_(2C=NZM)<G/"((3O-1,/C;9QU9UO;;WN/WKRVCQ!S>9\
M]R4Q&(^+9)+"YABAH$!>1/]W:?XUCO,<M*_7:[L$)^[IW>V@-\<GT5Z>?WXT
MG%?%U3K/%$S,L[N;F),D0[TQ% ICP;$[F9W.V'S#GGES'Z9&3I]14207.2)S
MB&-Y:M;* '501O.R*I8DI+!>VRF49+S[@_LD 77QN+ABO;(RVH=YF")GY'I-
MF!GTW<\/D\O<Y>QT]N<;ML[;^[ _OYM3:(TMS$^_OKO[#7-@3NM''Q>.UG:]
MYB1$+G5WDW20EMA\] 9U47.61AHBV2\P^[*U*>57H*<2-:?TNZVSSO1\P_KY
MQWVZ/BX9 :(2*S>=K3@\2"6$[L[=G3?XSO=*,GAOQ87;+R6<[+\;OOEX,+R?
M6L*&OY3OX%P]VWVR$_>VMZQ\<)J4&_TPY^9A]CU1^HU^G"_F<8Z3<U;R-"Z$
MZ)-OZ#-] T;AF1G5$<H2EZ^C@]AXZ!UDX18@"YU8S=KM@UL;OO)X_L_>T9L_
M,+QX=_K^X-?_ 5!+ P04    " "]B$=88G:J'T M  #M$ $ "@   &5X,3 M
M,BYH=&WM?6ESVTB2]G=&\#_4Z]WID")@6;)L][3M<00EP19G9%%+4O8Z-O8#
M2!0IM$& 70 D<W[]FT== $E9]OJ0+$Y$CT42J#,K*X\G,U\>#]^>O&JW7AZ'
MG2/X5^#_7@Z[PY/PU<M'_"_\^DC__/*@=_1!#(8?3L)_/)CD6?E<[.W.2S%,
M9K(0I_)*]/-9E 7\12 &4B63!_ BO'KVI>^]$+-(39/LN<!'[7\O1"D_E0^C
M-)G"3W]619E,%OK+)(LE-KZ;9 ]>O7S=.QWZG3Z<1+,D73S_7+?T;)'\6_(H
M==NEBK)BDJO9<U'-YU*-HT)")P>O?LM&Q?S%RT<'L&+8)?QS]CVGK)+I1?D]
M)TRS"C]=)*.D;+?V=G<>_[C)W</]O 53'E[(=HOHJA#Y1)074ESD:2P5?TH*
MD61%J:H9#$V4N5!R+)-+*>;1@KZZD$I6&3X?9;'(X7TE;MI<I*0HJM&?<ESB
MV^T6?,A5G&11*;$O?+O>UD!F2:[$83\\Z@Y[?;$5%2*6DR23,33,C]@VDCP3
MG:F2DCH["E]W3\,C<1">]-YOBWFEBBKB.>%KI50SZB9JM]8T$8BCSA!:Z Q$
M[[48'H?T61R'_1 ^;^$7OZ7Q7U7^XF7WU>#\H-<_ZIYVAMW>J8C>],/P;7@Z
M?/FH^^HW10]M!R*:Y=E4O \'P[!_*CHG)]W.Z6$H#CJG_PK:+1S6<>_D*.RO
M6+R 1CV+/JY96M@,?( W9!ZI,@&BP0^RS'=^'(6/83!2?7>6]:,/[@^:UEF_
M][8[&/3Z']JMT]XP_+4F:#:M/I]AY^ D%(?AR<G@K'/8/7WSCP>[#^CS6>?H
MR'S^XCE?)7%Y@8_N_NV%P.,MU<-QGJ;1O( !F;\>D"#T<MC_\@XN)9RQ<92:
M%2SS^0,M5KT<'GWU@)_B>/V=2>6D_):[\)__\]M__/'L]S]>_*_=B>'1]Q@X
M<?)O.?+7<J2J2"UXK'8:@7B\^_B)/QGXOSYO[".BKE<_^D+?>?HC3LZ=GM+K
M7K_=>M<Y.0]%/SP,N^_"HT#4FK]>CAF42D:S%"0!<2RCM+P0@SRM\ *'3KO9
MV+_SX.(51S*-KE  &>=JGBN^ZB^BRR2;MEM1)J(X5K(H1%2*QT]V=T4OC<7;
M)"WAJ;./5XN=0!SDG\3>_M-]T4GG%]!264:!>"-S6-%([._N[OXAMHP\ %UW
M7QWD2N574J$,@*-Q<L!<Y;.DP LZ1\&*_M%?@1A@O_-(G$<JZ@.UOXLMO/MK
MG1^3%-;LFF2$N4JR<3*/4I1'*A >0)YP31TA:U0PCBW'*6#((&W! DZJ5(PK
MI60V7A@9[3Q+2A#'!B5(<211=6:PY^,(!I5/)<DC5PGL3Y0MH!6X9611BG$T
M3TJ@N'_#FRB[P*S@+RV;N0&.HC3*QB"Q0O?1&+8NQH_<WLOS5P.0)'$?06LY
M?R5&,LVO>(HKED*<Y%&VO!4D."V-D\4H.]J<1,UVJ\KF41(OC\\LA=<3[@_)
MLRC;%K*$$Z"@<9B'-^Y]&K<1Y\Z(!(I<+<1I#F]MT;>UJ>#WS3GL_%)\X1=D
M=:1R3>!8Y5=XAF%/(U'@:2')79..TWLT$1F)?IQG<4)\#8_'U44ROF!R(1J!
M?[5&94A9/\*M!&($AP[:A<,CYR6?)4-OV "\A>I.\?R76O%?D(CV=M F]PJ8
MQQ'JOTP1R#Z0%>R(3B&JPBC%=F^1?ASA^3R7U5^X563CH9F,,OAW0Q#??$J_
M?^LY^1=#)V8F$:7M%EX_1>.6H'TMA(R -6B.D^)C,*'8VEZ,P((\![@3BDF9
MS*LB7?#-V+CB?O+%\\W7\S[1"/*'&] (2#]SE%6 332D$WCN,H%ACY%IX*.N
M=2*. JZFH@). Q?0];35;FGB,G>:ID;\FVV)!=QI.5-J4<'@FEUM"/'VS^DZ
M0M2[O)(< [+5, VFB\"S,+/U%H1UCQR(,C?D</OG5-.3JP+4^ )4SJ-HL9HG
MX3;'D='+R@O4K\0@*BM0"!>HW@^JC'X'N9D?S+0</(JRCR1U9S"SD@T$*"5U
M2M#<? T>;0-155[D"@4DD)*5R$>P*E')BNDXS0NY(:W;/R>?M Z!4J:L\AS"
M@RI/F_157$1I2E0&E$/6IHAU\\10$-*>;G0.7"?/S*M (?K[J<JKN?EZ"Z\S
M[9S2TC1R*JWSMUM[^UOQ-BEK>T_@KZW'V\[;-:Y40IZ;\-.8ABXZ8U(1]_[8
M?[(M1G*<S]BO8[H>R0ST@7$"S"^_RJ2RHZA[ROI5*L7>?OQP7Y#WCKU-G^LP
M$'&B8-PIG2S8,_TI(-8+E_$$NT8M-JMF(_9,%6@;8]X,"SM.HZ+@CT69CS]B
M.WR(Y5]54L+E7]@QP#F&DSZ?I\DX&J6LOF0BKTI0EJ%K7D8K1[#'3@&-"!A
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M:VF8!&B\SO&JTBT##>*1Q'LN%K,\D[ &6Z/M=NLS[VD3 EL)1GD6PY@S5.%
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MA=RU3ZOP,I$Q%_&+I4M."TA%MV 1/B6S:H;5WKGB*)$7\(]&5D';KTM'H+V
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MFG5^1</+=90*7_6./N"Y>W0\?'ORZO\#4$L#!!0    ( +V(1UB*3H)/MR0
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M=;XS[4M+U^'1SK/M<4CHT_/0LZ9M")QNOWQLVG+1#^9*Z6G_"#S?[$]6R:J
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M/<>R1,\W 0X !]^*-R <TIM:-!.\-P22,\Q;TPBXA6_RC/>2IT3O?0,FH;>
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M#ULG@;QF#A:)K&(!9=;#Y:.TH/@ E+ !?L]'3H!>FG[D?XS\/:"3#R/7.,A
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M>'YB\.7J0)>9OF2]Z"0JP>X*]Q:!P26,PW\R7 5 CJQ)02X94UA)>@;(N3V
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MF#FPAII]"*'T39@V*K-*YU Z1-3R+X1R%B[,!9K1[2-HV?+ S@$+[*5;U'+
MCI.>4ELJ1$HA2_8&*!;H&[ T45TD*PO5+/)!A2W4LJR:R!61UFU)K=L#U2QE
MR81*+FR4^ $V+7;;)#\.ND F<9O+8F&NYR/LLH.=.N\3<1M)$B_FVEAA8? 7
M4%;G-UW^*%TL%9BGUKA![>NK5J^!EO==^D>FW&G4'2XVFI0OP59M!$,/;>3I
M3#HZE)</* #8P23B2=,E,8H%5Y#3S_9#+P',=L==L/.H:=,LO\ND*/2O]DT@
MQJB!Z'3MC12U)KP2M%#99BKM&\2^M]T_E.>7FELE)LYHBIAP?\9&7]2@+FE#
M9[@[IIO730.#9(^IHX'=&W)[H/J=ACR*_-G2ST%>]O(4*XG[^CE3JU!+RSQ"
MD$:+@%8N^#NP#R4'5;LJ5-%W[)/ZI^19RH&1.77:.Q9ZQ;,..PPF8(<P><N$
M<>;!5UY?,LN05Z>'K%'4"S\W[>D.L\E&F@21*^35!(^<&E;</$PF\/X)CTG!
M*&P#,V')%S"#.(&MTF[E^Q/JRQCAA)*/Y&601&*S.]?T55A 3E.*9B"+?A!P
MI @'O0SDWT?"B8>Y-5T_R':E2?&7%DH %. $'P\QI18@0C<-166RD1,].=SR
MG-"%0XGOJ/#ZQ<(H18TAHKT"Q_H&=*Y_J04>HY10RUM=#N?-F0;F>)5,\@M=
MEP*G-J>U8(Q)0/53G#:969_JZ:>\\-CW6Q*WO,-!G*\O1-0)+.IA\?Z <B.F
M.R)KT5L70J0ZE1<+LM]@ZHDXYF8[MBOZ(%&(==SA?:$Q-R6O1D8]^2"X2UT0
ML=$T!;SXA)Y5]\#G.L1S>MKX!;X[^_2PT+L>1L1MU1%EYM13 ?C.+&,.M9_0
M^@HCK71_(Z*6$#VIV7H<AB=]C$+P"1%*<;"P TPLHDIQR\_P!E3<'WK[<?/E
M</!@/8T6IY&HG$P.H'@'M52]I;C)M%Y'G J-SEZ@$H1XW'759W8PZLJT @Q<
M ::@BN-1[,\ +=(U05T@;0VU!323I0;U EBRXLU]+3BB&OO,2+F%2"*F9!YF
M 9FN"LCU*4+-S!%F9X (LQ+^"8;R$,!!*1WX#FCF9AA()%MG)G3=)=G=Z\DP
M>J*A%(_#U3VZ,FP@L^*LXL*L/IA?H-U[+R,K<TS+Q#358$;_*S#!"&IQT[L/
MT03*+S#1*?Z,0E,Y]KKHBNB1G>\Y-N 5-GI&<YM03&E\)95!$;H\,60?CEPL
M#%S'(Q'9$\*(\@"8D,"9]JWP_-#SUPV' %RC!\G'@/!3P#; 0 9V2*.LM*Z,
MEI.[%87[U"U,F(!;""*:<;*:)KH;X($+O&D^VP+M8]P";>M1X!&1JH]YI&JE
MD:J/;RU2]4K8\-;2?%BANY7AV?T6>7:E(.B0[W9)#[ T:$+/9U:J)RDDRK3N
M 0\'4P=3DI3W#NC)!%:L$GJ!U8HX;4TFMRR&Y*^H 71W$@V':4],>@4B/\ T
M#-3Y$K\+IWZMG'W[EA$636I23EL+M0$L*A,Z<T/GR\T9T]#%+9._(Z\\GK$E
M!IRPRQ<R\ B6L:U"BU&QB/EY:Y1J-L?3'6>F&<)"$Q_+W;BQ:4:I7CT45089
M[FX(OC+;<RQ[D; E;GUXA,HE@W^/ $KT\X.9@AYW$X3PCO@ !HXERUA0>'N7
ME-G(OPFH@F&M,-26%>V('3%1U"0J<R-C%13AN=?9%'(Q-25/Q,:[<68!QO">
M";.V$H_6[:CZ645P+YNU"B72U;5OE#;W56_<Z"?LMYO6=];!Q#CV3:M]U5LG
MK*5?Z"V] 8]?MYI?:^U:LQ$*WVG73QQ:0\-:><13T:VX6DNQ8(B^-,S11$O'
M:3-S'# ,EHBI*BSUV,$!?7L09;].ORL1$Z6[:0.[&SMNR#I=T0>N"/ILL:#"
ML*_@C%\-LOX2WNCH*&2]J#4 ,;4O+9U2,Y4S /.9![;D<8 BH7B5%K4,H$::
MV4P.]V>VH^VJRU^*N<;Q[O@U&>$'? 59'7_?%?X=BM<P4FOB:G;.=V4V.6&<
M[;# #D<&Q$N\[F6_CP#N5.;!5"Q@1K4MNVO(='O#["ET#MT?X=V"L6MBI2:E
M,,#LMG "CR+"<1!V!BJZTQ"F;\"V1N6C7LX5F]/(O(7\^K"@427A<S]A%[Q'
M5P$$:P/,=!'%6QPTHGQ^O(Z9=._C+1;RZI-'EG+[)PS>(=[J1SD0\K8OJ@">
MP!0"7Z1" *7PTAZQZY*,?WI.-%4<B0HO9W*D*'. 1!EF&5ADB14+J=C"3-Z'
M8XLH^.7Q42)>7&::+?D)EY=F(L49'="*F\"O_6CGPBRYZ%(%N1WQGJ@% LIU
M;+,'S //8V1Z7DHI2MXQ32XF,7]^0WKC%G*P_S"2PW*DF1'9F30$O)YE<W7G
M-,I)P O->/\';4$2:90_!$@Y ;P2RL4=:?%+:%)>5)M2SAL'@K/NN"9"OG$A
M04HTD$4J5=OJZ#ZN3*13]Y]N.4B@P$M?=L1'2<#D:+U!"SDX>!A:UX"_#MRE
M\@Q\9R!O"D;^C$5WK(N%Z7RXA-8N,^EL,0 #6.%36CD)I<STW7MB]<IXD,X6
MA;^A91'K=RK5CAPI$26&U_V?,E6.[P\SW]<QNHR+/$=>TG\BG:I8H C%!26_
M>/_=],X/,SMS__DOB,<=Y_&XE<;CCM]:/.XE\7IEP"]745=--H.2\/OA_3,O
M7T-W<5&UA3NU=!YFJJQ9I8GK;OSSW>'B<Y@_.F@<X15B5#<^)^?)JC"W7-TX
MM=/'1(P/P8^LHFWA8"L<Z^-C!GOX=CP!WF5/EJKPMCLM7;NJUQHZN]2U>N>2
MM9OUFTZMV6B76*U1*2]3BG==2WG&-S=H6>>3SPL1<0E)O)">208:&&4D=?TS
M)KD#0]H[K9UY>^S<G:"]^UN9M028M,#+:K7:Z5YM4Y& A/&CMCEKH1*.E_US
M0S>Z8_K6XW8:[5+7'+'*T!1]4$EL;O<P;:,IK_]NZ'JWE;L\D?^76+U>83L7
M>[_O:2SC6Y0)N[E0>"-" 63"WIL7"ANZ2&+([/.<AK+WO.O*!C4Y\]T0YGNM
M?6<_\='XA)WK#?VBUFD3(\X9;<YH<T:["8SV4:O,V>PFL%GM*]:&PY<:[9LZ
MEJC+>>M;XJVY9R/GK3D-KUV%C=EKTH><,]J<T>:,]N47F3/:3:/A-*-]2ER;
M_G>T7,/:#T?9V4?+1GRUQN_I:.\*XO*)J/P&2[O7@BWKS.U:+2:2AO%-;W?T
M5J-8T.KUFH:7GB0.)G2*[4;!5\K>UJ^B; ZBWN/6DXM;]@>6^J< C<(T4CK3
M=;A'S[QL2BO;+-QYO,*6V-J-I(K':VEM89N.RZJJD';V^J+ND-N3O)>5L9E,
MC"3JFTI870*^.!68$CDQ2;PS-%UCMABQZJ<'#QS"OS0*TK18O:U-9PUORXYF
MIT,NR!?^]-:RA%,9P8FFL*=Y)N_SIP1O:M^(K&LXZ[W8\"[NVMI]7>MZC6=U
M>MY*]/<M%E(-?E_30K,/;SDV?]YL5?76W$S[)01]E(Y_[WZA_K:,AC?GNDBD
M)(<0KO865Z<YH_8M!F25DRL;FZ5,;+R$BF!HKOFW8W,6WOBCZX4SVN73=_9Q
M.?JK'O/9EG/1:EZMX,A3-H /NL?(,FW!+@6W_"%K.U8@6]RPFMTKPY&RJK#X
M'=;!2)PG*;KQVPB)'"!ZS6;-H>DDWRDE7@"5<1*F+ZD>@A3Y2<T7MHV,FDO2
M/6IN3TI,N\76!P:K *2!A7T3Y.L(2&*6^.ODPBC"-'N "5OG6>YU?MC60EG3
M]U-7J,\]8-]F)LQ\\\6U2NKI)6NQ &18\2+PAPYP2"S>)O/9D\UJHCH"4OB'
M74JQ1$</R[Q1"=RXIASU]$@5#X@N4VNJ0 !^VQ+4_--0][*)>$4O<)&FM)E2
M.*F&852G-]D=(7H^:HG =LS=^"535< #1490>9!0HXD:OH.:83H BY#UQ/XO
M_2-7)TLEJEIV85&%9!]RVZ&".<)R[F2Y'1. D&\MK."8W.MP4U25A<55)+-+
M)Y29YON\-U25&"3L^#95M53PQ]4"/5"R'-</B[GQ+JPL/&O5YJ%8P(J8ZJH#
MZP<N7;N?P@?XS)/%B6"Q8^ZJ*BY3*/(%6*O+L92[1I62X2E-5M5& *Y=T^Z9
M<$H>V_FB:=>[43];ZL?A8:<<:U(L8(,8K'A)59"Q[(H\O_":O UDES@7\6-L
M1<WLN82)F#9.*>-$5%+9<7P\PE57(MHNAKH.(^+LFIH"(58;9#PD29"Z!7M8
M_:9GNCT+S^2[\/8:CFI6KFA<FB'""TN]]4!XCNSRJF,HS[(=X2D^$^CS!E_B
M\F_2Z?XI)50?=/5X^0E3IM.JKAZO.64$3K0E0AY:48)A.F%H%>'39UB&% _K
M #X1^UUV(<N2XG*+"SG(TU.YINS\CXBK*S,&LV8X7.7E[ZV"]I=_/!P)7F+\
MQR/1(XY"LVWLWM"/;J&2UBC5N9W*M<:TP$ S=7=-#.@QGH+O.BF H($=_+(/
MZNK$>P;@ECO-[R(;EL>/V'!>##?6DJ2Q#?"LC#-L'3NX@@^&8%%E\@,RH%CL
MQ&=9/OP7QY)P"8I%'$D.\:AKH3F+V!B2W#1XWBZ+.-C_758SW__7YIS[#M8,
M14].#_ME/8>RDA/[BQ]Z3NS/91XX8VI?; ]8-S &PB\QCZ-G=>PZ?X1-#I G
MQ,^-+6X32;H.-:=#4+H3UG6XBY$!9JC$O.=0W1^T5NH6SK!U#;KS>:Q 4*GZ
MT"W<%0/3IHK^6$<;:Q[W30\.0,(Q$=S=&+3,65#.@K::!>VU5"Q=V[MFV@#[
M/80=TI$ S[F7LD1*K(H]4S!HU!*WP@Z$A**-8:S DE&OT$AH89S0Q6'4LTRZ
M7S<'P[+-F8W!N)R[Y-QEV[D+N3@WY]1KMNFCYP7YE-1)-@8#<FK/J7V;J;T*
MPMTS?=;E%CHP/9E(@DE FX,&[Z=3AO GQXKGPPKF!+Z'+2USO-A@O(CR69^4
MB[*:6V8/G'$;2^Z'3STLST)=)5NPQ8NR+*+2R!**/!WFI8#7>CYIH6O,Y#EZ
M-Y]-+'6/\I%+6ULFS^%2U1PRTO<69)CLE^<DU3\N866)P5X:Q+G=H38"R 7M
M<Y8"_"'[L*D0/YQ0GE:IXEY_&?]ACH(1TUHM&,UG=6Q$B)>$L<NADY+D!,\Z
M8<G0'IY_S@U077?X+ON-VP%W)^SHH,0.]P\_EA#A]C&><E#>WR^QG>XNT\:N
M:;&C_<PG)" [/1@JL-+C?#Q.C&/LLF;/=[K"33^3F(MN5(ALF(ZBL58LZ^YY
M$^^&K&?BU;M[7@*6ISJ*7L+Y\E;>7(O9N!G@K!S10OE4%5WJQ:D9R$2%P?3S
M6J>J38FIC6#=*;9\7&)',XP[R9'I@?TLOCW%EN'!P\1(DBL;,USY..[^:W'/
MQ_!7%'3_"QZ4@7J!?7WA5QPSGCQGX3D+S]_,6?AJ$>W"_ '\NC($E5R05RK#
MOGAQQCW-M*=XJ"\6,M&#\N&^A"+GI#DGW5JNMNVL:\/ 6;TR;-K269-6@C>'
MBV9[+G;>'Y=^/MXO[>_O[V9[+G;>?RP=?U)/S/5<[+P_+/WZ*1HGTW.Q\_Z@
M=+POGYGGN #V_O[C$3WSO&3P?K."D-O HA?5''UD''%K Z +BFS^_-:*;"[P
MS&]?X<VMP<!M+#V1:@F_CLKW"X_C]!S['F /8\L2%!>6 ,[YN7;Q3H@_83=C
M-#H\;)8P4ZV$%O@2*YE3/65M\&2,OJJZ7O?:@V$A)^ZQJ&XJ@J)A32O.+-/S
MU7V6Q*_<GH3WZE3Y+9>Y8@ /N#RJQV4FD &O!,D#=\W!T/=8W[1@TJBFUXU-
M1>_:>*O8 ZZ/99@D'*C;=%QN"%C2GZI"5 G&[EF!$5:4"NU6+Z ;-U3A)S1L
MDV AF FPF1V,0*N"73-I227FF9CHE1S2'ZI[ F0@TP39-YV9(2PL@2VH1A3F
MB)57BSS9>+(EX<DG\!3%(6!7)1SAA8V<9VP@S\!":@$=F!$?E/Q$$N4$2!<K
M[TH"](2/!?* "9BV)*[XI4Q:O)<,)2#/0(O/3D+O,L+VL[)_185WEDFH7/.&
MK:Q5S2J[WCQ&,5QBJ@<JADN;L#*339;I:(D!=TEDZE2W$,7T9^17 (2("CJ6
M%]J["C0R%)1!%6=XJB_1A)GY]BDY2O/+>BV$@Q2-+$"F;!M5-WNV:G;*E#L<
MWY.Q.I?H5_FS-.Q+""PL7OTP"&_:.FLVZM^GA-R,#W -V:O/B%1S\>8)7M&W
MN",MT1,@A W6G7S.NJ.PX,K"H[:NC?J"*ZQ):2NV[S%%X;2;SF6S5?M?'593
M^]+06SF^Y12XX (3Z,/+D-Z*"/ 5[=R*<&G9K9\7+-FV;?N*VJPIC.60[ND<
M'WB@UKEIZ5NQ>3G#SXET$[;MF:5"I]:I;P>!K@K?,@,R+XZ"L9-AA;63#^\O
MQ)QPT[6I#O\R*YC'0<-I?WY43>7OZ(*9FR*U-$97M<Y2"#T5>5Z_HV2IZ5<W
MP;Q#NF_YSW7A^R$NOM?<E&%!.L4O)ZRI/(&LCI[U-Y9=\?!,BC4U&7U1[-L[
M;U:_(P7M77:NZF?_#U!+ P04    " "]B$=8WZIJ9&1-  "(R $ "0   &5X
M-"TQ+FAT;>U]>W,:29;O_T3P'?+VW9T0$4AM^='3;7L<@21L,2V!%I"]CHT;
M&P44HMI0Q505DC6?_IY'OJL*(3>V)3<;]TY;4&1EGCQY\CQ_Y_7I\/SL3;WV
M^K3=.H'_"OR_U\/.\*S]YO7/_%_X]F?Y]>NCWLE',1A^/&O_XZ=I$N<OQ>&3
M92Z&T2+,1#>\$?UD$<1-_J I!F$:37^"'\)/+^[[NU=B$:174?Q2X*/Z_[\2
M>?@YWP_FT15\]<<JRZ/I[4]O_A:/LN6KUS]??,VWI='5+/_IS>NC-^W/LV@4
MY>+YP>'KGX_>?.7W?MM5ZK>]?MOK#NU7[$^#132_?7G72^C9+/IWR',BB@U/
MVX-VO39H'U_V.\-.>R!:W1,!GPKKH\Y@<-DZ.FN+RXM>5[3_N]T_[@S:HO=6
MT,_M1T];[]NBVQN*HW:[*_KM=YW!L-UOGXC+[DF[[P_<.A[B*(>_/7O6%*U!
MO=8Z;\-S)V(/'_S;?/*O5?+*??YO*7W8:(I>7[0N+LXZQS2UP; U=,8^:WT8
M'!1>N.GBZK6RU9VW/LK%P;3?TKK>PC0&K;,V4+EW=@(D[[>Z _@*O\,9#@:=
M=UU<4:<A.EUZ>>MHT.X>$_WV6@V8DVC#8,?##I".*=9O#3LP&5H34&18K^%K
MO(E74[0O]HYHW-;[5N>,%@?K.K^@0=_V>^=$/)A-BZ<+/\)O<&6#RZ-_PE3$
ML->DH>WYU&O]]G]==OHTI8'<?O_E2&$<^?BXUS]IX3(_=(:G=^X43NCH[!(^
M__TC?] :B/;[S@E2ZD0<?82YGK7?M<Y$[Z+3I<G ^X][E]U!^PQFV1KTNC Z
MB$&8ZN MS*37_PBKH"D>]\XO6MV//#>8N=HCT7H'*R%Z=6![+KMG[<& ]E%<
M7/:!+;I("-&_A%D?/G]>2G'@V>/A =(.UPEKZYYTNN_H(=BS]KL>_-7\8C8L
M/6/(A<"!%V?MDW=MHO9QK]MM'_,>,;G%$=!#O 7ZP>/]=W)'+GFU/1BR+\YZ
MP"'PU]M.%_8))]WJ V'>T?;R^YCR[DP/6+*B$/IF G9[(D^)ZD<Z?9+8'6"Z
M#[170V ;T>LJ-A'RTP%R+7#P\6EK0-Q_3L*D=_P[L5G;9>_A:6LHCMO]80NX
MQ&(S/4#K7;]-3-$4)W!T3_!HP@O?MH_ZEZW^QWKML"F>/GGZO$IJ%P<R0OR(
M3V4+9OBN<%;Q[T[W?1NFWA_ (9=BE4]UO]WI'@A\]!0.;+LO)3801-%FV/H=
MWCZX/#[5'QGQ1H/#U73.IQ%.T$D'#Q MC7ZS=@7X(YH]RA,X6NV+(0D[G%?O
M;1.D CY)&]$ZPE,HSU'I&X?\JX(0@<7!@I P2HYU072!7!NTARA=X*!+.NS.
MY(;3'X=Q'J;;F[T</4^#.)LFZ>*E6"V783H.LI!.*]R=[=;Y6:<+&@6HZV>P
M97"_7-*^-X&YC[_AUFU[[8]]Y^B#ZR"- IQFM@CF\_UQL,QHXSX$*>QI7J\-
M$W&Q2L<SV%%QG"P622P&>3+^M-NW[R8P]-YTDX.7XG_^]G]_^^7OO[WZ?X]V
M/=W58A2F]5HR%8-9D,)OX5\VKWV#16YS/2=!'M)J.EFV"N(Q?/$V'*6K(+TU
M"U$Z@]07X,BIIP7^'H^74A,>PYJ_PY&2'T;Q)*3!HWB;"QKD:1@LYE$,6WD:
M!O-\)@;)?)5'20R_ZL3C@Z8(Q$DX#VZ 9<4X29=)&N#78B^?A<+L*W#R,HAO
M[1UMBEF8AJ-;D&TI+"6"F>6S(&_"-%)QE203$<03<1W,5\%HCH/'630)>7A0
MKG#\-!R'$= &'\Q6TVDTCL)X?(M'YV86C6<"9R7?$HP_Q<G-/)Q<A1.'0FLN
M[Z;XGTY\'69YDJI#UQ3\XJLH X$<3NJU63*':=%KX+TP]RC/! RQB/(\A$5D
M&6Q8YA/DE'[ETB/*!.QBE,,DF[">T1_A.!=Y0F^$ERTRD84YD@?V813.DYLF
M?KN4-U.]-DV3!3TLJ0V;D]/?[<^PH@@NKXLT@K.U%V1B$DYA6R<\3@.?BD44
MBW ZA9?2#V$ D0-_X))R8AS85OAW,(6YT+#.86V*T2H7<0(BF9\X/'SYXC>Q
M/%@ DR#+?4S23S10$P?B:2TCR2X\0G%B32,LQ)[^9T-,5_/YK5@&T01>&0.-
MPRPC-LF4\*S7;.GIT#.8X.E9 *UA=\0R3:Z!L2:T@U&!<^5%(Z6RO6$'L(!Q
MN*1!$OA1>H,D5O/GT8!109V(<CBU_X8/>1<C7#YLMAHZKU OQ%X4C^>K211?
MT6[(Y[/J'T2P(_ :W,C/\'5\!41EUJ:[)07&7<Z#<4AK9XYM\EP*"W99$\@Z
MGXM9<!W2SBW"((99V0P)[WQ]^68 ),;]//SE]<^7;P[$T%YGA"S$MP(.8B]G
M6;Y^=ROHLE"_LN>GU@VC($<21:W)/#UXNA<T]J(H:N"L!+T_ $9%R1/ Q.'!
M51KE*((T75M7:4AT:HI)P <9?Z@O,6WPNG,<K$;9. 6AI+C:I2,*(A!6 :SQ
MRCZJ<&C@8_P@D@*G(#'4S%)WZ6D(>YLB;Y&@*&/AM<MS.!H.38%;5YDY&SA)
M..(E[.XQ"'T<T44!A ."C'B&V0JDLG4*PC+:@^6L9G?P ]VF/YQZX"_E_^SO
MB[=1.)^\%!?!5?@*?OBO54BZWZ'8WY=1K-<GG??J];R2_5&2YPE<O;^@239*
M4K@9]6='(*\^B<.#%[#(+)E'$WCOD+RDQ^VSLXO6";I)_O'3DY_H[\%%ZUC]
M+=\AQQLG\SD8=C 7]:]7XB::Y#-<S9/_+%O>L*_&N$8591S,%7GS9.G2>QY.
MZ1<GCE;A&&_.ZPPW#$\PGM?'_\%5P7^!/B6D&H$J]FE_%(*TA1DNB;Z2?# ;
MHMWCH,S]J6#QU<_(6,Q+C_OL_'#"X/! +NGRC1- DV[7 [QYO>5N<\F'!T]?
M_' [=+#E)8$6!$NX?',>HG(8C4FC4<8!*VR#,K,#KWVPOR;R0I>FCM%.FR O
M\ED"^O\\ K.'333ZO?G;U17K-:TI[H6-1M-5B!?!+>C_H,/RS":H-N%H;#1]
MD7$"VL8-6&KT _CW,DASU,;JM;VH =K*/ )!=JM6+94RI$X@)BNP-& JXQ5J
M@3<IFG4Q:D%@2C65%H.F(\PK#\8SJ2VAG9&A%JH2$EJD>WJJF2(^^K%P0%=;
ME(HR+_MO:88?@XTXEZ2#5R@2N?3#_0)UMT&QY65P2^I^R=IB5$17\!W<T\$<
MGF"S.E@NYR#3T9SR+,?%:IY'\*79DIC\5CB::RCAXN&-;(;GGA4P"M&D,=OK
M$:5U!>K?%3F0W/>[.G\LP$J?X41N(K#SE9V#<XD6BW 2P0BP=<%U$,UI,=-5
M/*%9X<+'8UKY)$3SG!1\9!'41&%J<G%:.0>FP7 Z?(S[/KV-7.W=_BE:%G<N
MV#94 G$,RYB# 6NH;1O"CF%5KQWN3<B* ?.SF\"7G_:3- +Y ONG?\Z\)'7R
M$;HK_K4"$DV:,/U4?HS3!B+!/Y&5KL"F@?F$\&IX@M1[D=\N0R2F^0Z^@O4'
M:?1O.M(-,N5P(/_-SCNU@2U)8\AF&0UQ K(B&$7S*-?'4!YW] ?-$I@YV<%H
M[^^73'QB,8N<1>%]H$)E20R\@.(%N/@Z)': V5Z%\0JHC0:K[=U14^")HN5C
MK0Q_*B4'O47M0[VF=QYE$OX>3RIY5I#U])E%,0$L&:;H24#Y@@O"LZOED10
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M3@C0.PRO@>'XK-'6D/CPYFDD10;CUFNV.D//V[,49I)2C0(Y9U2AZZA$='(
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MCYX;WUW U\Q=I@.\=1%\8G$AJT<S->'K4,;U)ZYMJZXBODGYWEF3WS1N.(9
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M&Y8,+%Q7=3?,!4,[V[FJVL5(H2/'8S@)V=^+VC=5+A %E$6N,!?0F[*:!VY
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M@%0WU,LL='(F'$7_-=VT/>H3K@*6QJEXE4)*S>DZ2N:!:0E9ND\^:HTRRD%
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M'#X;:H8*(3G3UGN!"5*0:'*76N)[]5;L$)&48WWU,>P-MIR6Z?&%I-.=J'G
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M-CF".%W%$WC)-,1B,/Z+ ,V#.,!PA\RGP&FP28MS(/1>#VE#<&(N3L\#GIN
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ML%-TJE-G=$5I;H.:6'+4*L6WVX.Q>'T(6MGC!&9G[^<V9_\_KSMO!C V-4Z
MXXX<^Y; &++7/W?>_+]ONRY75[[#(WZX\XAOUR-^N/.(/WJ/^)/O;G0^V;:
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M[:]]-'X^ZIU\)"%P.CP_>_/_ 5!+ P04    " "]B$=8ZEHLK6<3  #'8P
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M234WW;$3>)-LB/7+5 ??"V:'AH>I1IWKJ[.HE1]X@@\1WP/![6!0= 2UKI4
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M;I ]/:EB0:"UL=#@HT+ET@'+A[,P[9 =H><HZ9)BJ^\)2@'0EZ>+F3?FHB#
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M4P?S1-!#RM<QLH/4V#P.!P.@FYA.*/IC6]D21Q3-'=M]BNR2J%" 0%-H;[M
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MM_BJF+F].-#221<#=@<CE YFR[10QY+$7(U6;IL(&&F;$J%=U/6'3MO1+59
MC(>*P4QKM'I2N>-" @N_I%*Z.+0(CT HHOM\X7;(0B?*T&\7W"#C1UK(_8>9
MZQMSU\PU!>A_3/G:Z)=S;;O+$Z;?5Z>PK=/E0B%6&NNJVS7[+EQS/Y6JH)@W
MN^#9QF1[=;OA.3,9O$6Z2Q!O)[!;$ 5OCR VW/'K_,M-<+,P+=38UNF&;T6E
MT[4<%ZB2A67O$!:_+'\10RJS4Q!+Y0R4<(V$$:W;NHX-;W,X?V*F[W*O)O!Y
MS)1XW:41%BG%RW[5>/LGV*X0!3XK@OE-V-?M'EU0=KZN!=INIJ:7OP%02P,$
M%     @ O8A'6/T< OO]"@  @(8  !4   !S=')M+3(P,C0P,C Q7VQA8BYX
M;6S-G5UOX[@5AN\+]#]PW9L6&,<3!RV0[&07&4^R,#:;9&//;-M%L: EQA%"
MDP$E)_:_+RF)LD3Q2$J*DIR+&8_X'NJE^)BDOHX__;C;4/1"1)IP=CXZ/OHX
M0H1%/$[8^GST=3&^6,SF\Q%*,\QB3#DCYR/&1S_^\.<_(?GGTW?C,;I*"(W/
MT!<>C>?L@7^/;O"&G*&?"","9UQ\C[YANE5;^%5"B4 SOGFF)".RH-CQ&?K[
MT?08H_%X0+W?"(NY^'H_K^I]S++G]&PR>7U]/6+\!;]R\90>17PSK,)%AK-M
M6M7V<?>Q_%.$?Z()>SI3?ZUP2I \7BP]VZ7)^4CMM]SMZ\D1%^O)]./'X\D_
M?[E>1(]D@\<)4\<M(B,=I6JQQ1V?GIY.\E(M;2EW*T'U/DXFVDY5LRQ-.O0U
M)VEREN;VKGF$L[S;>W>#0(7ZWUC+QFK3^'@Z/CD^VJ7Q2!_\_ @*3LD]>4!Y
M,\^R_;-$*4T4":-RVZ,@#W8S5(B)BI\PLL89B=6.3M6.CO^A=O27<O,U7A$Z
M0DHI^0#;==JHJPR:N#9[1T3"XTOV/M=FM"?[\KLCLO^A ?5XYTU8\@S3=YFO
M1SJW?4/>=\0/<>Z/M!SGR?N.="WR_V([:UM^\^&U'U>J-E[+3PV+9)?)"8S$
MVJ2JHF,$SO>03PQEW57M/&K42]5HSD6[[6IFS.M,272TYB^3F"2R[NF)^C!6
M'_)FR__\,>-R)7"Q2C.!HTS7E#?C?&0IGYB6E/)":%]81#V-*Q63B,NIZ3D;
MT^(P%N$/@F^LNRU;S2V%?]!5%5\<%KD+P&A#)DC*MR(B;^J5NEOH*)6.-E0J
MU)**L/'7Q>B'7(-^UZK_?)H<:G'0T7()M-T0EBUEC986-(M==;/-E.[E>ED0
MG6PQ9/:QEB"E<=S!%W+'L=KY%<5KBWVCW%476VWI/FX4!M')-D=F+U<:I$2^
MNOD+22.1/*OE?%<[&C+GG6XQV>K[FB8L!-K&8!)J6D\#^SU9)VIJ41;4^2U1
M&SN&,4#O>NCOM&W.!59Q$- ,<0C.%O4@5$5YXNB"L2VF]^29BRY\FC+7U-A,
MFK#4-4$Q8C$&HE%H42'V1,2O6WG&3@3=]T+14KKF K!JHF'(@J+#[@T$I)+[
M960I,$L3-8#U0M*6.C_= ,RV3CT,75"< .;@4Y)*[Y>4Q2.A5-T/P*Q_0+&)
M7=,"&S9Y:2N#(@:T!S*31Z R)!QL+E_4ZEPNDP8VMJ;W"4_+=A<_E3A8A$R'
M RG*PY"*\T12[39$#T,MI6MZ *LF-X8L*&+LWD!6"CG*]?XAN63Q($0JG1]
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MF?KH;$A(3Z#[H&P3]="\LNTG+H8A)[-RG$<2(,\.!M!2-UA$WU,=*[9P7"K
M'BB!?+NH?$N\U8QY>^P\T!ES\;I0W.F7NHWA<<%3! B^ASE2!-TB]<"5$!GA
M#W0A507X0R60]QM,WF7>D##_G1%EJ.)K".D3,1#V;YBP/0Z1>#\J(C1S?"#
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M:J0  !]?!  *              "  0    !E>#$P+3$N:'1M4$L! A0#%
M  @ O8A'6&)VJA] +0  [1 !  H              ( !DJ0  &5X,3 M,BYH
M=&U02P$"% ,4    " "]B$=8BDZ"3[<D   05P$ "@              @ 'Z
MT0  97@Q,"TS+FAT;5!+ 0(4 Q0    ( +V(1UC?JFID9$T  (C( 0 )
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H;2TR,#(T,#(P,5]P<F4N>&UL4$L%!@     )  D %0(  /*. 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="strm-20240201.xsd" xlink:type="simple"/>
    <context id="AsOf2024-02-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001008586</identifier>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-01</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-02-01" id="ixv-598">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-02-01" id="ixv-599">0001008586</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-02-01" id="xdx2ixbrl0012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentType contextRef="AsOf2024-02-01" id="ixv-620">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-02-01" id="ixv-621">2024-02-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-02-01" id="ixv-622">Streamline Health Solutions, Inc.</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2024-02-01" id="ixv-623">0-28132</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-02-01" id="ixv-624">31-1455414</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-02-01" id="ixv-625">2400     Old Milton Pkwy.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2024-02-01" id="ixv-626">Box     1353</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-02-01" id="ixv-627">Alpharetta</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-02-01" id="ixv-628">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-02-01" id="ixv-629">30009</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-02-01" id="ixv-630">(888)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-02-01" id="ixv-631">997-8732</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-02-01" id="ixv-632">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-02-01" id="ixv-633">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-02-01" id="ixv-634">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-02-01" id="ixv-635">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2024-02-01" id="ixv-636">Common     Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2024-02-01" id="ixv-637">STRM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2024-02-01" id="ixv-638">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-02-01" id="ixv-639">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
